id,cell_type,ctrl_ids,curator,drug_name,drugbank_id,geo_id,organism,pert_ids,platform,pubchem_cid,smiles,version
drug:3639,Bone marrow Sca+ SP hematopoeitic stem cells (HSC) - 10 Day,GSM26734|GSM26735,cadimo,Fluorouracil,DB00544,GSE1559,mouse,GSM26744|GSM26745,GPL81,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:3499,vastus lateralis muscle,GSM801199|GSM801201|GSM801202|GSM801204|GSM801206|GSM801208|GSM801211|GSM801212|GSM801214|GSM801216,MicrotaskManic,Resveratrol,DB02709,GSE32357,human,GSM801198|GSM801200|GSM801203|GSM801205|GSM801207|GSM801209|GSM801210|GSM801213|GSM801215|GSM801217,GPL11532,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3292,lymphoblastoid cells,GSM162898|GSM162900|GSM162903,garibr01,Citalopram,DB00215,GSE7036,human,GSM162897|GSM162899|GSM162901,GPL570,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,1.0
drug:3638,Bone marrow Sca+ SP hematopoeitic stem cells (HSC) - 6 Day,GSM26734|GSM26735,cadimo,Fluorouracil,DB00544,GSE1559,mouse,GSM26742|GSM26743,GPL81,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:3475,liver,GSM1273512|GSM1273513|GSM1273514|GSM1273515,MicrotaskManic,Ethanol,DB00898,GSE52644,mouse,GSM1273500|GSM1273501|GSM1273502|GSM1273503,GPL1261,702.0,CCO,1.0
drug:3498,PBMC (peripheral blood mononuclear cells),GSM906497|GSM906498|GSM906499|GSM906500|GSM906501|GSM906502,MicrotaskManic,Resveratrol,DB02709,GSE36930,human,GSM906515|GSM906516|GSM906517|GSM906518|GSM906519|GSM906520,GPL6244,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3637,Bone marrow Sca+ SP hematopoeitic stem cells (HSC) - 3 Day,GSM26734|GSM26735,cadimo,Fluorouracil,DB00544,GSE1559,mouse,GSM26740|GSM26741,GPL81,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:3497,peripheral blood mononuclear cells (PBMCs),GSM906491|GSM906492|GSM906493|GSM906494|GSM906495|GSM906496,MicrotaskManic,Resveratrol,DB02709,GSE36930,human,GSM906509|GSM906510|GSM906511|GSM906512|GSM906513|GSM906514,GPL6244,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3357,LUNGS of C57BL/6 males (on AIN-76A Diet) - Added to food - 10ppb,GSM279232|GSM279235|GSM279264|GSM279270|GSM279275,cadimo,Sodium arsenite,,GSE11056,mouse,GSM279230|GSM279249|GSM279258|GSM279265|GSM279273,GPL1261,443495.0,[O-][As]=O.[Na+],1.0
drug:3510,mouse embryonic fibroblast cells (MEF cells),GSM817298|GSM817299,MicrotaskManic,Vitamin c,DB00126,GSE32994,mouse,GSM817296|GSM817297,GPL6246,,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O,1.0
drug:3511,mouse embryonic fibroblast cells (MEF cells),GSM817302|GSM817303,MicrotaskManic,Vitamin c,DB00126,GSE32994,mouse,GSM817300|GSM817301,GPL6246,,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O,1.0
drug:3516,liver,GSM326974|GSM326976|GSM326978|GSM326980|GSM326982,MicrotaskManic,Perfluorooctanoic acid,,GSE13044,mouse,GSM326983|GSM326985|GSM326987|GSM326989|GSM326991,GPL1261,9554.0,C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,1.0
drug:3517,liver,GSM326974|GSM326976|GSM326978|GSM326980|GSM326982,MicrotaskManic,Perfluorooctanoic acid,,GSE13044,mouse,GSM326993|GSM326995|GSM326997|GSM326999|GSM327001,GPL1261,9554.0,C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,1.0
drug:3550,Nasal EPITHELIA exposed to 6 ppm - Inhalation - 19 Days,GSM159799|GSM159800|GSM159801|GSM159812,cadimo,Formaldehyde,,GSE7002,rat,GSM159741|GSM159742|GSM159743|GSM159755,GPL1355,712.0,C=O,1.0
drug:3634,cranial neural crest - 48 Hours,GSM27271|GSM27272|GSM27273|GSM27274,cadimo,Tretinoin,DB00755,GSE1588,mouse,GSM27275|GSM27276|GSM27277,GPL81,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3515,aorta,GSM478610|GSM478611,MicrotaskManic,Vitamin e,DB00163,GSE42813,mouse,GSM1050380|GSM1050381,GPL1261,14985.0,CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O,1.0
drug:3474,PC-3 cells,GSM1286084|GSM1286089,MicrotaskManic,Gefitinib,DB00317,GSE53180,human,GSM1286087|GSM1286092,GPL4133,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,1.0
drug:3668,Skeletal muscle - 8 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5215|GSM5216|GSM5217,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3669,Skeletal muscle - 12 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5072|GSM5073|GSM5074,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:2671,hippocampus,GSM53447|GSM53448|GSM53449|GSM53450|GSM53451|GSM53452|GSM53453,candicek,Levetiracetam,,GSE2880,rat,GSM53433|GSM53434|GSM53435|GSM53436|GSM53437|GSM53438|GSM53439,GPL1355,5284583.0,CCC(C(=O)N)N1CCCC1=O,1.0
drug:2672,left sciatic nerve,GSM286159|GSM286160|GSM286163|GSM286165,AliDot,Rosiglitazone,,GSE11343,mouse,GSM286431|GSM286432|GSM286433|GSM286434|GSM286436,GPL1261,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,1.0
drug:2673,liver   b,GSM89873|GSM89875|GSM89878|GSM89881,Axel,Alitretinoin,DB00523,GSE3952,rat,GSM89858|GSM89861|GSM89864|GSM89867,GPL85,,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C,1.0
drug:3233,NB4 APL 9 acute promyelocytic leukemia cells - 72 Hours,GSM594067|GSM594068|GSM594069,cadimo,Tretinoin,DB00755,GSE23702,human,GSM594079|GSM594080|GSM594081,GPL6244,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3232,NB4 APL 9 acute promyelocytic leukemia cells -  (TG2-knockdown) 72 Hours,GSM594070|GSM594071|GSM594072,cadimo,Tretinoin,DB00755,GSE23702,human,GSM594082|GSM594083|GSM594084,GPL6244,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3231,NB4 APL 9 - acute promyelocytic leukemia cells - (TG2-knockdown) 48 Hours,GSM594070|GSM594071|GSM594072,cadimo,Tretinoin,DB00755,GSE23702,human,GSM594076|GSM594077|GSM594078,GPL6244,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3230,Mesentery - BALB/DBA F1 hybrid mice - Day 3,GSM432913|GSM432914|GSM432915,cadimo,Pristane,,GSE17297,mouse,GSM432910|GSM432911|GSM432912,GPL1261,15979.0,CC(C)CCCC(C)CCCC(C)CCCC(C)C,1.0
drug:3237,MCF-7 breast cancer cells,GSM797427|GSM797430,cadimo,Tretinoin,DB00755,GSE32161,human,GSM797428|GSM797431,GPL570,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3198,AEC (primary airway epithelial cells) -  6 Hours with 0.4mM,GSM245430|GSM245432|GSM245440|GSM245452,cadimo,Hypochlorous acid,,GSE11630,human,GSM245427|GSM245437|GSM245449|GSM245457,GPL571,24341.0,OCl,1.0
drug:3235,Culture from neonates ovaries,GSM585549|GSM585550|GSM585551,cadimo,Methoxychlor,,GSE23725,mouse,GSM585555|GSM585556|GSM585557,GPL1261,4115.0,COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)C(Cl)(Cl)Cl,1.0
drug:3234,Culture from ovaries neonates,GSM585549|GSM585550|GSM585551,cadimo,4-vinylcyclohexene diepoxide,,GSE23725,mouse,GSM585552|GSM585553|GSM585554,GPL1261,7833.0,C1CC2C(O2)CC1C3CO3,1.0
drug:3665,Skeletal muscle - 5.5 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5191|GSM5192|GSM5193,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3239,MCF7 breast cancer cells - 100nM,GSM645710|GSM645711|GSM645718|GSM645719,cadimo,4-hydroxytamoxifen,,GSE26298,human,GSM645712|GSM645713,GPL570,449459.0,CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,1.0
drug:3199,AEC (primary airway epithelial cells) -  2 Hours with 1mM,GSM245436|GSM245444|GSM245448|GSM245456,cadimo,Hypochlorous acid,,GSE11630,human,GSM245434|GSM245442|GSM245446|GSM245454,GPL571,24341.0,OCl,1.0
drug:3592,Gallbladders (from leptin-deficient obese females following daily treatment with 5 ug/g recombinant leptin for 4 weeks),GSM74081|GSM74083|GSM74171|GSM74189,cadimo,Leptin,DB05098,GSE3293,mouse,GSM74190|GSM74191|GSM74192|GSM74194,GPL1261,,,1.0
drug:3304,No Data,GSM1217777|GSM1217782|GSM1217785,gswaminath,Morphine,DB00295,GSE50382,mouse,GSM1217776|GSM1217778|GSM1217779|GSM1217780|GSM1217781|GSM1217783|GSM1217784|GSM1217786|GSM1217787|GSM1217788|GSM1217789|GSM1217790,GPL6246,5288826.0,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,1.0
drug:3302,No Data,GSM365306|GSM365308|GSM365310|GSM365312|GSM365314,gswaminath,Mycophenolic acid,DB01024,GSE14630,human,GSM365307|GSM365309|GSM365311|GSM365313|GSM365315,GPL96,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)O)OC,1.0
drug:3301,No Data,GSM929282|GSM929283|GSM929284|GSM929288|GSM929289|GSM929290,gswaminath,Acetaminophen,DB00316,GSE37874,mouse,GSM929285|GSM929286|GSM929287|GSM929291|GSM929292|GSM929293,GPL8321,1983.0,CC(=O)NC1=CC=C(C=C1)O,1.0
drug:3300,No Data,GSM1195853|GSM1195856|GSM1195857|GSM1195862|GSM1195865,gswaminath,Abiraterone,DB05812,GSE49244,human,GSM1195851|GSM1195852|GSM1195854|GSM1195855|GSM1195858|GSM1195859|GSM1195860|GSM1195861|GSM1195863|GSM1195864|GSM1195866|GSM1195867,GPL6244,,O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC=C2c2cccnc2)C)C1)C,1.0
drug:3309,Liver (129S1/SvImJ strain) - 24 hours after treatment,GSM597130|GSM597144|GSM597168,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597077|GSM597095|GSM597113,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3160,OVCAR-8 ovarian carcinoma cell line,GSM1160828|GSM1160829|GSM1160830,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160831|GSM1160832|GSM1160833,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3494,muscle,GSM1009750|GSM1009754|GSM1009758|GSM1009762|GSM1009766|GSM1009770|GSM1009774|GSM1009780|GSM1009786|GSM1009790|GSM1009794|GSM1009798|GSM1009802|GSM1009808|GSM1009814|GSM1009818|GSM1009822|GSM1009826|GSM1009830|GSM1009834|GSM1009838|GSM1009842|GSM1009846|GSM1009850|GSM1009852|GSM1009856|GSM1009860|GSM1009864|GSM1009868|GSM1009870|GSM1009876|GSM1009880|GSM1009884|GSM1009888,MicrotaskManic,Resveratrol,DB02709,GSE41168,human,GSM1009763|GSM1009793|GSM1009815|GSM1009823|GSM1009831|GSM1009839|GSM1009847|GSM1009857|GSM1009889,GPL570,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3493,Striatum - SWR/J mice - Chronic morphine treatment,GSM187992|GSM187993|GSM187994,cadimo,Morphine,DB00295,GSE7762,mouse,GSM187998|GSM187999|GSM188000,GPL1261,5288826.0,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,1.0
drug:3492,Striatum - DBA/2J mice - Chronic morphine treatment,GSM187983|GSM187984|GSM187985,cadimo,Morphine,DB00295,GSE7762,mouse,GSM187989|GSM187990|GSM187991,GPL1261,5288826.0,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,1.0
drug:3490,Striatum - 129P3/J mice - Chronic morphine treatment,GSM187965|GSM187966|GSM187967,cadimo,Morphine,DB00295,GSE7762,mouse,GSM187971|GSM187972|GSM187973,GPL1261,5288826.0,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,1.0
drug:2786,NA,GSM75876|GSM75877|GSM75878,Axel,Metoprolol,DB00264,GSE3356,human,GSM75879|GSM75880|GSM75881,GPL96,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,1.0
drug:2787,NA,GSM396141|GSM396145|GSM396161|GSM396197|GSM396205|GSM396225,Axel,Morphine,DB00295,GSE15774,mouse,GSM396131|GSM396157|GSM396173,GPL6105,5288826.0,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,1.0
drug:2542,H1299,GSM720489|GSM720490,MicrotaskManic,Azacitidine,DB00928,GSE29077,human,GSM720491|GSM720492,GPL571,9444.0,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,1.0
drug:2543,HT29,GSM288491|GSM288497|GSM288499,alanstern,Methotrexate,DB00563,GSE11440,human,GSM288501|GSM288502|GSM288536,GPL570,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,1.0
drug:2540,A549,GSM720475|GSM720476,MicrotaskManic,Decitabine,DB01262,GSE29077,human,GSM720487|GSM720488,GPL571,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:2546,H1299,GSM720489|GSM720490,MicrotaskManic,Decitabine,DB01262,GSE29077,human,GSM720497|GSM720498,GPL571,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:2547,H1299,GSM720489|GSM720490,MicrotaskManic,Decitabine,DB01262,GSE29077,human,GSM720499|GSM720500,GPL571,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:2544,H1299,GSM720489|GSM720490,MicrotaskManic,Azacitidine,DB00928,GSE29077,human,GSM720493|GSM720494,GPL571,9444.0,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,1.0
drug:2545,H1299,GSM720489|GSM720490,MicrotaskManic,Azacitidine,DB00928,GSE29077,human,GSM720495|GSM720496,GPL571,9444.0,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,1.0
drug:3545,Nasal EPITHELIA exposed to 2 ppm - Inhalation - 19 Days,GSM159799|GSM159800|GSM159801|GSM159812,cadimo,Formaldehyde,,GSE7002,rat,GSM159773|GSM159774|GSM159775|GSM159776,GPL1355,712.0,C=O,1.0
drug:3544,Nasal EPITHELIA exposed to 2 ppm - Inhalation - 8 Days,GSM159779|GSM159780|GSM159781|GSM159782|GSM159783,cadimo,Formaldehyde,,GSE7002,rat,GSM159748|GSM159749|GSM159750|GSM159761,GPL1355,712.0,C=O,1.0
drug:2548,H1299,GSM720489|GSM720490,MicrotaskManic,Decitabine,DB01262,GSE29077,human,GSM720501|GSM720502,GPL571,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:3546,Nasal EPITHELIA exposed to 6 ppm - Inhalation - 6 Hours,GSM159785|GSM159786|GSM159787|GSM159788|GSM159789|GSM159796|GSM159797|GSM159798,cadimo,Formaldehyde,,GSE7002,rat,GSM159729|GSM159738|GSM159739|GSM159740,GPL1355,712.0,C=O,1.0
drug:3541,Nasal EPITHELIA exposed to 2 ppm - Inhalation - 6 Hours,GSM159785|GSM159786|GSM159787|GSM159788|GSM159789|GSM159796|GSM159797|GSM159798,cadimo,Formaldehyde,,GSE7002,rat,GSM159757|GSM159758|GSM159759|GSM159760,GPL1355,712.0,C=O,1.0
drug:3540,Nasal EPITHELIA exposed to 0.7ppm - Inhalation - 19 Days,GSM159799|GSM159800|GSM159801|GSM159812,cadimo,Formaldehyde,,GSE7002,rat,GSM159813|GSM159814|GSM159815|GSM159816,GPL1355,712.0,C=O,1.0
drug:3543,Nasal EPITHELIA exposed to 2 ppm - Inhalation - 5 Days,GSM159792|GSM159793|GSM159794|GSM159795,cadimo,Formaldehyde,,GSE7002,rat,GSM159756|GSM159766|GSM159767|GSM159768|GSM159769,GPL1355,712.0,C=O,1.0
drug:3542,Nasal EPITHELIA exposed to 2 ppm - Inhalation - 24 Hours,GSM159802|GSM159803|GSM159804|GSM159805,cadimo,Formaldehyde,,GSE7002,rat,GSM159762|GSM159763|GSM159764|GSM159765,GPL1355,712.0,C=O,1.0
drug:2763,NA,GSM577857|GSM577859|GSM577861|GSM577863,Axel,Imatinib,DB00619,GSE23743,human,GSM577858|GSM577860|GSM577862|GSM577913,GPL571,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2723,NA,GSM11709|GSM11720,Axel,Doxorubicin,DB00997,GSE763,human,GSM11687|GSM11693,GPL550,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3069,HT29 colon adenocarcinoma cells (6 Hours following treatment with 10nM),GSM60133|GSM60134,cadimo,Apratoxin a,,GSE2742,human,GSM60137|GSM60138,GPL96,6326668.0,CCC(C)C1C(=O)N2CCCC2C(=O)OC(CC(CC(C(C3=NC(CS3)C=C(C(=O)NC(C(=O)N(C(C(=O)N1C)C)C)CC4=CC=C(C=C4)OC)C)C)O)C)C(C)(C)C,1.0
drug:3324,Liver ( c57BL/6J strain) - 24 hours after treatment,GSM597102|GSM597119,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597135|GSM597151|GSM597163,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3609,Thymus (of ovariectomized C57BL/6) - 6 Days,GSM63205|GSM63206,cadimo,Estradiol,DB00783,GSE2889,mouse,GSM63218|GSM63220,GPL339,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2721,NA,GSM11707|GSM11716,Axel,Doxorubicin,DB00997,GSE763,human,GSM11694|GSM11695,GPL550,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:2485,CD4+,GSM788303|GSM788304|GSM788305|GSM788306|GSM788307|GSM788308|GSM788309|GSM788310,vcogliani,Hydroxyzine,DB00557,GSE31773,human,GSM788311|GSM788312|GSM788313|GSM788314|GSM788315|GSM788316|GSM788317|GSM788318,GPL570,3658.0,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,1.0
drug:2481,uninfected hepatoma Huh7.5.1 cells,GSM568463|GSM568464|GSM568465,timkenny92,Ribavirin,DB00811,GSE23031,human,GSM568466|GSM568467|GSM568468,GPL570,37542.0,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,1.0
drug:3059,MCF-7 BREAST CANCER cell line,GSM213330|GSM213331|GSM213332|GSM213333,cadimo,Cycloheximide,,GSE8597,human,GSM213322|GSM213323|GSM213324|GSM213325,GPL570,6197.0,CC1CC(C(=O)C(C1)C(CC2CC(=O)NC(=O)C2)O)C,1.0
drug:3587,Lymphoblastoid cell line (Bleomycin-insensitive),GSM81940|GSM81942|GSM81948|GSM81950|GSM81954|GSM81956|GSM81958,cadimo,Bleomycin,DB00290,GSE3598,human,GSM81941|GSM81943|GSM81949|GSM81951|GSM81955|GSM81957|GSM81959,GPL2902,5360373.0,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1.0
drug:3058,HL60 promyelocytic leukemia cell line,GSM697692|GSM697693,maroulisv,Diclofenac,DB00586,GSE28185,human,GSM697696|GSM697697,GPL571,3033.0,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,1.0
drug:2591,plaque on epidermis,GSM1155752|GSM1155757|GSM1155763|GSM1155769|GSM1155775|GSM1155780,MicrotaskManic,Etanercept,DB00005,GSE47751,human,GSM1155753|GSM1155758|GSM1155764|GSM1155770|GSM1155776|GSM1155781,GPL570,,,1.0
drug:3662,Skeletal muscle - 2 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5183|GSM5184|GSM5185,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:2590,subcutaneous fat tissues of type 2 Lepr(db/db) mice,GSM99687|GSM99688|GSM99689|GSM99690,nbongio,Chromium(iii) nicotinate,,GSE4420,mouse,GSM99691|GSM99692|GSM99693|GSM99694,GPL1261,56843898.0,C1=CC(=CN=C1)C(=O)[O-].C1=CC(=CN=C1)C(=O)[O-].C1=CC(=CN=C1)C(=O)[O-].[Cr+3],1.0
drug:3603,macrophages -  100 ng/ml LPS for 18 hours,GSM35899|GSM35900|GSM35901,cadimo,Lipopolysaccharide,,GSE2002,mouse,GSM35902|GSM35903|GSM35904,GPL339,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:2593,plaque on epidermis,GSM1155752|GSM1155757|GSM1155763|GSM1155769|GSM1155775|GSM1155780,MicrotaskManic,Etanercept,DB00005,GSE47751,human,GSM1155755|GSM1155760|GSM1155766|GSM1155772|GSM1155777|GSM1155783,GPL570,,,1.0
drug:3055,SLM2 melanoma cells,GSM957759|GSM957763,maroulisv,Sorafenib,DB00398,GSE39192,human,GSM957760|GSM957764,GPL6947,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,1.0
drug:3454,heart,GSM378051|GSM378052|GSM378053,MicrotaskManic,Coenzyme q10,,GSE15129,mouse,GSM378054|GSM378055|GSM378056,GPL1261,5281915.0,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3068,HT29 colon adenocarcinoma cells (6 Hours following treatment with 2nM),GSM60133|GSM60134,cadimo,Apratoxin a,,GSE2742,human,GSM60135|GSM60136,GPL96,6326668.0,CCC(C)C1C(=O)N2CCCC2C(=O)OC(CC(CC(C(C3=NC(CS3)C=C(C(=O)NC(C(=O)N(C(C(=O)N1C)C)C)CC4=CC=C(C=C4)OC)C)C)O)C)C(C)(C)C,1.0
drug:3681,epithelial lung cells,GSM980285|GSM980286|GSM980287,MicrotaskManic,"2,3-dimethoxy-1,4-naphtoquinone (dmnq)",,GSE39843,human,GSM980288|GSM980289|GSM980290,GPL570,3136.0,COC1=C(C(=O)C2=CC=CC=C2C1=O)OC,1.0
drug:3054,MCF7 breast adenocarcinoma cells - 24 Hours,GSM212654|GSM212661|GSM297803,cadimo,Argyrin a,,GSE8565,human,GSM212659|GSM297802|GSM297806,GPL570,24978550.0,CCC1C2=NC(=CS2)C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(=C)C(=O)N(CC(=O)N1)C)C)CC3=CNC4=C3C(=CC=C4)OC)CC5=CNC6=CC=CC=C65,1.0
drug:3252,SKBR3 parental and resistant (SKBR3-R) cell lines,GSM940879|GSM940880|GSM940881,Pascal,Lapatinib,DB01259,GSE38376,human,GSM940888|GSM940889|GSM940890,GPL6947,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1.0
drug:3682,epithelial lung cells,GSM980291|GSM980292|GSM980293,MicrotaskManic,"2,3-dimethoxy-1,4-naphtoquinone (dmnq)",,GSE39843,human,GSM980294|GSM980295|GSM980296,GPL570,3136.0,COC1=C(C(=O)C2=CC=CC=C2C1=O)OC,1.0
drug:3470,cerebellum,GSM1521847|GSM1521848|GSM1521849,MicrotaskManic,Nicotinamide riboside,,GSE62194,mouse,GSM1521844|GSM1521845|GSM1521846,GPL6885,439924.0,C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)N,1.0
drug:3053,liver,GSM1311186|GSM1311188|GSM1311190|GSM1311192|GSM1311194,maroulisv,Diclofenac,DB00586,GSE54255,human,GSM1311187|GSM1311189|GSM1311191|GSM1311193|GSM1311195,GPL13158,3033.0,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,1.0
drug:3407,U937 monoctyes exposed to oxidative stress - 4 Hours,GSM276211|GSM276219|GSM276227,cadimo,Curcumin,,GSE10896,human,GSM276212|GSM276220|GSM276228,GPL570,969516.0,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,1.0
drug:3588,Lymphoblastoid cell line (Bleomycin-sensitive),GSM81933|GSM81935|GSM81938|GSM81944|GSM81946|GSM81952|GSM81960,cadimo,Bleomycin,DB00290,GSE3598,human,GSM81934|GSM81936|GSM81937|GSM81939|GSM81945|GSM81947|GSM81953,GPL2902,5360373.0,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1.0
drug:3686,Uterus - 6 Hours,GSM3053|GSM3058,cadimo,Progesterone,DB00396,GSE6440,mouse,GSM3056|GSM3059,GPL81,5994.0,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,1.0
drug:3158,C13 ovarian carcinoma cell line,GSM1160816|GSM1160817|GSM1160818,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160819|GSM1160820|GSM1160821,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3663,Skeletal muscle - 4 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5200|GSM5201|GSM5202,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3133,CAL27 squamous cell carcinoma (HNSCC) cell line - (15nM for 13 hours),GSM1506255|GSM1506256|GSM1506257,cadimo,Cetuximab,DB00002,GSE61495,human,GSM1506252|GSM1506253|GSM1506254,GPL10558,,,1.0
drug:3504,gastrocnemius muscle,GSM284992|GSM284993|GSM284994|GSM284995|GSM284996,MicrotaskManic,Resveratrol,DB02709,GSE11291,mouse,GSM285002|GSM285003|GSM285004|GSM285005|GSM285006,GPL1261,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3159,IGROV-1 ovarian carcinoma cell line,GSM1160822|GSM1160823|GSM1160824,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160825|GSM1160826|GSM1160827,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3604,Thymus (of ovariectomized C57BL/6) - 2 Days,GSM63205|GSM63206,cadimo,Genistein,,GSE2889,mouse,GSM63207|GSM63208,GPL339,5280961.0,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,1.0
drug:2658,Ishikawa endometrial cells - 24 Hours 100pM,GSM439991|GSM439992|GSM439993|GSM439994,cadimo,Bisphenol a,,GSE17624,human,GSM440015|GSM440016|GSM440017|GSM440018,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3605,Thymus (of ovariectomized C57BL/6) - 3 Days,GSM63205|GSM63206,cadimo,Genistein,,GSE2889,mouse,GSM63210|GSM63211,GPL339,5280961.0,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,1.0
drug:2541,PBMC,GSM580950|GSM580952|GSM580954|GSM580956|GSM580958|GSM580960|GSM580962|GSM580964|GSM580966|GSM580968|GSM580970,alanstern,Methotrexate,DB00563,GSE23687,human,GSM580951|GSM580953|GSM580955|GSM580957|GSM580959|GSM580961|GSM580963|GSM580965|GSM580967|GSM580969|GSM580971,GPL570,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,1.0
drug:2659,Ishikawa endometrial cells - 24 Hours 1uM,GSM439991|GSM439992|GSM439993|GSM439994,cadimo,Bisphenol a,,GSE17624,human,GSM440027|GSM440028|GSM440029|GSM440030,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3224,AGS gastric adenocarcinoma cells (NET1 knockdown - 63shRNA),GSM646071|GSM646072,cadimo,Lysophosphatidic acid,,GSE26309,human,GSM646065|GSM646066,GPL571,3988.0,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O,1.0
drug:3225,AGS gastric adenocarcinoma cells (NET1 knockdown - 65shRNA),GSM646073|GSM646074,cadimo,Lysophosphatidic acid,,GSE26309,human,GSM646067|GSM646068,GPL571,3988.0,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O,1.0
drug:3226,Mesentery - BALB/c mice - Day 3,GSM432894|GSM432895|GSM432896|GSM432897|GSM432907|GSM432908|GSM432909,cadimo,Pristane,,GSE17297,mouse,GSM432904|GSM432905|GSM432906,GPL1261,15979.0,CC(C)CCCC(C)CCCC(C)CCCC(C)C,1.0
drug:3227,Mesentery - BALB/c mice - Day 18,GSM432894|GSM432895|GSM432896|GSM432897|GSM432907|GSM432908|GSM432909,cadimo,Pristane,,GSE17297,mouse,GSM432890|GSM432891|GSM432892|GSM432893,GPL1261,15979.0,CC(C)CCCC(C)CCCC(C)CCCC(C)C,1.0
drug:3220,AML FAB class M4 - acute myeloid leukemia lymphoblasts,GSM766235|GSM766237|GSM766247,cadimo,Adenosine triphosphate,,GSE30903,human,GSM766236|GSM766238|GSM766248,GPL570,5957.0,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,1.0
drug:3222,Primary chronic lymphocytic leukemia cell - 2 uM for 24 Hours,GSM506907|GSM506909|GSM506911|GSM506913|GSM506915|GSM506917|GSM506919|GSM506921|GSM506923|GSM506925|GSM506927|GSM506929|GSM506931,cadimo,Lmp-420,,GSE20211,human,GSM506908|GSM506910|GSM506912|GSM506914|GSM506916|GSM506918|GSM506920|GSM506922|GSM506924|GSM506926|GSM506928|GSM506930|GSM506932,GPL570,497668.0,B(CCCCCN1C=NC2=C1N=C(N=C2Cl)N)(O)O,1.0
drug:3228,Mesentery - DBA mice - Day 3,GSM432901|GSM432902|GSM432903|GSM432919|GSM432920|GSM432921,cadimo,Pristane,,GSE17297,mouse,GSM432916|GSM432917|GSM432918,GPL1261,15979.0,CC(C)CCCC(C)CCCC(C)CCCC(C)C,1.0
drug:3229,Mesentery - DBA mice - Day 18,GSM432901|GSM432902|GSM432903|GSM432919|GSM432920|GSM432921,cadimo,Pristane,,GSE17297,mouse,GSM432898|GSM432899|GSM432900,GPL1261,15979.0,CC(C)CCCC(C)CCCC(C)CCCC(C)C,1.0
drug:3482,Astrocytes,GSM113365|GSM113366|GSM113367,cadimo,Harman,,GSE5080,human,GSM113374|GSM113375|GSM113376,GPL570,5281404.0,CC1=NC=CC2=C1NC3=CC=CC=C23,1.0
drug:3311,Liver ( AKR/J strain) - 24 hours after treatment,GSM597116|GSM597146|GSM597159,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597079|GSM597097|GSM597115,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3313,Liver (BALB/cByJ strain) - 24 hours after treatment,GSM597120|GSM597133|GSM597148,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597081|GSM597099|GSM597118,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3314,Liver ( BTBR+tf/J strain) - 24 hours after treatment,GSM597082|GSM597100|GSM597121,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597134|GSM597149|GSM597161,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3315,Liver ( C3H/HeJ strain) - 24 hours after treatment,GSM597084|GSM597150|GSM597162,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597083|GSM597101|GSM597122,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3316,Liver ( CAST/EiJ strain) - 24 hours after treatment,GSM597136|GSM597152|GSM597164,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597085|GSM597103|GSM597123,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3317,Liver ( DBA/2J strain) - 24 hours after treatment,GSM597086|GSM597104|GSM597124,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597137|GSM597145|GSM597153|GSM597165,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:2737,NA,GSM74493|GSM74494|GSM74495,Axel,Ethanol,DB00898,GSE3311,rat,GSM74496|GSM74497|GSM74498,GPL341,702.0,CCO,1.0
drug:3172,H295R cells,GSM399572|GSM399573|GSM399574,shvetank,Torcetrapib,,GSE15918,human,GSM399575|GSM399576|GSM399577|GSM399578|GSM399579|GSM399580,GPL570,159325.0,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,1.0
drug:3480,Skins biopsies from nickel-allergic patients whose skins were exposed to nickel - 48 hours,GSM144434|GSM144437|GSM144441|GSM144444,cadimo,Nickel,,GSE6281,human,GSM144432|GSM144439|GSM144448,GPL570,935.0,[Ni],1.0
drug:3483,Peripheral blood-derived MONOCYTES - 2 hours,GSM126988|GSM126993,cadimo,Lipopolysaccharide,,GSE5504,human,GSM126994|GSM126995,GPL570,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:3488,Striatum - DBA/2J mice - Acute morphine treatment,GSM187983|GSM187984|GSM187985,cadimo,Morphine,DB00295,GSE7762,mouse,GSM187986|GSM187987|GSM187988,GPL1261,5288826.0,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,1.0
drug:3489,Striatum - SWR/J mice - Acute morphine treatment,GSM187992|GSM187993|GSM187994,cadimo,Morphine,DB00295,GSE7762,mouse,GSM187995|GSM187996|GSM187997,GPL1261,5288826.0,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,1.0
drug:2577,CD19+ selected B cells,GSM388583|GSM388584|GSM388585|GSM388586|GSM388587|GSM388588|GSM388589|GSM388590|GSM388591|GSM388592,vcogliani,Rituximab,DB00073,GSE15490,human,GSM388593|GSM388594|GSM388595|GSM388596|GSM388597|GSM388598|GSM388599|GSM388600|GSM388601|GSM388602,GPL570,,,1.0
drug:2576,left internal mammary artery,GSM474493|GSM474496|GSM474499|GSM474502,vcogliani,Paclitaxel,DB01229,GSE19136,human,GSM474495|GSM474498|GSM474501|GSM474504,GPL570,36314.0,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,1.0
drug:2575,NCI-H69,GSM226184|GSM226185|GSM226186,MicrotaskManic,Aminolevulinic acid,DB00855,GSE8920,human,GSM226181|GSM226182|GSM226183,GPL571,137.0,C(CC(=O)O)C(=O)CN,1.0
drug:2574,skin,GSM803586|GSM803589|GSM803592|GSM803595|GSM803598|GSM803601|GSM803604|GSM803607|GSM803610|GSM803613,vcogliani,Pimecrolimus,DB00337,GSE32473,human,GSM803587|GSM803590|GSM803593|GSM803596|GSM803599|GSM803602|GSM803605|GSM803608|GSM803611|GSM803614,GPL570,17753757.0,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,1.0
drug:2573,C33KD2 cells,GSM287516|GSM288241|GSM288243,MicrotaskManic,Doxycycline,DB00254,GSE11422,human,GSM288248|GSM288249|GSM288260,GPL1708,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:2572,K562 (human myeloid leukemia cells),GSM296608|GSM296609,MicrotaskManic,Deferasirox,DB01609,GSE11670,human,GSM296615|GSM296616,GPL570,5493381.0,C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1,1.0
drug:2571,K562 (human myeloid leukemia cells),GSM296608|GSM296609,MicrotaskManic,Deferasirox,DB01609,GSE11670,human,GSM296612|GSM296613,GPL570,5493381.0,C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1,1.0
drug:2570,M238_R1  melanoma  resistant sub-line,GSM611407|GSM611409,cadimo,Plx4032,DB05238,GSE24862,human,GSM611419|GSM611421,GPL6244,,,1.0
drug:3556,Lung fibroblasts - 8 Hours,GSM120312|GSM120313|GSM120314,cadimo,Vanadium pentoxide,,GSE5339,human,GSM120342|GSM120343|GSM120344,GPL571,14814.0,O=[V](=O)O[V](=O)=O,1.0
drug:3557,Lung fibroblasts - 12 Hours,GSM120300|GSM120301|GSM120302,cadimo,Vanadium pentoxide,,GSE5339,human,GSM120330|GSM120331|GSM120332,GPL571,14814.0,O=[V](=O)O[V](=O)=O,1.0
drug:3554,Lung fibroblasts - 1 Hour,GSM120303|GSM120304|GSM120305,cadimo,Vanadium pentoxide,,GSE5339,human,GSM120333|GSM120334|GSM120335,GPL571,14814.0,O=[V](=O)O[V](=O)=O,1.0
drug:3129,Mtb H37Rv-infected THP-1 macrophages,GSM1276666|GSM1276667|GSM1276668,cadimo,Calcitriol,,GSE52819,human,GSM1276669|GSM1276670|GSM1276671,GPL6244,5280453.0,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,1.0
drug:3552,Nasal EPITHELIA exposed to 400mM - Istillation - 6 Hours,GSM159777|GSM159778|GSM159790|GSM159791,cadimo,Formaldehyde,,GSE7002,rat,GSM159751|GSM159752|GSM159753|GSM159754,GPL1355,712.0,C=O,1.0
drug:3553,C2C12 - Myoblast cell line,GSM152022|GSM152023|GSM152024,cadimo,Palmitic acid,,GSE6766,mouse,GSM152025|GSM152026|GSM152027,GPL8321,985.0,CCCCCCCCCCCCCCCC(=O)O,1.0
drug:2578,MGHU3 bladder cancer cells,GSM1267150|GSM1267151|GSM1267152,cadimo,Pd173074,,GSE52452,human,GSM1267153|GSM1267154|GSM1267155,GPL6244,1401.0,CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C,1.0
drug:2498,skin cells,GSM263921|GSM263923|GSM263925|GSM263927|GSM263929|GSM263931,mmluxy,Isotretinoin,,GSE10433,human,GSM263922|GSM263924|GSM263926|GSM263928|GSM263930|GSM263932,GPL571,5282379.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:2689,NA,GSM478606|GSM478607,Axel,Captopril,DB01197,GSE19286,mouse,GSM478608|GSM478609,GPL1261,44093.0,CC(CS)C(=O)N1CCCC1C(=O)O,1.0
drug:2499,brain,GSM831337|GSM831338|GSM831339,saulc07,Methylphenidate,DB00422,GSE33619,mouse,GSM831340|GSM831341|GSM831342,GPL11180,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,1.0
drug:3585,Pancreas,GSM84549|GSM84550|GSM84551,cadimo,Caerulein,,GSE3644,mouse,GSM84552|GSM84553|GSM84554,GPL339,16132921.0,CC(C(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C5CCC(=O)N5)O,1.0
drug:3584,Colonic epithelial cells - 24 Hours,GSM99411|GSM99416,cadimo,Sodium butyrate,,GSE4410,mouse,GSM99415|GSM99419,GPL339,5222465.0,CCCC(=O)[O-].[Na+],1.0
drug:2681,NA,GSM320837|GSM320841|GSM320845|GSM320849,Axel,Bexarotene,DB00307,GSE12791,human,GSM320838|GSM320842|GSM320846|GSM320850,GPL96,82146.0,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,1.0
drug:3380,RAW 264.7 macrophage cell line - 0.14 mM,GSM387601|GSM387602|GSM387605|GSM387606,cadimo,Hypochlorous acid,,GSE15457,mouse,GSM387645|GSM387646|GSM387647,GPL1261,24341.0,OCl,1.0
drug:3155,OVCA433 ovarian carcinoma cell line,GSM1160798|GSM1160799|GSM1160800,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160801|GSM1160802|GSM1160803,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3310,Liver ( A/J strain) - 24 hours after treatment,GSM597078|GSM597096|GSM597114,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597131|GSM597158,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3586,Pancreas (Mist1 knockouts),GSM84555|GSM84556|GSM84557,cadimo,Caerulein,,GSE3644,mouse,GSM84558|GSM84559|GSM84560,GPL339,16132921.0,CC(C(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C5CCC(=O)N5)O,1.0
drug:3364,RWPE1 - Prostate epithelial cell line - 48 Hours,GSM400067|GSM400068|GSM400069|GSM400070,cadimo,Alfacalcidol,DB01436,GSE15947,human,GSM400071|GSM400072|GSM400073|GSM400074,GPL570,5282181.0,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,1.0
drug:2662,Ishikawa endometrial cells - 48 Hours 100pM,GSM439995|GSM439996|GSM439997|GSM439998,cadimo,Bisphenol a,,GSE17624,human,GSM440019|GSM440020|GSM440021|GSM440022,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3243,HT29 and Colo205 parental colorectal cancer (CRC) cell lines,GSM846889|GSM846891,Pascal,Plx4720,,GSE34299,human,GSM846890|GSM846892,GPL570,24180719.0,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F,1.0
drug:3063,MCF7/BUS human breast cancer cells - 60 pM,GSM105292|GSM105293|GSM105294|GSM105295|GSM105296,cadimo,Estradiol,DB00783,GSE4668,human,GSM105307|GSM105308|GSM105309|GSM105310|GSM105311,GPL96,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2595,cultured molar teeth from embryonic day 14 fetuses,GSM109312|GSM109590,nbongio,"2,3,7,8-tetrachlorodibenzo-p-dioxin",,GSE4873,mouse,GSM109592|GSM109593,GPL81,15625.0,C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl,1.0
drug:3401,"Monocytes from (male, familial combined hyperlipidemia (FCH) patients) - following 4 weeks of treatment",GSM287664|GSM287665|GSM287666,cadimo,Atorvastatin,DB01076,GSE11393,human,GSM287670|GSM287671|GSM287672,GPL571,,OC(CC(CC(=O)[O-])O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1,1.0
drug:2594,plaque on epidermis,GSM1155757|GSM1155763|GSM1155769|GSM1155775|GSM1155780,MicrotaskManic,Etanercept,DB00005,GSE47751,human,GSM1155761|GSM1155767|GSM1155773|GSM1155778|GSM1155784,GPL570,,,1.0
drug:2597,whole-blood leukocytes,GSM882390|GSM882392|GSM882394|GSM882396|GSM882398|GSM882400|GSM882402,MicrotaskManic,Etanercept,DB00005,GSE36177,human,GSM882404|GSM882406|GSM882408|GSM882410|GSM882412|GSM882414|GSM882416|GSM882418,GPL6947,,,1.0
drug:3148,PA-1 ovarian carcinoma cell line,GSM1160754|GSM1160755|GSM1160756,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160757|GSM1160758|GSM1160759,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:2596,whole-blood leukocytes,GSM882389|GSM882391|GSM882393|GSM882395|GSM882397|GSM882399|GSM882401,MicrotaskManic,Etanercept,DB00005,GSE36177,human,GSM882403|GSM882405|GSM882407|GSM882409|GSM882411|GSM882413|GSM882415|GSM882417,GPL6947,,,1.0
drug:2636,Hippocampus (of Sprauge-Dawley males) - 3 Hours after exposure,GSM338857|GSM338858|GSM338859,cadimo,Soman,,GSE13428,rat,GSM338865|GSM338866|GSM338867|GSM338868|GSM338869|GSM338870,GPL1355,7305.0,CC(C(C)(C)C)OP(=O)(C)F,1.0
drug:3066,HT29 colon adenocarcinoma cells (3 Hours following treatment with 2nM),GSM60127|GSM60128,cadimo,Apratoxin a,,GSE2742,human,GSM60129|GSM60130,GPL96,6326668.0,CCC(C)C1C(=O)N2CCCC2C(=O)OC(CC(CC(C(C3=NC(CS3)C=C(C(=O)NC(C(=O)N(C(C(=O)N1C)C)C)CC4=CC=C(C=C4)OC)C)C)O)C)C(C)(C)C,1.0
drug:3615,Lungs - 24 Hour after exposure,GSM49362|GSM49363|GSM49364|GSM49365|GSM49366|GSM49367,cadimo,Phosgene,,GSE2565,mouse,GSM49408|GSM49409|GSM49410|GSM49411|GSM49412|GSM49413,GPL339,6371.0,C(=O)(Cl)Cl,1.0
drug:3062,MCF7/BUS human breast cancer cells - 30 pM,GSM105292|GSM105293|GSM105294|GSM105295|GSM105296,cadimo,Estradiol,DB00783,GSE4668,human,GSM105302|GSM105303|GSM105304|GSM105305|GSM105306,GPL96,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2652,MCF-7 breast cancer (BC) cells,GSM1290791|GSM1290792,cadimo,Estradiol,DB00783,GSE53394,human,GSM1290793|GSM1290794,GPL96,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3067,HT29 colon adenocarcinoma cells (3 Hours following treatment with 10nM),GSM60127|GSM60128,cadimo,Apratoxin a,,GSE2742,human,GSM60131|GSM60132,GPL96,6326668.0,CCC(C)C1C(=O)N2CCCC2C(=O)OC(CC(CC(C(C3=NC(CS3)C=C(C(=O)NC(C(=O)N(C(C(=O)N1C)C)C)CC4=CC=C(C=C4)OC)C)C)O)C)C(C)(C)C,1.0
drug:3368,Skeletal muscle - Vastus lateralis muscle biopsies - from insulin-sensitive subjects,GSM555237|GSM555239|GSM555241|GSM555243|GSM555245|GSM555247|GSM555249|GSM555251|GSM555253|GSM555255|GSM555257|GSM555259|GSM555261|GSM555263|GSM555265|GSM555267|GSM555269|GSM555271|GSM555273|GSM555275,cadimo,Insulin,,GSE22309,human,GSM555238|GSM555240|GSM555242|GSM555244|GSM555246|GSM555248|GSM555250|GSM555252|GSM555254|GSM555256|GSM555258|GSM555260|GSM555262|GSM555264|GSM555266|GSM555268|GSM555270|GSM555272|GSM555274|GSM555276,GPL91,3989.0,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)N,1.0
drug:3365,Liver (from Balb/C males) - 1 Hour,GSM429426|GSM429428|GSM429430,cadimo,Concanavalin a,,GSE17184,mouse,GSM429856|GSM429857|GSM429858,GPL1261,596316.0,CC1=C(C=C(C=C1)Cl)NC(=O)CSC2=NC3=CC=CC=C3N2,1.0
drug:3367,Liver (from Balb/C males) - 6 Hours,GSM429426|GSM429428|GSM429430,cadimo,Concanavalin a,,GSE17184,mouse,GSM429861|GSM429863|GSM429864,GPL1261,596316.0,CC1=C(C=C(C=C1)Cl)NC(=O)CSC2=NC3=CC=CC=C3N2,1.0
drug:3366,Liver (from Balb/C males) - 3 Hours,GSM429426|GSM429428|GSM429430,cadimo,Concanavalin a,,GSE17184,mouse,GSM429859|GSM429860|GSM429862,GPL1261,596316.0,CC1=C(C=C(C=C1)Cl)NC(=O)CSC2=NC3=CC=CC=C3N2,1.0
drug:3361,LUNGS of C57BL/6 males (on LRD-5001 Diet) - Added to drinking water - 10ppb,GSM279224|GSM279225|GSM279229|GSM279256,cadimo,Sodium arsenite,,GSE11056,mouse,GSM279223|GSM279228|GSM279237|GSM279242|GSM279244,GPL1261,443495.0,[O-][As]=O.[Na+],1.0
drug:3360,LUNGS of C57BL/6 males (on LRD-5001 Diet) - Added to drinking water - 10ppb,GSM279224|GSM279225|GSM279229|GSM279256,cadimo,Sodium arsenite,,GSE11056,mouse,GSM279222|GSM279226|GSM279246|GSM279259|GSM279266,GPL1261,443495.0,[O-][As]=O.[Na+],1.0
drug:3363,RWPE1 - Prostate epithelial cell line - 24 Hours,GSM400059|GSM400060|GSM400061|GSM400062,cadimo,Alfacalcidol,DB01436,GSE15947,human,GSM400063|GSM400064|GSM400065|GSM400066,GPL570,5282181.0,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,1.0
drug:3362,RWPE1 - Prostate epithelial cell line - 6 Hours,GSM400051|GSM400052|GSM400053|GSM400054,cadimo,Alfacalcidol,DB01436,GSE15947,human,GSM400055|GSM400056|GSM400057|GSM400058,GPL570,5282181.0,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,1.0
drug:3105,fibroblasts,GSM106152|GSM106154|GSM106156,AliDot,Decitabine,DB01262,GSE4768,mouse,GSM106151|GSM106153|GSM106155,GPL1261,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:2560,SW1736  thyroid cancer cell line (vemurafenib-refractory cell line) - 6 Hours,GSM919379|GSM919380|GSM919381,cadimo,Vemurafenib,DB08881,GSE37441,human,GSM919385|GSM919386|GSM919387,GPL10558,,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F,1.0
drug:2561,SW1736  thyroid cancer cell line (vemurafenib-refractory cell line) - 48 Hours,GSM919379|GSM919380|GSM919381,cadimo,Vemurafenib,DB08881,GSE37441,human,GSM919388|GSM919389|GSM919390,GPL10558,,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F,1.0
drug:2562,SK-MEL-28 melanoma cell line (vemurafenib sensitive cell line) - 1 Hour,GSM919367|GSM919368|GSM919369,cadimo,Vemurafenib,DB08881,GSE37441,human,GSM919370|GSM919371|GSM919372,GPL10558,,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F,1.0
drug:2563,SK-MEL-28 melanoma cell line (vemurafenib sensitive cell line) - 6 Hours,GSM919367|GSM919368|GSM919369,cadimo,Vemurafenib,DB08881,GSE37441,human,GSM919373|GSM919374|GSM919375,GPL10558,,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F,1.0
drug:2564,SK-MEL-28 melanoma cell line (vemurafenib sensitive cell line) - 48 Hours,GSM919367|GSM919368|GSM919369,cadimo,Vemurafenib,DB08881,GSE37441,human,GSM919376|GSM919377|GSM919378,GPL10558,,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F,1.0
drug:2566,M249_R4 melanoma resistant sub-line,GSM611400|GSM611402,cadimo,Plx4032,DB05238,GSE24862,human,GSM611412|GSM611414,GPL6244,,,1.0
drug:2567,M249 melanoma cell line,GSM611401|GSM611410,cadimo,Plx4032,DB05238,GSE24862,human,GSM611413|GSM611422,GPL6244,,,1.0
drug:3563,MAMMARY GLAND from Sprague Dawleys,GSM89874|GSM89877|GSM89880|GSM90169,cadimo,Fenretinide,,GSE3952,rat,GSM89845|GSM89848|GSM89872,GPL85,5288209.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,1.0
drug:3562,LUNG from Sprague Dawleys,GSM89876|GSM89879|GSM90168,cadimo,Bexarotene,DB00307,GSE3952,rat,GSM89850|GSM89853|GSM89856,GPL85,82146.0,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,1.0
drug:3561,LUNG from Sprague Dawleys,GSM89876|GSM89879|GSM90168,cadimo,Fenretinide,,GSE3952,rat,GSM89842|GSM89844|GSM89847|GSM89871,GPL85,5288209.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,1.0
drug:3560,LIVER from Sprague Dawleys,GSM89873|GSM89875|GSM89878|GSM89881,cadimo,Bexarotene,DB00307,GSE3952,rat,GSM89849|GSM89852|GSM89855,GPL85,82146.0,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,1.0
drug:3567,Livers - 48 hours after exposure,GSM127079|GSM127080|GSM127081|GSM127082|GSM127083|GSM127084|GSM127085|GSM127086|GSM127087,cadimo,Rosiglitazone,,GSE5509,rat,GSM127074|GSM127075|GSM127076|GSM127077|GSM127078,GPL1355,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,1.0
drug:3566,Livers - 48 hours after exposure,GSM127079|GSM127080|GSM127081|GSM127082|GSM127083|GSM127084|GSM127085|GSM127086|GSM127087,cadimo,Caerulein,,GSE5509,rat,GSM127054|GSM127055|GSM127056|GSM127057|GSM127058,GPL1355,16132921.0,CC(C(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C5CCC(=O)N5)O,1.0
drug:3565,C2C12 myoblasts,GSM126586|GSM126587|GSM126588,cadimo,Sodium pyruvate,,GSE5497,mouse,GSM126589|GSM126590|GSM126591,GPL1261,23662274.0,CC(=O)C(=O)[O-].[Na+],1.0
drug:3564,MAMMARY GLAND from Sprague Dawleys,GSM89874|GSM89877|GSM89880|GSM90169,cadimo,Bexarotene,DB00307,GSE3952,rat,GSM89851|GSM89854|GSM89857,GPL85,82146.0,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,1.0
drug:3569,Livers - 48 hours after exposure,GSM127079|GSM127080|GSM127081|GSM127082|GSM127083|GSM127084|GSM127085|GSM127086|GSM127087,cadimo,N-nitrosodimethylamine,,GSE5509,rat,GSM127059|GSM127060|GSM127061|GSM127062|GSM127063,GPL1355,6124.0,CN(C)N=O,1.0
drug:3568,Livers - 48 hours after exposure,GSM127079|GSM127080|GSM127081|GSM127082|GSM127083|GSM127084|GSM127085|GSM127086|GSM127087,cadimo,1-naphthyl isothiocyanate,,GSE5509,rat,GSM127049|GSM127050|GSM127051|GSM127052|GSM127053,GPL1355,11080.0,C1=CC=C2C(=C1)C=CC=C2N=C=S,1.0
drug:3140,ME180 squamous cell carcinoma cell line - 3 hours 10&Icirc;&frac14;M,GSM1315852|GSM1315853|GSM1315854|GSM1315855,cadimo,Tretinoin,DB00755,GSE54464,human,GSM1315860|GSM1315861|GSM1315862|GSM1315863,GPL10558,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:2740,hme-cc,GSM11708|GSM11735,Axel,Fluorouracil,DB00544,GSE1647,human,GSM11680|GSM11698,GPL550,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:2741,mcf-7,GSM11709|GSM11720,Axel,Fluorouracil,DB00544,GSE1647,human,GSM11703|GSM11705,GPL550,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:2749,NA,GSM45690|GSM45691|GSM45692|GSM45693,Axel,Glipizide,DB01067,GSE2431,mouse,GSM45698|GSM45699|GSM45700|GSM45701,GPL81,3478.0,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,1.0
drug:2698,NA,GSM677940|GSM677941|GSM677942|GSM677943|GSM677944|GSM677945|GSM677946|GSM677947,Axel,Cyclophosphamide,DB00531,GSE27440,mouse,GSM677948|GSM677949|GSM677950|GSM677951|GSM677952|GSM677953|GSM677954|GSM677955,GPL13209,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,1.0
drug:2699,NA,GSM677970|GSM677971|GSM677972|GSM677973|GSM677974|GSM677975|GSM677976|GSM677977|GSM677978|GSM677979,Axel,Cyclophosphamide,DB00531,GSE27440,mouse,GSM677980|GSM677981|GSM677982|GSM677983|GSM677984|GSM677985|GSM677986|GSM677987,GPL13209,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,1.0
drug:2487,Breast adenocarcinoma MCF-7 cell line,GSM1141244|GSM1141245|GSM1141246,timkenny92,Estradiol,DB00783,GSE46924,human,GSM1141241|GSM1141242|GSM1141243,GPL570,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3402,NPrEC immortalized normal prostate epithelial cell line - 2.5uM - 0 Hour,GSM251630|GSM251633,cadimo,Cadmium,,GSE9951,human,GSM251620|GSM251621,GPL570,23973.0,[Cd],1.0
drug:3403,NPrEC immortalized normal prostate epithelial cell line - 2.5uM - 8 Hour,GSM251637|GSM251638,cadimo,Cadmium,,GSE9951,human,GSM251623|GSM251624,GPL570,23973.0,[Cd],1.0
drug:3404,NPrEC immortalized normal prostate epithelial cell line - 2.5uM - 16 Hour,GSM251639|GSM251640,cadimo,Cadmium,,GSE9951,human,GSM251625|GSM251626,GPL570,23973.0,[Cd],1.0
drug:2653,Ishikawa endometrial cells - 8 Hours 10nM,GSM439987|GSM439988|GSM439989|GSM439990,cadimo,Bisphenol a,,GSE17624,human,GSM439999|GSM440000|GSM440001|GSM440002,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3405,NPrEC immortalized normal prostate epithelial cell line - 2.5uM - 32 Hour,GSM251649|GSM251686,cadimo,Cadmium,,GSE9951,human,GSM251627|GSM251629,GPL570,23973.0,[Cd],1.0
drug:2743,zr-75-1,GSM11706|GSM11853,Axel,Fluorouracil,DB00544,GSE1647,human,GSM11692|GSM11841|GSM11901,GPL550,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:2484,Primary umbilical vein endothelial cell,GSM46388|GSM46389,timkenny92,Atorvastatin,DB01076,GSE2450,human,GSM46394|GSM46395,GPL96,,OC(CC(CC(=O)[O-])O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1,1.0
drug:2651,MOLM-13  leukemia cell line - Day 6,GSM739169|GSM739170|GSM739171,cadimo,Epz004777,,GSE29828,human,GSM739166|GSM739167|GSM739168,GPL570,56962336.0,CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=CC4=C3N=CN=C4N)O)O,1.0
drug:2748,NA,GSM440157|GSM440158|GSM440159|GSM440160|GSM440161|GSM440162|GSM440163|GSM440164|GSM440165|GSM440166|GSM440167,Axel,Folic acid,DB00158,GSE17635,human,GSM440168|GSM440169|GSM440170|GSM440171|GSM440172|GSM440173|GSM440174|GSM440175|GSM440176|GSM440177,GPL2700,6037.0,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,1.0
drug:3610,Lungs - 0.5 Hours after exposure,GSM49328|GSM49329|GSM49330|GSM49331|GSM49332|GSM49333,cadimo,Phosgene,,GSE2565,mouse,GSM49426|GSM49427|GSM49428|GSM49429|GSM49430|GSM49431,GPL339,6371.0,C(=O)(Cl)Cl,1.0
drug:3613,Lungs - 8 Hour after exposure,GSM49350|GSM49351|GSM49352|GSM49353|GSM49380|GSM49381,cadimo,Phosgene,,GSE2565,mouse,GSM49396|GSM49397|GSM49398|GSM49399|GSM49400|GSM49401,GPL339,6371.0,C(=O)(Cl)Cl,1.0
drug:3612,Lungs - 4 Hour after exposure,GSM49342|GSM49343|GSM49344|GSM49345|GSM49346|GSM49347,cadimo,Phosgene,,GSE2565,mouse,GSM49390|GSM49391|GSM49392|GSM49393|GSM49394|GSM49395,GPL339,6371.0,C(=O)(Cl)Cl,1.0
drug:2483,Human primary fibroblasts (IMR90) stably expressing H-RasV12,GSM831051|GSM831052|GSM831053,timkenny92,Metformin,DB00331,GSE33612,human,GSM831054|GSM831055|GSM831056,GPL6244,4091.0,CN(C)C(=N)N=C(N)N,1.0
drug:2656,Ishikawa endometrial cells - 8 Hours 1pM,GSM439987|GSM439988|GSM439989|GSM439990,cadimo,Bisphenol a,,GSE17624,human,GSM440035|GSM440036|GSM440037|GSM440038,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3614,Lungs - 12 Hour after exposure,GSM49354|GSM49355|GSM49356|GSM49357|GSM49360|GSM49361,cadimo,Phosgene,,GSE2565,mouse,GSM49402|GSM49403|GSM49404|GSM49405|GSM49406|GSM49407,GPL339,6371.0,C(=O)(Cl)Cl,1.0
drug:2768,jejunum,GSM297534|GSM297535,Axel,Irinotecan,DB00762,GSE11722,rat,GSM297536|GSM297537,GPL1355,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,1.0
drug:3617,Lungs - 72 Hour after exposure,GSM49372|GSM49373|GSM49386|GSM49387|GSM49388|GSM49389,cadimo,Phosgene,,GSE2565,mouse,GSM49420|GSM49421|GSM49422|GSM49423|GSM49424|GSM49425,GPL339,6371.0,C(=O)(Cl)Cl,1.0
drug:3616,Lungs - 48 Hour after exposure,GSM49368|GSM49369|GSM49370|GSM49371|GSM49382|GSM49383|GSM49384|GSM49385,cadimo,Phosgene,,GSE2565,mouse,GSM49414|GSM49415|GSM49416|GSM49417|GSM49418|GSM49419,GPL339,6371.0,C(=O)(Cl)Cl,1.0
drug:3589,Ramos B-cell lymphoma line - 25 uM,GSM64867|GSM64868|GSM64869,cadimo,Zinc acetate,,GSE2964,human,GSM64870|GSM64871|GSM64872,GPL570,11192.0,CC(=O)[O-].CC(=O)[O-].[Zn+2],1.0
drug:2769,NA,GSM297544|GSM297545,Axel,Irinotecan,DB00762,GSE11722,rat,GSM297546|GSM297547,GPL1355,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,1.0
drug:3071,HT29 colon adenocarcinoma cells (12 Hours following treatment with 10nM),GSM92816|GSM92817,cadimo,Apratoxin a,,GSE2742,human,GSM60143|GSM60144,GPL96,6326668.0,CCC(C)C1C(=O)N2CCCC2C(=O)OC(CC(CC(C(C3=NC(CS3)C=C(C(=O)NC(C(=O)N(C(C(=O)N1C)C)C)CC4=CC=C(C=C4)OC)C)C)O)C)C(C)(C)C,1.0
drug:3580,Testes (prepubertal) - 12 Hours,GSM100951|GSM100952|GSM100953,cadimo,Mehp,,GSE4514,rat,GSM100966|GSM100967|GSM100968,GPL1355,20393.0,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)O,1.0
drug:3583,Colonic epithelial cells - 12 Hours,GSM99411|GSM99416,cadimo,Sodium butyrate,,GSE4410,mouse,GSM99414|GSM99418,GPL339,5222465.0,CCCC(=O)[O-].[Na+],1.0
drug:3582,Colonic epithelial cells - 6 Hours,GSM99411|GSM99416,cadimo,Sodium butyrate,,GSE4410,mouse,GSM99413|GSM99417,GPL339,5222465.0,CCCC(=O)[O-].[Na+],1.0
drug:3070,HT29 colon adenocarcinoma cells (12 Hours following treatment with 2nM),GSM92816|GSM92817,cadimo,Apratoxin a,,GSE2742,human,GSM60141|GSM60142,GPL96,6326668.0,CCC(C)C1C(=O)N2CCCC2C(=O)OC(CC(CC(C(C3=NC(CS3)C=C(C(=O)NC(C(=O)N(C(C(=O)N1C)C)C)CC4=CC=C(C=C4)OC)C)C)O)C)C(C)(C)C,1.0
drug:3538,Nasal EPITHELIA exposed to 0.7ppm - Inhalation - 5 Days,GSM159792|GSM159793|GSM159794|GSM159795,cadimo,Formaldehyde,,GSE7002,rat,GSM159724|GSM159725|GSM159726|GSM159821,GPL1355,712.0,C=O,1.0
drug:3072,HT29 colon adenocarcinoma cell line,GSM288501|GSM288502|GSM288536,vcogliani,Methotrexate,DB00563,GSE11440,human,GSM288491|GSM288497|GSM288499,GPL570,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,1.0
drug:2696,NA,GSM93641|GSM93644,Axel,Colchicine,DB01394,GSE4090,human,GSM93637|GSM93640,GPL3386,,COc1c(OC)cc2c(c1OC)c1ccc(c(=O)cc1C(CC2)NC(=O)C)OC,1.0
drug:2697,NA,GSM677900|GSM677901|GSM677902|GSM677903|GSM677904|GSM677905|GSM677906|GSM677907|GSM677908|GSM677909,Axel,Cyclophosphamide,DB00531,GSE27440,mouse,GSM677910|GSM677911|GSM677912|GSM677913|GSM677914|GSM677915|GSM677916|GSM677917|GSM677918|GSM677919,GPL13209,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,1.0
drug:2692,NA,GSM143373|GSM143374|GSM143375,Axel,Cisplatin,DB00515,GSE6206,mouse,GSM143379|GSM143380|GSM143381,GPL339,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3075,HeLa cells - 1 Hour,GSM50297|GSM50308|GSM50316|GSM50324,cadimo,Doxycycline,DB00254,GSE2624,human,GSM50302|GSM50312|GSM50320|GSM50328,GPL8300,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:2691,NA,GSM219392|GSM219393|GSM219394,Axel,Chlorambucil,DB00291,GSE8832,human,GSM219395|GSM219396|GSM219397,GPL570,2708.0,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,1.0
drug:3672,Skeletal muscle - 48 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5197|GSM5198|GSM5199,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3074,HeLa cells - 0 Hour,GSM50270|GSM50306|GSM50315|GSM50323|GSM50331,cadimo,Doxycycline,DB00254,GSE2624,human,GSM50301|GSM50310|GSM50319|GSM50327,GPL8300,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:2649,MV4 -11 leukemia cell line - Day 4,GSM739157|GSM739158|GSM739159,cadimo,Epz004777,,GSE29828,human,GSM739154|GSM739155|GSM739156,GPL570,56962336.0,CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=CC4=C3N=CN=C4N)O)O,1.0
drug:3664,Skeletal muscle - 5 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5203|GSM5204|GSM5205,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3236,Immortalized B cells (from MZ twin pairs - African American ancestry),GSM494452|GSM494454|GSM494456|GSM494458|GSM494460|GSM494462|GSM494464|GSM494466|GSM494468|GSM494470|GSM494472|GSM494474|GSM494476|GSM494478|GSM494480|GSM494482|GSM494484|GSM494486|GSM494488|GSM494490|GSM494492|GSM494494|GSM494496|GSM494498,cadimo,Thapsigargin,,GSE19519,human,GSM494453|GSM494455|GSM494457|GSM494459|GSM494461|GSM494463|GSM494465|GSM494467|GSM494469|GSM494471|GSM494473|GSM494475|GSM494477|GSM494479|GSM494481|GSM494483|GSM494485|GSM494487|GSM494489|GSM494491|GSM494493|GSM494495|GSM494497|GSM494499,GPL570,446378.0,CCCCCCCC(=O)OC1C2C(=C(C1OC(=O)C(=CC)C)C)C3C(C(CC2(C)OC(=O)C)OC(=O)CCC)(C(C(=O)O3)(C)O)O,1.0
drug:3667,Skeletal muscle - 7 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5212|GSM5213|GSM5214,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3378,WI-38  Lung fibroblasts - 0.5uM,GSM484752|GSM484813|GSM484814|GSM484815,cadimo,Bpde,,GSE19510,human,GSM486528|GSM486529|GSM486530,GPL570,41322.0,C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C6C(O6)C(C5O)O)C=C2,1.0
drug:3379,WI-38  Lung fibroblasts - 0.1uM,GSM484752|GSM484813|GSM484814|GSM484815,cadimo,Bpde,,GSE19510,human,GSM486531|GSM486532|GSM486533,GPL570,41322.0,C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C6C(O6)C(C5O)O)C=C2,1.0
drug:3076,HeLa cells - 3 Hours,GSM50298|GSM50299|GSM50317|GSM50325,cadimo,Doxycycline,DB00254,GSE2624,human,GSM50304|GSM50313|GSM50321|GSM50329,GPL8300,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:3377,WI-38  Lung fibroblasts - 1uM,GSM484752|GSM484813|GSM484814|GSM484815,cadimo,Bpde,,GSE19510,human,GSM484816|GSM484817|GSM484818|GSM484819,GPL570,41322.0,C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C6C(O6)C(C5O)O)C=C2,1.0
drug:3374,A673,GSM159856|GSM159857|GSM159858|GSM159859|GSM159860,AliDot,Cytarabine,DB00987,GSE6930,human,GSM159870|GSM159871|GSM159872,GPL4685,6253.0,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,1.0
drug:2648,Aortic valve interstitial cells,GSM786185|GSM786186|GSM786187,cadimo,Dapt,,GSE31668,rat,GSM786182|GSM786183|GSM786184,GPL1355,5311272.0,CC(C(=O)NC(C1=CC=CC=C1)C(=O)OC(C)(C)C)NC(=O)CC2=CC(=CC(=C2)F)F,1.0
drug:3370,Skeletal muscle - Vastus lateralis muscle biopsies - from diabetic patients,GSM555317|GSM555319|GSM555321|GSM555323|GSM555325|GSM555327|GSM555329|GSM555331|GSM555333|GSM555335|GSM555337|GSM555339|GSM555341|GSM555343|GSM555345,cadimo,Insulin,,GSE22309,human,GSM555318|GSM555320|GSM555322|GSM555324|GSM555326|GSM555328|GSM555330|GSM555332|GSM555334|GSM555336|GSM555338|GSM555340|GSM555342|GSM555344|GSM555346,GPL91,3989.0,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)N,1.0
drug:3371,A673,GSM159850|GSM159851|GSM159852|GSM159853|GSM159854|GSM159855,AliDot,"Puromycin, 2xec50, 1d",,GSE6930,human,GSM159911|GSM159912|GSM159913,GPL4685,439530.0,CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)NC(=O)C(CC4=CC=C(C=C4)OC)N)O,1.0
drug:3116,H4IIEC3 liver cell line - 29uM,GSM1240502|GSM1240505|GSM1240508|GSM1240511,cadimo,Cobalt dichloride hexahydrate,,GSE51207,rat,GSM1240503|GSM1240506|GSM1240509|GSM1240512,GPL1355,24643.0,O.O.O.O.O.O.[Cl-].[Cl-].[Co+2],1.0
drug:3117,H4IIEC3 liver cell line - 62uM,GSM1240502|GSM1240505|GSM1240508|GSM1240511,cadimo,Cobalt dichloride hexahydrate,,GSE51207,rat,GSM1240504|GSM1240507|GSM1240510|GSM1240513,GPL1355,24643.0,O.O.O.O.O.O.[Cl-].[Cl-].[Co+2],1.0
drug:3110,Spinal cord - (30 mg/kg for 21 days),GSM718693|GSM718694,cadimo,Acrylamide,,GSE29004,rat,GSM718695|GSM718696,GPL1355,6579.0,C=CC(=O)N,1.0
drug:3111,Hypothalamus (postnatal day70 male rats exposed in utero to dioxin at gestational day15),GSM1168492|GSM1168493|GSM1168494,cadimo,"2,3,7,8-tetrachlorodibenzo-p-dioxin",,GSE48100,rat,GSM1168495|GSM1168496|GSM1168497,GPL6101,10852289.0,CC(C)C=CC(=O)ONC(=O)COC1=CC=C(C=C1)[N+](=O)[O-],1.0
drug:2767,stomach,GSM297524|GSM297525,Axel,Irinotecan,DB00762,GSE11722,rat,GSM297526|GSM297527,GPL1355,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,1.0
drug:2519,K562 leukemia cell line (II) - 24 Hours,GSM34134|GSM34140|GSM34146,cadimo,Imatinib,DB00619,GSE1922,human,GSM34162|GSM34163|GSM34164,GPL96,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2517,K562 leukemia cell line (III) - 24 Hours,GSM34909|GSM34910|GSM34911,cadimo,Imatinib,DB00619,GSE1922,human,GSM34912|GSM34913|GSM34914,GPL96,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2516,K562 leukemia cell line (IV) - 24 Hours,GSM34915|GSM34916|GSM34917,cadimo,Imatinib,DB00619,GSE1922,human,GSM34918|GSM34919|GSM34920,GPL96,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2511,brain frontal cortex tissue,GSM48559|GSM48577|GSM48578|GSM48579,mmluxy,Olanzapine,,GSE2547,rat,GSM48580|GSM48581|GSM48582|GSM48583,GPL1355,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,1.0
drug:2510,Chronic myelogenous leukemia CD34+CD38- cells,GSM521987|GSM521991|GSM521995,cadimo,Imatinib,DB00619,GSE20876,human,GSM521988|GSM521992|GSM521996,GPL570,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2513,K562 leukemia cell line (VII) - 24 Hours,GSM34933|GSM34934|GSM34935,cadimo,Imatinib,DB00619,GSE1922,human,GSM34936|GSM34937|GSM34938,GPL96,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2512,K562 leukemia cell line (VIII),GSM34939|GSM34940|GSM34941,cadimo,Imatinib,DB00619,GSE1922,human,GSM34942|GSM34943|GSM34944,GPL96,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:3574,testicular Sertoli cells -  6 Hours,GSM104743|GSM104744,cadimo,Bisphenol a,,GSE4650,mouse,GSM104747|GSM104748,GPL339,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3576,Testes (prepubertal) - 1 hour,GSM100955|GSM100956|GSM100957,cadimo,Mehp,,GSE4514,rat,GSM100969|GSM100970|GSM100971,GPL1355,20393.0,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)O,1.0
drug:3577,Testes (prepubertal) - 2 Hours,GSM100958|GSM100959|GSM100972,cadimo,Mehp,,GSE4514,rat,GSM100973|GSM100974|GSM100975,GPL1355,20393.0,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)O,1.0
drug:3570,Livers - 48 hours after exposure,GSM127079|GSM127080|GSM127081|GSM127082|GSM127083|GSM127084|GSM127085|GSM127086|GSM127087,cadimo,N-methylformamide,,GSE5509,rat,GSM127069|GSM127070|GSM127071|GSM127072|GSM127073,GPL1355,31254.0,CNC=O,1.0
drug:3571,primary fetal ASTROCYTES,GSM113365|GSM113366|GSM113367,cadimo,Chlorpyrifos,,GSE5023,human,GSM113371|GSM113372|GSM113373,GPL570,2730.0,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl,1.0
drug:3572,primary fetal ASTROCYTES,GSM113365|GSM113366|GSM113367,cadimo,Cyfluthrin,,GSE5023,human,GSM113368|GSM113369|GSM113370,GPL570,104926.0,CC1(C(C1C(=O)OC(C#N)C2=CC(=C(C=C2)F)OC3=CC=CC=C3)C=C(Cl)Cl)C,1.0
drug:3573,testicular Sertoli cells - 3 Hours,GSM104743|GSM104744,cadimo,Bisphenol a,,GSE4650,mouse,GSM104745|GSM104746,GPL339,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:2764,NA,GSM603097|GSM603099|GSM603101,Axel,Imatinib,DB00619,GSE24493,human,GSM603098|GSM603100|GSM603102,GPL570,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:3578,Testes (prepubertal) - 3 Hours,GSM100960|GSM100961|GSM100962,cadimo,Mehp,,GSE4514,rat,GSM100976|GSM100977|GSM100978,GPL1355,20393.0,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)O,1.0
drug:2734,eralpha,GSM19191|GSM19291,Axel,Estradiol,DB00783,GSE1153,human,GSM19292|GSM19293,GPL91,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2731,NA,GSM213330|GSM213331|GSM213332|GSM213333,Axel,Estradiol,DB00783,GSE8597,human,GSM213326|GSM213327|GSM213328|GSM213329,GPL570,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3602,17.5 day fetal hearts - 6ug/kg,GSM60894|GSM60895|GSM60896|GSM60897|GSM60902|GSM60903|GSM60906|GSM60907,cadimo,"2,3,7,8-tetrachlorodibenzo-p-dioxin",,GSE2812,mouse,GSM60910|GSM60911|GSM60912|GSM60913,GPL81,10852289.0,CC(C)C=CC(=O)ONC(=O)COC1=CC=C(C=C1)[N+](=O)[O-],1.0
drug:2663,Ishikawa endometrial cells - 48 Hours 1uM,GSM439995|GSM439996|GSM439997|GSM439998,cadimo,Bisphenol a,,GSE17624,human,GSM440031|GSM440032|GSM440033|GSM440034,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:2739,NA,GSM3870|GSM3871,Axel,Ethinyl estradiol,DB00977,GSE280,mouse,GSM3880|GSM3881,GPL75,,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)O,1.0
drug:2738,NA,GSM87870|GSM87875|GSM87903|GSM87912|GSM87940,Axel,Ethanol,DB00898,GSE3846,human,GSM87865|GSM87889|GSM87898|GSM87915|GSM87936|GSM87945,GPL96,702.0,CCO,1.0
drug:3598,Myotubes (derived from C2C12 myoblasts) - 100uM,GSM67664|GSM67690|GSM67711|GSM67712,cadimo,Hydrogen peroxide,,GSE3078,mouse,GSM67668|GSM67719|GSM67720|GSM67721,GPL339,784.0,OO,1.0
drug:3599,Myotubes (derived from C2C12 myoblasts) - 1000uM,GSM67664|GSM67690|GSM67711|GSM67712,cadimo,Hydrogen peroxide,,GSE3078,mouse,GSM67669|GSM67722|GSM67723|GSM67724,GPL339,784.0,OO,1.0
drug:3527,HepG2 - liver carcinoma cells,GSM159303|GSM159305|GSM159306,cadimo,"Dmnq   (2,3-dimethoxy-1,4-naphthoquinone)",,GSE6907,human,GSM159336|GSM159337|GSM159338,GPL201,3136.0,COC1=C(C(=O)C2=CC=CC=C2C1=O)OC,1.0
drug:2641,MCF-7 BREAST CANCER cell line,GSM339721|GSM339722,cadimo,Doxorubicin,DB00997,GSE13477,human,GSM339727|GSM339765,GPL570,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:2640,Hippocampus (of Sprauge-Dawley males) - 96 Hours after exposure,GSM338857|GSM338858|GSM338859,cadimo,Soman,,GSE13428,rat,GSM338889|GSM338890|GSM338891,GPL1355,7305.0,CC(C(C)(C)C)OP(=O)(C)F,1.0
drug:2643,A375 melanoma cell line - 1 Hour,GSM757113|GSM757114|GSM757115,cadimo,Mln4924,,GSE30531,human,GSM757128|GSM757129|GSM757130,GPL570,73014187.0,C1CC2=CC=CC=C2C1NC3=NC=NC4=C3C=CN4C5CC(C(C5)O)COS(=O)(=O)N,1.0
drug:2642,Metastatic alveolar soft part sarcoma (ASPS) biopsies,GSM807204|GSM807206|GSM807208|GSM807210|GSM807212|GSM807214,cadimo,Cediranib,,GSE32569,human,GSM807203|GSM807205|GSM807207|GSM807209|GSM807211|GSM807213,GPL570,9933475.0,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,1.0
drug:3427,Colon,GSM96781|GSM96782|GSM96783,MicrotaskManic,Quercetin,DB04216,GSE4262,mouse,GSM96784|GSM96785|GSM96786,GPL339,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:2712,NA,GSM185889|GSM185923|GSM185977,Axel,Dexamethasone,DB01234,GSE7683,mouse,GSM185924|GSM185964|GSM185976,GPL1261,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:3424,A673,GSM159861|GSM159862|GSM159863|GSM159864|GSM159865|GSM159866,AliDot,Cytarabine,DB00987,GSE6930,human,GSM159882|GSM159883|GSM159884,GPL4685,6253.0,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,1.0
drug:3065,Liver tissue,GSM978535|GSM978536|GSM978537|GSM978538|GSM978539|GSM978540|GSM978541,rcaneva,Streptozocin,DB00428,GSE39752,mouse,GSM978542|GSM978543|GSM978544|GSM978545|GSM978546|GSM978547,GPL6246,29327.0,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,1.0
drug:3425,HL-60 leukemia cells,GSM405501|GSM405502,MicrotaskManic,Curcumin,,GSE16160,human,GSM405497|GSM405498,GPL571,969516.0,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,1.0
drug:3513,MaF pre-induced pluripotent stem cells,GSM480935|GSM480936|GSM480937|GSM480938,MicrotaskManic,Vitamin c,DB00126,GSE19379,mouse,GSM480939|GSM480940|GSM480941|GSM480942,GPL6246,,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O,1.0
drug:3523,lung,GSM326943|GSM326945|GSM326947|GSM326949|GSM326951,MicrotaskManic,Perfluorooctanoic acid,,GSE13044,mouse,GSM326963|GSM326965|GSM326967|GSM326969|GSM326971,GPL1261,9554.0,C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,1.0
drug:2779,NA,GSM262682|GSM262683|GSM262684|GSM262685|GSM262686|GSM262687,Axel,Medroxyprogesterone acetate,DB00603,GSE10392,mouse,GSM262676|GSM262677|GSM262678|GSM262679|GSM262680|GSM262681,GPL1261,,O=C1CC[C@]2(C(=C1)[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(OC(=O)C)C(=O)C)C)C,1.0
drug:2645,A375 melanoma cell line - 4 Hours,GSM757119|GSM757120|GSM757121,cadimo,Mln4924,,GSE30531,human,GSM757134|GSM757135|GSM757136,GPL570,73014187.0,C1CC2=CC=CC=C2C1NC3=NC=NC4=C3C=CN4C5CC(C(C5)O)COS(=O)(=O)N,1.0
drug:2715,aci,GSM92200|GSM92201|GSM92202,Axel,Diethylstilbestrol,DB00255,GSE4028,rat,GSM92203|GSM92204|GSM92205|GSM92206,GPL1355,448537.0,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:2655,Ishikawa endometrial cells - 8 Hours 1uM,GSM439987|GSM439988|GSM439989|GSM439990,cadimo,Bisphenol a,,GSE17624,human,GSM440023|GSM440024|GSM440025|GSM440026,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:2644,A375 melanoma cell line - 2 Hours,GSM757116|GSM757117|GSM757118,cadimo,Mln4924,,GSE30531,human,GSM757131|GSM757132|GSM757133,GPL570,73014187.0,C1CC2=CC=CC=C2C1NC3=NC=NC4=C3C=CN4C5CC(C(C5)O)COS(=O)(=O)N,1.0
drug:2714,NA,GSM847200|GSM847201|GSM847202|GSM847203,Axel,Dexamethasone,DB01234,GSE34313,human,GSM847204|GSM847205|GSM847206,GPL6480,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:2647,A375 melanoma cell line - 24 Hours,GSM757125|GSM757126|GSM757127,cadimo,Mln4924,,GSE30531,human,GSM757140|GSM757141|GSM757142,GPL570,73014187.0,C1CC2=CC=CC=C2C1NC3=NC=NC4=C3C=CN4C5CC(C(C5)O)COS(=O)(=O)N,1.0
drug:2624,primary human hepatocytes (PHH),GSM231324|GSM231326,AliDot,Ciprofloxacin,DB00537,GSE9166,human,GSM231332|GSM231333,GPL96,2764.0,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,1.0
drug:3346,MCF7 cells depleted of ERK2 - 4 Hours after treatment,GSM606113|GSM606114|GSM606115,cadimo,Estradiol,DB00783,GSE24592,human,GSM606116|GSM606117|GSM606118,GPL571,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3575,testicular Sertoli cells -  12 Hours,GSM104743|GSM104744,cadimo,Bisphenol a,,GSE4650,mouse,GSM104749|GSM104750,GPL339,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:2646,A375 melanoma cell line - 8 Hours,GSM757122|GSM757123|GSM757124,cadimo,Mln4924,,GSE30531,human,GSM757137|GSM757138|GSM757139,GPL570,73014187.0,C1CC2=CC=CC=C2C1NC3=NC=NC4=C3C=CN4C5CC(C(C5)O)COS(=O)(=O)N,1.0
drug:2797,NA,GSM806188|GSM806189|GSM806190|GSM806191|GSM806192|GSM806193|GSM806194|GSM806195,Axel,Pioglitazone,DB01132,GSE32536,mouse,GSM806196|GSM806197|GSM806198|GSM806199|GSM806200|GSM806201|GSM806202|GSM806203,GPL1261,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,1.0
drug:3306,Pancreatic Cancer Cell Lines,GSM1435693|GSM1435694|GSM1435695|GSM1435696|GSM1435697|GSM1435698|GSM1435699|GSM1435700|GSM1435701,gswaminath,Dasatinib,DB01254,GSE59357,human,GSM1435684|GSM1435685|GSM1435686|GSM1435687|GSM1435688|GSM1435689|GSM1435690|GSM1435691|GSM1435692,GPL10558,3062316.0,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,1.0
drug:3308,liver,GSM878116|GSM878117|GSM878118|GSM878119|GSM878120|GSM878121|GSM878122|GSM878123,gswaminath,Metformin,DB00331,GSE35961,mouse,GSM878124|GSM878125|GSM878126|GSM878127,GPL1261,4091.0,CN(C)C(=N)N=C(N)N,1.0
drug:3294,colon,GSM282865|GSM282866|GSM282867|GSM282868|GSM282869,garibr01,Cholestyramine,DB01432,GSE11223,human,GSM283030|GSM283033|GSM283035|GSM283036|GSM283038,GPL1708,,,1.0
drug:3297,lymphocytes,GSM217766|GSM217767|GSM217768|GSM217771|GSM217772|GSM217773,garibr01,Oprelvekin,DB00038,GSE8762,human,GSM217776|GSM217777|GSM217778|GSM217784|GSM217785|GSM217786,GPL570,,,1.0
drug:3296,colon,GSM283131|GSM283133|GSM283137|GSM283139|GSM283140,garibr01,Celecoxib,DB00482,GSE11237,human,GSM283136|GSM283138|GSM283142|GSM283145|GSM283147,GPL8300,2662.0,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,1.0
drug:3291,brainstem,GSM53440|GSM53441|GSM53442|GSM53443|GSM53444,garibr01,Phenytoin,DB00252,GSE2880,rat,GSM53412|GSM53413|GSM53414|GSM53415|GSM53416,GPL1355,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,1.0
drug:3290,Liver,GSM978535|GSM978536|GSM978537|GSM978538|GSM978539,garibr01,Insulin regular,DB00030,GSE39752,mouse,GSM978543|GSM978544|GSM978545|GSM978546|GSM978547,GPL6246,,,1.0
drug:3293,jeujunum,GSM1144771|GSM1144772|GSM1144773|GSM1144777|GSM1144778|GSM1144779,garibr01,Carbidopa,DB00190,GSE47099,mouse,GSM1144768|GSM1144769|GSM1144770|GSM1144774|GSM1144775|GSM1144776,GPL6246,,NN[C@](C(=O)O)(Cc1ccc(c(c1)O)O)C.O,1.0
drug:3299,No Data,GSM31167|GSM31168|GSM31169|GSM31172,gswaminath,Cyclosporine,DB00091,GSE1809,mouse,GSM31170|GSM31171,GPL339,,C/C=C/CC(C(C1C(=NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=NC(C(=NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)O)C)O)O)O)O)C,1.0
drug:3343,Peripheral mononuclear blood cells (NAB+) - 3 Months of treatment,GSM641342|GSM641346|GSM641350|GSM641354,cadimo,Interferon beta-1b,DB00068,GSE26104,human,GSM641343|GSM641351|GSM641355,GPL570,,,1.0
drug:3347,MCF7 cells depleted of ERK2 - 24 Hours after treatment,GSM606129|GSM606130,cadimo,Estradiol,DB00783,GSE24592,human,GSM606131|GSM606132,GPL571,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3169,Airway smooth muscle cells,GSM847200|GSM847201|GSM847202|GSM847203,shvetank,Dexamethasone,DB01234,GSE34313,human,GSM847207|GSM847208|GSM847209,GPL6480,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:3345,hNHEPS Hepatocytes - 6 Hours after exposure with 0.1 &Icirc;&frac14;M,GSM830929|GSM830930|GSM830931,cadimo,Vx,,GSE33606,human,GSM830932|GSM830933|GSM830934|GSM830935,GPL570,39793.0,CCOP(=O)(C)SCCN(C(C)C)C(C)C,1.0
drug:3344,MCF7 cells depleted of ERK1 - 4 Hours after treatment,GSM606119|GSM606120|GSM606121,cadimo,Estradiol,DB00783,GSE24592,human,GSM606122|GSM606123|GSM606124,GPL571,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3349,HepG2 cells (metabolically competent) - 1.5 Hours after exposure,GSM149381|GSM149382|GSM149383,cadimo,"2,2',4,4',5,5'-hexachlorobiphenyl   (pcb-153)",,GSE6878,human,GSM149387|GSM149388,GPL570,37034.0,C1=C(C(=CC(=C1Cl)Cl)Cl)C2=CC(=C(C=C2Cl)Cl)Cl,1.0
drug:3618,Lung (from C57BL/6J),GSM29706|GSM29707|GSM29708,cadimo,Simvastatin,,GSE1871,mouse,GSM29712|GSM29713|GSM29714,GPL1261,54454.0,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,1.0
drug:2826,NA,GSM4141|GSM4142,Axel,Tretinoin,DB00755,GSE484,mouse,GSM4143|GSM4144,GPL81,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:2508,Primary leukemic cells (purified from peripheral blood) - 48 Hours,GSM1557452|GSM1557458|GSM1557460|GSM1557464|GSM1557468|GSM1557472,cadimo,Vemurafenib,DB08881,GSE63790,human,GSM1557453|GSM1557454|GSM1557459|GSM1557461|GSM1557465|GSM1557469|GSM1557473,GPL570,,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F,1.0
drug:2509,Primary leukemic cells (purified from peripheral blood) - 72 Hours,GSM1557455|GSM1557462|GSM1557466|GSM1557470|GSM1557474,cadimo,Vemurafenib,DB08881,GSE63790,human,GSM1557456|GSM1557457|GSM1557463|GSM1557467|GSM1557471|GSM1557475,GPL570,,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F,1.0
drug:2506,HT29 3D culture cell - Day 3,GSM1229357|GSM1229363,cadimo,Plx4720,,GSE50791,human,GSM1229358|GSM1229364,GPL10558,24180719.0,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F,1.0
drug:2507,HT29 3D culture cell - Day 8,GSM1229359|GSM1229365,cadimo,Plx4720,,GSE50791,human,GSM1229360|GSM1229366,GPL10558,24180719.0,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F,1.0
drug:2504,MCF-7,GSM339721|GSM339722,AliDot,Sangivamycin (nsc 65346),,GSE13477,human,GSM339725|GSM339726,GPL570,14978.0,C1=C(C2=C(N1C3C(C(C(O3)CO)O)O)N=CN=C2N)C(=O)N,1.0
drug:2505,HT29 3D culture cell - Day 1,GSM1229355|GSM1229361,cadimo,Plx4720,,GSE50791,human,GSM1229356|GSM1229362,GPL10558,24180719.0,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F,1.0
drug:2502,lung,GSM1230990|GSM1230991,AliDot,Mepenzolate bromide,,GSE50836,mouse,GSM1230986|GSM1230987,GPL6246,6461.0,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C.[Br-],1.0
drug:2503,MCF-7,GSM339721|GSM339722,AliDot,Arc (nsc 188491),,GSE13477,human,GSM339723|GSM339724,GPL570,302576.0,C1=NC2=C(C(=C(N2C3C(C(C(O3)CO)O)O)NN)C(=O)N)C(=N1)N,1.0
drug:2500,cortical pyramidal cells,GSM874591|GSM874592|GSM874594,,Fluoxetine,DB00472,GSE35765,mouse,GSM874589|GSM874590|GSM874593,GPL1261,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,1.0
drug:2501,AGS cells,GSM1321413|GSM1321414|GSM1321415,saulc07,Celecoxib,DB00482,GSE54657,human,GSM1321416|GSM1321417|GSM1321418,GPL6244,2662.0,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,1.0
drug:2720,NA,GSM325240|GSM325242|GSM325244|GSM325246|GSM325248|GSM325250|GSM325252|GSM325254|GSM325256|GSM325258|GSM325260|GSM325262|GSM325264|GSM325266|GSM325268|GSM325270|GSM325272|GSM325274|GSM325276,Axel,Doxorubicin,DB00997,GSE12972,human,GSM325241|GSM325243|GSM325245|GSM325247|GSM325249|GSM325251|GSM325253|GSM325255|GSM325257|GSM325259|GSM325261|GSM325263|GSM325265|GSM325267|GSM325269|GSM325271|GSM325273|GSM325275|GSM325277,GPL96,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3636,Bone marrow Sca+ SP hematopoeitic stem cells (HSC) - 2 Day,GSM26734|GSM26735,cadimo,Fluorouracil,DB00544,GSE1559,mouse,GSM26738|GSM26739,GPL81,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:3633,cranial neural crest - 24 Hours,GSM27263|GSM27264|GSM27265|GSM27266,cadimo,Tretinoin,DB00755,GSE1588,mouse,GSM27267|GSM27268|GSM27269|GSM27270,GPL81,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3632,cranial neural crest - 12 Hours,GSM27257|GSM27258|GSM27259,cadimo,Tretinoin,DB00755,GSE1588,mouse,GSM27260|GSM27261|GSM27262,GPL81,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3631,cranial neural crest - 6 Hours,GSM24606|GSM27252|GSM27253,cadimo,Tretinoin,DB00755,GSE1588,mouse,GSM27254|GSM27255|GSM27256,GPL81,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3495,Adipose,GSM1009752|GSM1009756|GSM1009760|GSM1009764|GSM1009768|GSM1009772|GSM1009776|GSM1009778|GSM1009782|GSM1009784|GSM1009788|GSM1009796|GSM1009800|GSM1009804|GSM1009806|GSM1009810|GSM1009812|GSM1009816|GSM1009820|GSM1009824|GSM1009828|GSM1009832|GSM1009836|GSM1009840|GSM1009844|GSM1009848|GSM1009854|GSM1009858|GSM1009862|GSM1009866|GSM1009872|GSM1009874|GSM1009878|GSM1009882|GSM1009886,MicrotaskManic,Resveratrol,DB02709,GSE41168,human,GSM1009761|GSM1009773|GSM1009777|GSM1009801|GSM1009805|GSM1009813|GSM1009821|GSM1009829|GSM1009837|GSM1009845|GSM1009855|GSM1009873|GSM1009887,GPL570,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:2778,NA,GSM457637|GSM457639,Axel,Lubiprostone,DB01046,GSE18327,mouse,GSM457638|GSM457640,GPL1261,656719.0,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,1.0
drug:3596,Myotubes (derived from C2C12 myoblasts) - 1uM,GSM67664|GSM67690|GSM67711|GSM67712,cadimo,Hydrogen peroxide,,GSE3078,mouse,GSM67666|GSM67713|GSM67714|GSM67715,GPL339,784.0,OO,1.0
drug:3123,SKOV3 ovarian cancer xenograft tumor,GSM780707|GSM780708|GSM780709|GSM780719|GSM780720|GSM780721,cadimo,Trastuzumab,DB00072,GSE31432,human,GSM780710|GSM780711|GSM780712|GSM780722|GSM780723|GSM780724,GPL6947,,,1.0
drug:3122,Lung (FIZZ2 deficient),GSM629997|GSM629998|GSM629999,cadimo,Bleomycin,DB00290,GSE25640,mouse,GSM630000|GSM630001|GSM630002,GPL1261,5360373.0,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1.0
drug:3121,Lung (wild type),GSM629991|GSM629992|GSM629993,cadimo,Bleomycin,DB00290,GSE25640,mouse,GSM629994|GSM629995|GSM629996,GPL1261,5360373.0,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1.0
drug:3120,Hematopoietic stem cell (Female),GSM1274476|GSM1274477|GSM1274478,cadimo,Estradiol,DB00783,GSE52711,mouse,GSM1274479|GSM1274480|GSM1274481,GPL6246,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3126,Macrophages,GSM1276660|GSM1276661|GSM1276662,cadimo,Calcitriol,,GSE52819,human,GSM1276663|GSM1276664|GSM1276665,GPL6244,5280453.0,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,1.0
drug:3125,A549,GSM39804|GSM39805|GSM39806,AliDot,Motexafin gadolinium (4 h),DB05428,GSE2189,human,GSM39801|GSM39802|GSM39803,GPL96,,[O-]C(=O)C.[O-]C(=O)C.OCCCC1=C(C)/C/2=C/N=c/3\cc(OCCOCCOCCOC)c(c\c3=N/C=C/3\N=C(/C=c/4\[n-]/c(=C\C1=N2)/c(CC)c4CC)C(=C3C)CCCO)OCCOCCOCCOC.[Gd+3],1.0
drug:3124,SKOV3 ovarian cancer xenograft tumor,GSM780707|GSM780708|GSM780709|GSM780719|GSM780720|GSM780721,cadimo,Pertuzumab,DB06366,GSE31432,human,GSM780713|GSM780714|GSM780715|GSM780725|GSM780726|GSM780727,GPL6947,,,1.0
drug:3512,mouse embryonic fibroblast cells (MEF cells),GSM480923|GSM480924|GSM480925|GSM480926|GSM480927|GSM480928,MicrotaskManic,Vitamin c,DB00126,GSE19379,mouse,GSM480929|GSM480930|GSM480931|GSM480932|GSM480933|GSM480934,GPL6246,,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O,1.0
drug:2603,lesioned skin,GSM1021297|GSM1021302|GSM1021307|GSM1021312|GSM1021317|GSM1021322|GSM1021327|GSM1021333|GSM1021339|GSM1021345|GSM1021351|GSM1021355|GSM1021360|GSM1021366|GSM1021372,MicrotaskManic,Etanercept,DB00005,GSE41663,human,GSM1021299|GSM1021304|GSM1021309|GSM1021314|GSM1021319|GSM1021324|GSM1021329|GSM1021335|GSM1021341|GSM1021347|GSM1021353|GSM1021357|GSM1021362|GSM1021368|GSM1021374,GPL570,,,1.0
drug:3597,Myotubes (derived from C2C12 myoblasts) - 10uM,GSM67664|GSM67690|GSM67711|GSM67712,cadimo,Hydrogen peroxide,,GSE3078,mouse,GSM67667|GSM67716|GSM67717|GSM67718,GPL339,784.0,OO,1.0
drug:3548,Nasal EPITHELIA exposed to 6 ppm - Inhalation - 5 Days,GSM159792|GSM159793|GSM159794|GSM159795,cadimo,Formaldehyde,,GSE7002,rat,GSM159734|GSM159735|GSM159736|GSM159737,GPL1355,712.0,C=O,1.0
drug:3547,Nasal EPITHELIA exposed to 6 ppm - Inhalation - 24 Hours,GSM159802|GSM159803|GSM159804|GSM159805,cadimo,Formaldehyde,,GSE7002,rat,GSM159744|GSM159745|GSM159746|GSM159747,GPL1355,712.0,C=O,1.0
drug:3608,Thymus (of ovariectomized C57BL/6) - 3 Days,GSM63205|GSM63206,cadimo,Estradiol,DB00783,GSE2889,mouse,GSM63216|GSM63217,GPL339,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2601,PBMC (peripheral blood mononuclear cells),GSM1025164|GSM1025165|GSM1025166|GSM1025167|GSM1025168|GSM1025169|GSM1025170|GSM1025171|GSM1025172|GSM1025173|GSM1025174|GSM1025175|GSM1025176|GSM1025177|GSM1025178,MicrotaskManic,Methotrexate,DB00563,GSE41831,human,GSM1025179|GSM1025180|GSM1025181|GSM1025182|GSM1025183|GSM1025184|GSM1025185|GSM1025186|GSM1025187|GSM1025188|GSM1025189|GSM1025190|GSM1025191|GSM1025192,GPL570,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,1.0
drug:2742,me16c,GSM11707|GSM11716,Axel,Fluorouracil,DB00544,GSE1647,human,GSM11697|GSM11714,GPL550,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:3643,Livers ( from outbred Wistars - fed a diet with 1% orotic acid) - 14 Day,GSM10009|GSM10010|GSM13064,cadimo,Orotic acid,,GSE665,rat,GSM10007|GSM10008|GSM13063,GPL85,967.0,C1=C(NC(=O)NC1=O)C(=O)O,1.0
drug:2650,MV4 -11 leukemia cell line - Day 6,GSM739163|GSM739164|GSM739165,cadimo,Epz004777,,GSE29828,human,GSM739160|GSM739161|GSM739162,GPL570,56962336.0,CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=CC4=C3N=CN=C4N)O)O,1.0
drug:3422,A673,GSM159850|GSM159851|GSM159852|GSM159853|GSM159854|GSM159855,AliDot,Cytarabine,DB00987,GSE6930,human,GSM159876|GSM159877|GSM159878,GPL4685,6253.0,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,1.0
drug:3282,H4-II-E-C3 LIVER-derived cell line - 0.55 uM,GSM782280|GSM782281|GSM782291|GSM782292|GSM782302|GSM782303|GSM782313|GSM782314,cadimo,Cadmium dichloride,,GSE31503,rat,GSM782289|GSM782300|GSM782311|GSM782322,GPL1355,24947.0,Cl[Cd]Cl,1.0
drug:2496,LY2,GSM709765|GSM709771|GSM709772|GSM709775,saulc07,Tamoxifen,DB00675,GSE28645,human,GSM709767|GSM709769,GPL570,2733526.0,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,1.0
drug:3283,H4-II-E-C3 LIVER-derived cell line -  0.2 uM,GSM782280|GSM782281|GSM782291|GSM782292|GSM782302|GSM782303|GSM782313|GSM782314,cadimo,Cadmium dichloride,,GSE31503,rat,GSM782288|GSM782299|GSM782310|GSM782321,GPL1355,24947.0,Cl[Cd]Cl,1.0
drug:3287,colon,GSM282862|GSM282863|GSM282864|GSM282865|GSM282866|GSM282867,garibr01,Metoprolol,DB00264,GSE11223,human,GSM282946|GSM282947|GSM282948|GSM282949|GSM282950,GPL1708,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,1.0
drug:3284,H4-II-E-C3 LIVER-derived cell line -  10 uM,GSM782280|GSM782281|GSM782291|GSM782292|GSM782302|GSM782303|GSM782313|GSM782314,cadimo,Sodium dichromate,,GSE31503,rat,GSM782287|GSM782298|GSM782309|GSM782320,GPL1355,25408.0,[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Na+].[Na+],1.0
drug:3285,H4-II-E-C3 LIVER-derived cell line -  1 uM,GSM782280|GSM782281|GSM782291|GSM782292|GSM782302|GSM782303|GSM782313|GSM782314,cadimo,Sodium dichromate,,GSE31503,rat,GSM782286|GSM782297|GSM782308|GSM782319,GPL1355,25408.0,[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Na+].[Na+],1.0
drug:3280,H4-II-E-C3 LIVER-derived cell line - 40 uM,GSM782280|GSM782281|GSM782291|GSM782292|GSM782302|GSM782303|GSM782313|GSM782314,cadimo,Nickel chloride,,GSE31503,rat,GSM782282|GSM782293|GSM782304|GSM782315,GPL1355,24385.0,Cl[Ni]Cl,1.0
drug:3281,H4-II-E-C3 LIVER-derived cell line - 1.2 uM,GSM782280|GSM782281|GSM782291|GSM782292|GSM782302|GSM782303|GSM782313|GSM782314,cadimo,Cadmium dichloride,,GSE31503,rat,GSM782290|GSM782301|GSM782312|GSM782323,GPL1355,24947.0,Cl[Cd]Cl,1.0
drug:3288,Striatum,GSM187965|GSM187966|GSM187967,garibr01,Morphine,DB00295,GSE7762,human,GSM187968|GSM187969|GSM187970,GPL1261,5288826.0,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,1.0
drug:3289,colon,GSM948552|GSM948553|GSM948554|GSM948555|GSM948556|GSM948557|GSM948558|GSM948559|GSM948560,garibr01,Mesalazine,DB00244,GSE38713,human,GSM948567|GSM948568|GSM948570|GSM948572|GSM948577|GSM948578|GSM948581|GSM948582|GSM948588,GPL570,4075.0,C1=CC(=C(C=C1N)C(=O)O)O,1.0
drug:3354,LUNGS of C57BL/6 males (on AIN-76A Diet) - Injection 1mg/kg,GSM279232|GSM279235|GSM279264|GSM279270|GSM279275,cadimo,Sodium arsenite,,GSE11056,mouse,GSM279240|GSM279245|GSM279248|GSM279250|GSM279253,GPL1261,443495.0,[O-][As]=O.[Na+],1.0
drug:3355,LUNGS of C57BL/6 males (on AIN-76A Diet) - Added to drinking water -100ppb,GSM279232|GSM279235|GSM279264|GSM279270|GSM279275,cadimo,Sodium arsenite,,GSE11056,mouse,GSM279231|GSM279243|GSM279261|GSM279263,GPL1261,443495.0,[O-][As]=O.[Na+],1.0
drug:3356,LUNGS of C57BL/6 males (on AIN-76A Diet) - Added to drinking water -10ppb,GSM279232|GSM279235|GSM279264|GSM279270|GSM279275,cadimo,Sodium arsenite,,GSE11056,mouse,GSM279234|GSM279262|GSM279269|GSM279272,GPL1261,443495.0,[O-][As]=O.[Na+],1.0
drug:3350,HepG2 cells (metabolically competent) - 6 Hours after exposure,GSM149381|GSM149382|GSM149383,cadimo,"2,2',4,4',5,5'-hexachlorobiphenyl   (pcb-153)",,GSE6878,human,GSM149389|GSM149390,GPL570,37034.0,C1=C(C(=CC(=C1Cl)Cl)Cl)C2=CC(=C(C=C2Cl)Cl)Cl,1.0
drug:3351,HepG2 cells (metabolically competent) - 18 Hours after exposure,GSM154182|GSM154183|GSM154184,cadimo,"2,2',4,4',5,5'-hexachlorobiphenyl   (pcb-153)",,GSE6878,human,GSM149391|GSM149392|GSM149393,GPL570,37034.0,C1=C(C(=CC(=C1Cl)Cl)Cl)C2=CC(=C(C=C2Cl)Cl)Cl,1.0
drug:3358,LUNGS of C57BL/6 males (AIN-76A on  Diet) - Injection 1mg/kg,GSM279232|GSM279235|GSM279264|GSM279270|GSM279275,cadimo,Dexamethasone,DB01234,GSE11056,mouse,GSM279233|GSM279236|GSM279239|GSM279247|GSM279252,GPL1261,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:3359,LUNGS of C57BL/6 males (on LRD-5001 Diet) - Added to drinking water - 100ppb,GSM279224|GSM279225|GSM279229|GSM279256,cadimo,Sodium arsenite,,GSE11056,mouse,GSM279227|GSM279254|GSM279257,GPL1261,443495.0,[O-][As]=O.[Na+],1.0
drug:2533,MCF-7/ADR,GSM602658|GSM602659,alanstern,Doxorubicin,DB00997,GSE24460,human,GSM602660|GSM602661,GPL571,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:2532,A549,GSM147889|GSM147890|GSM147891,alanstern,Cisplatin,DB00515,GSE6410,human,GSM147892|GSM147893|GSM147894,GPL201,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:2530,Lung,GSM1230992|GSM1230993,zero323,Mepenzolate,DB04843,GSE50836,mouse,GSM1230988|GSM1230989,GPL6246,4057.0,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C,1.0
drug:2537,ischemic cerebral cortex,GSM120463|GSM120464,alanstern,Estradiol,DB00783,GSE5315,rat,GSM120461|GSM120462,GPL85,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2536,A549,GSM720475|GSM720476,MicrotaskManic,Azacitidine,DB00928,GSE29077,human,GSM720481|GSM720482,GPL571,9444.0,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,1.0
drug:2535,A549,GSM720475|GSM720476,MicrotaskManic,Azacitidine,DB00928,GSE29077,human,GSM720479|GSM720480,GPL571,9444.0,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,1.0
drug:2534,A549,GSM720475|GSM720476,MicrotaskManic,Azacitidine,DB00928,GSE29077,human,GSM720477|GSM720478,GPL571,9444.0,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,1.0
drug:2539,A549,GSM720475|GSM720476,MicrotaskManic,Decitabine,DB01262,GSE29077,human,GSM720485|GSM720486,GPL571,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:3457,heart,GSM378060|GSM378061|GSM378062,MicrotaskManic,Ubiquinol,,GSE15129,mouse,GSM378066|GSM378067|GSM378068,GPL1261,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3623,Uterus - single injection of 400 ug/kg - 24 Hours after treatment,GSM31747|GSM40022|GSM40036,cadimo,Estradiol,DB00783,GSE2195,mouse,GSM31748|GSM40023|GSM40037,GPL81,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3136,LICR HN1 squamous cell carcinoma (HNSCC) cell line - 15nM for 13 hours,GSM1506273|GSM1506274|GSM1506275,cadimo,Cetuximab,DB00002,GSE61495,human,GSM1506270|GSM1506271|GSM1506272,GPL10558,,,1.0
drug:3130,HeLa cell line (treated with casiopeinas II-gly 40&Acirc;&micro;M for 6 hours),GSM1025049|GSM1025050|GSM1025051,cadimo,Casiigly,,GSE41827,human,GSM1025052|GSM1025053|GSM1025054,GPL570,144221079.0,,1.0
drug:3184,Peripheral mononuclear blood cells (NAB+) - 12 months,GSM641342|GSM641346|GSM641350|GSM641354,cadimo,Interferon beta-1b,DB00068,GSE26104,human,GSM641344|GSM641352|GSM641356,GPL570,,,1.0
drug:2669,brainstem,GSM53440|GSM53441|GSM53442|GSM53443|GSM53444|GSM53445|GSM53446,candicek,Levetiracetam,,GSE2880,rat,GSM53426|GSM53427|GSM53428|GSM53429|GSM53430|GSM53431|GSM53432,GPL1355,5284583.0,CCC(C(=O)N)N1CCCC1=O,1.0
drug:2668,"striatum, day 24 withdrawal",GSM751165|GSM751183|GSM751213,candicek,Heroin,DB01452,GSE30305,mouse,GSM751177|GSM751195|GSM751224,GPL6887,5462328.0,CC(=O)OC1C=CC2C3CC4=C5C2(C1OC5=C(C=C4)OC(=O)C)CCN3C,1.0
drug:2661,Ishikawa endometrial cells - 48 Hours 10nM,GSM439995|GSM439996|GSM439997|GSM439998,cadimo,Bisphenol a,,GSE17624,human,GSM440007|GSM440008|GSM440009|GSM440010,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3452,brain,GSM378042|GSM378043|GSM378044,MicrotaskManic,Coenzyme q10,,GSE15129,mouse,GSM378045|GSM378046|GSM378047,GPL1261,5281915.0,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:2713,NA,GSM389536|GSM389537|GSM389538|GSM389539|GSM389540|GSM389541,Axel,Dexamethasone,DB01234,GSE15563,rat,GSM389560|GSM389561|GSM389562|GSM389563|GSM389564|GSM389565,GPL1355,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:2711,NA,GSM4141|GSM4142,Axel,Dexamethasone,DB01234,GSE484,mouse,GSM4139|GSM4140,GPL81,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:2710,NA,GSM95113|GSM95235|GSM95238,Axel,Dexamethasone,DB01234,GSE4165,mouse,GSM95240|GSM95241|GSM95243,GPL339,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:2717,brown norway,GSM92214|GSM92215|GSM92216,Axel,Diethylstilbestrol,DB00255,GSE4028,rat,GSM92217|GSM92218|GSM92219|GSM92220,GPL1355,448537.0,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3530,HepG2 - liver carcinoma cells,GSM159303|GSM159305|GSM159306,cadimo,Cadmium,,GSE6907,human,GSM159316|GSM159318|GSM159319,GPL201,23973.0,[Cd],1.0
drug:3500,MCF7 cells,GSM624008|GSM624009|GSM624010,MicrotaskManic,Resveratrol,DB02709,GSE25412,human,GSM624011|GSM624012|GSM624013,GPL6244,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3035,H295R human adrenal carcinoma cells,GSM399572|GSM399573|GSM399574,AliDot,Torcetrapib,,GSE15918,human,GSM399578|GSM399579|GSM399580,GPL570,159325.0,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,1.0
drug:3503,heart,GSM284972|GSM284973|GSM284974|GSM284975|GSM284976,MicrotaskManic,Resveratrol,DB02709,GSE11291,mouse,GSM284982|GSM284983|GSM284984|GSM284985|GSM284986,GPL1261,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3034,frontal cortex,GSM53468|GSM53469|GSM53470|GSM53471|GSM53472|GSM53473,candicek,Phenytoin,DB00252,GSE2880,rat,GSM53461|GSM53462|GSM53463|GSM53464|GSM53465|GSM53466|GSM53467,GPL1355,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,1.0
drug:3524,Fetal CONDROCYTES treated with pharmacological doses of dexamethasone (DEX) for 24 hours.,GSM185888|GSM185892|GSM185893,cadimo,Dexamethasone,DB01234,GSE7683,mouse,GSM185887|GSM185890|GSM185891,GPL1261,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:3621,Uterus - single injection of 400 ug/kg - 4 Hours after treatment,GSM31741|GSM40018|GSM40032,cadimo,Estradiol,DB00783,GSE2195,mouse,GSM31742|GSM40019|GSM40033,GPL81,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3522,lung,GSM326943|GSM326945|GSM326947|GSM326949|GSM326951,MicrotaskManic,Perfluorooctanoic acid,,GSE13044,mouse,GSM326953|GSM326955|GSM326957|GSM326959|GSM326961,GPL1261,9554.0,C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,1.0
drug:3520,liver,GSM326944|GSM326946|GSM326948|GSM326950|GSM326952,MicrotaskManic,Perfluorooctanoic acid,,GSE13044,mouse,GSM326954|GSM326956|GSM326958|GSM326960|GSM326962,GPL1261,9554.0,C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,1.0
drug:3505,neocortex,GSM285012|GSM285013|GSM285014|GSM285015|GSM285016,MicrotaskManic,Resveratrol,DB02709,GSE11291,mouse,GSM285022|GSM285023|GSM285024|GSM285025|GSM285026,GPL1261,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3039,RT112 cancer cell line (FGFR3 knocked down with shRNA 2-4),GSM1007032|GSM1007033|GSM1007046,cadimo,Doxycycline,DB00254,GSE41035,human,GSM1007035|GSM1007036|GSM1007049,GPL570,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:3038,"hippocampus, male",GSM1085665|GSM1085667|GSM1085669|GSM1085672|GSM1085675|GSM1085676|GSM1085686|GSM1085688|GSM1085690|GSM1085692|GSM1085693|GSM1085702|GSM1085703,candicek,Ethanol,DB00898,GSE44456,human,GSM1085666|GSM1085668|GSM1085670|GSM1085671|GSM1085674|GSM1085678|GSM1085680|GSM1085682|GSM1085683|GSM1085684|GSM1085687|GSM1085691|GSM1085697|GSM1085700,GPL6244,702.0,CCO,1.0
drug:3529,HepG2 - liver carcinoma cells,GSM159303|GSM159305|GSM159306,cadimo,Arsenic,,GSE6907,human,GSM159312|GSM159314|GSM159315,GPL201,5359596.0,[As],1.0
drug:3528,HepG2 - liver carcinoma cells,GSM159303|GSM159305|GSM159306,cadimo,Phenol,DB03255,GSE6907,human,GSM159342|GSM159343|GSM159344,GPL201,996.0,C1=CC=C(C=C1)O,1.0
drug:2709,NA,GSM124988|GSM124989,Axel,Dexamethasone,DB01234,GSE5463,mouse,GSM124990|GSM124991,GPL81,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:3507,mouse embryonic fibroblast cells (MEF cells),GSM817286|GSM817287,MicrotaskManic,Vitamin c,DB00126,GSE32994,mouse,GSM817284|GSM817285,GPL6246,,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O,1.0
drug:3506,Oct4-GiP mouse embryonic stem (ES) cells,GSM1128601|GSM1128602|GSM1128603,MicrotaskManic,Vitamin c,DB00126,GSE46319,mouse,GSM1128604|GSM1128605|GSM1128606,GPL6246,,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O,1.0
drug:3141,ME180 squamous cell carcinoma cell line - 6 hours 10&Icirc;&frac14;M,GSM1315852|GSM1315853|GSM1315854|GSM1315855,cadimo,Tretinoin,DB00755,GSE54464,human,GSM1315864|GSM1315865|GSM1315866|GSM1315867,GPL10558,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3509,mouse embryonic fibroblast cells (MEF cells),GSM817294|GSM817295,MicrotaskManic,Vitamin c,DB00126,GSE32994,mouse,GSM817292|GSM817293,GPL6246,,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O,1.0
drug:3508,mouse embryonic fibroblast cells (MEF cells),GSM817290|GSM817291,MicrotaskManic,Vitamin c,DB00126,GSE32994,mouse,GSM817288|GSM817289,GPL6246,,OC[C@@H]([C@H]1OC(=O)C(=C1O)O)O,1.0
drug:3458,kidney,GSM378069|GSM378070|GSM378071,MicrotaskManic,Coenzyme q10,,GSE15129,mouse,GSM378072|GSM378073|GSM378074,GPL1261,5281915.0,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:2538,A549,GSM720475|GSM720476,MicrotaskManic,Decitabine,DB01262,GSE29077,human,GSM720483|GSM720484,GPL571,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:3479,Skins biopsies from nickel-allergic patients whose skins were exposed to nickel - 7 hours,GSM144434|GSM144437|GSM144441|GSM144444,cadimo,Nickel,,GSE6281,human,GSM144435|GSM144438|GSM144442|GSM144445|GSM144447,GPL570,935.0,[Ni],1.0
drug:3453,brain,GSM378042|GSM378043|GSM378044,MicrotaskManic,Ubiquinol,,GSE15129,mouse,GSM378048|GSM378049|GSM378050,GPL1261,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3320,Liver ( MOLF/EiJ strain) - 24 hours after treatment,GSM597140|GSM597154|GSM597169,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597091|GSM597107|GSM597126,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3451,brain,GSM378033|GSM378034|GSM378035,MicrotaskManic,Ubiquinol,,GSE15129,mouse,GSM378039|GSM378040|GSM378041,GPL1261,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3431,colon (POR null),GSM96787|GSM96788|GSM96789,MicrotaskManic,Quercetin,DB04216,GSE4262,mouse,GSM96790|GSM96791|GSM96792,GPL339,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3430,liver (wild type),GSM96885|GSM96886|GSM96887,MicrotaskManic,Quercetin,DB04216,GSE4262,mouse,GSM96888|GSM96889|GSM96890,GPL339,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3433,jejunum (POR null),GSM96879|GSM96880|GSM96881,MicrotaskManic,Quercetin,DB04216,GSE4262,mouse,GSM96882|GSM96883|GSM96884,GPL339,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3432,ileum (POR null),GSM96867|GSM96868|GSM96869,MicrotaskManic,Quercetin,DB04216,GSE4262,mouse,GSM96870|GSM96871|GSM96872,GPL339,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3435,liver (Western diet),GSM935760|GSM935761|GSM935762|GSM935763|GSM935764|GSM935765,MicrotaskManic,Quercetin,DB04216,GSE38141,mouse,GSM935766|GSM935767|GSM935768|GSM935769|GSM935770|GSM935771,GPL1261,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3434,liver (POR null),GSM96891|GSM96892|GSM96893,MicrotaskManic,Quercetin,DB04216,GSE4262,mouse,GSM96894|GSM96895|GSM96896,GPL339,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3389,Forebrains - Animals treated with 50mg/kg,GSM271362|GSM271365|GSM271367|GSM271369,cadimo,D-serine,,GSE10748,rat,GSM271386|GSM271387|GSM271388|GSM271389,GPL1355,71077.0,C(C(C(=O)O)N)O,1.0
drug:3388,Forebrains - Animals treated with 20mg/kg,GSM271362|GSM271365|GSM271367|GSM271369,cadimo,D-serine,,GSE10748,rat,GSM271382|GSM271383|GSM271384|GSM271385,GPL1355,71077.0,C(C(C(=O)O)N)O,1.0
drug:3387,Forebrains - Animals treated with 5mg/kg,GSM271362|GSM271365|GSM271367|GSM271369,cadimo,D-serine,,GSE10748,rat,GSM271372|GSM271375|GSM271377|GSM271379,GPL1355,71077.0,C(C(C(=O)O)N)O,1.0
drug:3386,RAW 264.7 macrophage cell line - 3.5 mM,GSM387601|GSM387602|GSM387605|GSM387606,cadimo,Hypochlorous acid,,GSE15457,mouse,GSM387750|GSM387751|GSM387752,GPL1261,24341.0,OCl,1.0
drug:3385,RAW 264.7 macrophage cell line - 2.8 mM,GSM387601|GSM387602|GSM387605|GSM387606,cadimo,Hypochlorous acid,,GSE15457,mouse,GSM387713|GSM387714|GSM387716,GPL1261,24341.0,OCl,1.0
drug:3326,Lung (from B6D2F1 females infected with Mycobacterium tuberculosis) - 63 days post infection,GSM1165966|GSM1165967,cadimo,Pyrazinamide,DB00339,GSE48027,mouse,GSM1165970|GSM1165971,GPL6246,1046.0,C1=CN=C(C=N1)C(=O)N,1.0
drug:3383,RAW 264.7 macrophage cell line - 1.4 mM,GSM387601|GSM387602|GSM387605|GSM387606,cadimo,Hypochlorous acid,,GSE15457,mouse,GSM387698|GSM387699|GSM387700,GPL1261,24341.0,OCl,1.0
drug:3382,RAW 264.7 macrophage cell line - 0.7 mM,GSM387601|GSM387602|GSM387605|GSM387606,cadimo,Hypochlorous acid,,GSE15457,mouse,GSM387677|GSM387678|GSM387679,GPL1261,24341.0,OCl,1.0
drug:3381,RAW 264.7 macrophage cell line - 0.35 mM,GSM387601|GSM387602|GSM387605|GSM387606,cadimo,Hypochlorous acid,,GSE15457,mouse,GSM387648|GSM387649|GSM387676,GPL1261,24341.0,OCl,1.0
drug:3579,Testes (prepubertal) - 6 Hours,GSM100963|GSM100964|GSM100965,cadimo,Mehp,,GSE4514,rat,GSM100979|GSM100980|GSM100981,GPL1355,20393.0,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)O,1.0
drug:2526,GIST882 cells,GSM557498|GSM557499|GSM557500,cadimo,Imatinib,DB00619,GSE22433,human,GSM557501|GSM557502|GSM557503,GPL6947,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2527,K562 cells,GSM487691|GSM487692|GSM487693|GSM487694,cadimo,Imatinib,DB00619,GSE19567,human,GSM487687|GSM487688|GSM487689|GSM487690,GPL571,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2520,K562 leukemia cell line (I) - 24 Hours,GSM34039|GSM34040|GSM34041,cadimo,Imatinib,DB00619,GSE1922,human,GSM34042|GSM34043|GSM34044,GPL96,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2521,Chronic myelogenous leukemia CD34+ cells,GSM23406|GSM23407|GSM23408|GSM23409|GSM23410|GSM23411,cadimo,Imatinib,DB00619,GSE1418,human,GSM23412|GSM23414|GSM23415|GSM23416|GSM23418|GSM23420|GSM23421|GSM23423,GPL201,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2522,TAMs (tumor associated macrophages),GSM1250711|GSM1250712,cadimo,Imatinib,DB00619,GSE51698,mouse,GSM1250713|GSM1250714,GPL8321,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:2838,NA,GSM234794|GSM234795|GSM234796|GSM234797,Axel,Valproic acid,DB00313,GSE9247,mouse,GSM234805|GSM234806|GSM234807|GSM234808,GPL1261,3121.0,CCCC(CCC)C(=O)O,1.0
drug:2528,K562 cells,GSM487691|GSM487692|GSM487693|GSM487694,cadimo,Nilotinib,DB04868,GSE19567,human,GSM487683|GSM487684|GSM487685|GSM487686,GPL571,644241.0,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:3655,mIMCD-3 - inner medullary collecting duct cell line,GSM6603|GSM6605|GSM6607,cadimo,Aldosterone,,GSE434,mouse,GSM6604|GSM6606,GPL81,5839.0,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C=O)O,1.0
drug:3149,TYK-nu ovarian carcinoma cell line,GSM1160760|GSM1160761|GSM1160762,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160763|GSM1160764|GSM1160765,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3657,Hypothalamus - 3 Hours,GSM5433|GSM5434,cadimo,Lipopolysaccharide,,GSE367,mouse,GSM5415|GSM5418,GPL81,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:3656,Hypothalamus - 1 Hour,GSM5419|GSM5421,cadimo,Lipopolysaccharide,,GSE367,mouse,GSM5429|GSM5430,GPL81,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:3624,Uterus - single injection of 400 ug/kg - 48 Hours after treatment,GSM31750|GSM40024|GSM40038,cadimo,Estradiol,DB00783,GSE2195,mouse,GSM31751|GSM40025|GSM40039,GPL81,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3627,Pancreatic islets (from BDC2.5/NOD transgenics) - 200 mg/kg - 2 Day after treatment,GSM41439|GSM41440|GSM41441|GSM41442|GSM41443|GSM41444|GSM41445|GSM41446,cadimo,Cyclophosphamide,DB00531,GSE2254,mouse,GSM41451|GSM41452|GSM41453,GPL81,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,1.0
drug:2810,NA,GSM162889|GSM162890,Axel,Rosiglitazone,DB00412,GSE7035,human,GSM162891|GSM162892,GPL96,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:2670,brainstem,GSM53440|GSM53441|GSM53442|GSM53443|GSM53444|GSM53445|GSM53446,candicek,Phenytoin,DB00252,GSE2880,rat,GSM53412|GSM53413|GSM53414|GSM53415|GSM53416|GSM53417|GSM53418,GPL1355,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,1.0
drug:2674,lung,GSM89876|GSM89879|GSM90168,Axel,Alitretinoin,DB00523,GSE3952,rat,GSM89859|GSM89862|GSM89865|GSM89868,GPL85,,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C,1.0
drug:2675,mammary gland,GSM89874|GSM89877|GSM89880|GSM90169,Axel,Alitretinoin,DB00523,GSE3952,rat,GSM89860|GSM89863|GSM89866|GSM89869,GPL85,,C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C,1.0
drug:2677,distal small intestine,GSM42553|GSM42554|GSM42555|GSM42556|GSM42557|GSM42558,Axel,Amoxicillin,DB01060,GSE2354,rat,GSM42534|GSM42535|GSM42536|GSM42537|GSM42539|GSM42540,GPL341,33613.0,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,1.0
drug:3146,OVCA420 ovarian carcinoma cell line,GSM1160742|GSM1160743|GSM1160744,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160745|GSM1160746|GSM1160747,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:2812,NA,GSM257423|GSM257427,Axel,Rosiglitazone,DB00412,GSE10192,mouse,GSM257422|GSM257426,GPL1261,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:2700,wild type,GSM120234|GSM120244|GSM120254|GSM120263|GSM120272,Axel,Dactinomycin,DB00970,GSE5324,mouse,GSM120236|GSM120246|GSM120256|GSM120265|GSM120274,GPL1261,,O=C1N[C@H](C(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)N([C@H](C(=O)O[C@@H]([C@@H]1NC(=O)c1c2nc3c(ccc(c3oc2c(c(=O)c1N)C)C)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C(=O)[C@H]2N(C(=O)[C@H](NC1=O)C(C)C)CCC2)C)C)C(C)C)C,1.0
drug:3115,MH1C1 liver cell line - 310 uM,GSM1240490|GSM1240493|GSM1240496|GSM1240499,cadimo,Cobalt dichloride hexahydrate,,GSE51207,rat,GSM1240492|GSM1240495|GSM1240498|GSM1240501,GPL1355,24643.0,O.O.O.O.O.O.[Cl-].[Cl-].[Co+2],1.0
drug:3526,Ovaries - cultured neonatal ovaries treated with progesterone for 2 days,GSM203966|GSM203967,cadimo,Progesterone,DB00396,GSE8238,rat,GSM203968|GSM203969,GPL1355,5994.0,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,1.0
drug:3660,Skeletal muscle - 45 minutes,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5194|GSM5195|GSM5196,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:2730,NA,GSM289651|GSM289652|GSM289653,Axel,Estradiol,DB00783,GSE11506,human,GSM289654|GSM289655|GSM289656,GPL570,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2474,"lung epithelial A549 cells, 24h treatment",GSM128897|GSM128898|GSM128906|GSM128915,nbongio,Natural alpha interferon,DB05258,GSE5542,human,GSM128894|GSM128903|GSM128907|GSM128912,GPL96,,,1.0
drug:3487,Striatum - C57BL/65 mice - Acute morphine treatment,GSM187974|GSM187975|GSM187976,cadimo,Morphine,DB00295,GSE7762,mouse,GSM187977|GSM187978|GSM187979,GPL1261,5288826.0,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,1.0
drug:3139,ME180 squamous cell carcinoma cell line - 1 hour 10&Icirc;&frac14;M,GSM1315852|GSM1315853|GSM1315854|GSM1315855,cadimo,Tretinoin,DB00755,GSE54464,human,GSM1315856|GSM1315857|GSM1315858|GSM1315859,GPL10558,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:2780,NA,GSM585549|GSM585550|GSM585551,Axel,Menadione,DB00170,GSE23725,mouse,GSM585558|GSM585559|GSM585560,GPL1261,4055.0,CC1=CC(=O)C2=CC=CC=C2C1=O,1.0
drug:3469,cerebellum,GSM1521836|GSM1521837|GSM1521838,MicrotaskManic,Nicotinamide riboside,,GSE62194,mouse,GSM1521839|GSM1521840|GSM1521841|GSM1521842|GSM1521843,GPL6885,439924.0,C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)N,1.0
drug:3134,SC263 squamous cell carcinoma (HNSCC) cell line - 15nM for 13 hours,GSM1506261|GSM1506262|GSM1506263,cadimo,Cetuximab,DB00002,GSE61495,human,GSM1506258|GSM1506259|GSM1506260,GPL10558,,,1.0
drug:3135,LICR HN2 squamous cell carcinoma (HNSCC) cell line - 15nM for 13 hours,GSM1506267|GSM1506268|GSM1506269,cadimo,Cetuximab,DB00002,GSE61495,human,GSM1506264|GSM1506265|GSM1506266,GPL10558,,,1.0
drug:3132,Mc3T3-E1 osteoblast (OB) cell line (50ug of ascorbic acid for 5 days),GSM925429|GSM925430|GSM925431,cadimo,Ascorbic acid,,GSE37676,mouse,GSM925432|GSM925433|GSM925434,GPL1261,54670067.0,C(C(C1C(=C(C(=O)O1)O)O)O)O,1.0
drug:2808,NA,GSM45690|GSM45691|GSM45692|GSM45693,Axel,Rosiglitazone,DB00412,GSE2431,mouse,GSM45714|GSM45715|GSM45716|GSM45717,GPL81,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:2660,Ishikawa endometrial cells - 24 Hours 1pM,GSM439991|GSM439992|GSM439993|GSM439994,cadimo,Bisphenol a,,GSE17624,human,GSM440039|GSM440040|GSM440041|GSM440042,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3635,Bone marrow Sca+ SP hematopoeitic stem cells (HSC) - 1 Day,GSM26734|GSM26735,cadimo,Fluorouracil,DB00544,GSE1559,mouse,GSM26736|GSM26737,GPL81,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:3390,Forebrains - Animals treated with 200mg/kg,GSM271362|GSM271365|GSM271367|GSM271369,cadimo,D-serine,,GSE10748,rat,GSM271390|GSM271391|GSM271392|GSM271393,GPL1355,71077.0,C(C(C(=O)O)N)O,1.0
drug:3391,Forebrains - Animals treated with 500mg/kg,GSM271362|GSM271365|GSM271367|GSM271369,cadimo,D-serine,,GSE10748,rat,GSM271394|GSM271395|GSM271396|GSM271397,GPL1355,71077.0,C(C(C(=O)O)N)O,1.0
drug:3392,LIVERS (animals exposed to low doses from gestational day 15 to post-natal day 20) - 0.002mg/kg,GSM496404|GSM496405|GSM496406|GSM496407|GSM496408|GSM496409,cadimo,Pbde 47,,GSE19868,rat,GSM496410|GSM496411|GSM496412|GSM496413|GSM496414|GSM496415,GPL6101,95170.0,C1=CC(=C(C=C1Br)Br)OC2=C(C=C(C=C2)Br)Br,1.0
drug:3393,LIVERS (animals exposed to low doses from gestational day 15 to post-natal day 20) - 0.2mg/kg,GSM496404|GSM496405|GSM496406|GSM496407|GSM496408|GSM496409,cadimo,Pbde 47,,GSE19868,rat,GSM496416|GSM496417|GSM496418|GSM496419|GSM496420|GSM496421,GPL6101,95170.0,C1=CC(=C(C=C1Br)Br)OC2=C(C=C(C=C2)Br)Br,1.0
drug:3394,Endothelial cells (cultured umbilical vein endothelial cells) - treated with 1 nmol/L estradiol for 24 hours,GSM418126|GSM418127|GSM418128,cadimo,Estradiol,DB00783,GSE16683,human,GSM418129|GSM418130|GSM418131,GPL570,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3395,Kidney (of BALB/c females) - Intravenous - 50mg/kg,GSM189045|GSM189047|GSM189048|GSM189049|GSM189050|GSM189051,cadimo,Vancomycin,DB14969,GSE7793,mouse,GSM189052|GSM189053|GSM189054|GSM189055|GSM189056|GSM189057,GPL1261,,,1.0
drug:3396,Kidney (of BALB/c females) - Intravenous - 200mg/kg,GSM189045|GSM189047|GSM189048|GSM189049|GSM189050|GSM189051,cadimo,Vancomycin,DB14969,GSE7793,mouse,GSM189058|GSM189059|GSM189060|GSM189062|GSM189063|GSM189064,GPL1261,,,1.0
drug:3397,Kidney (of BALB/c females) - Intravenous - 400mg/kg,GSM189045|GSM189047|GSM189048|GSM189049|GSM189050|GSM189051,cadimo,Vancomycin,DB14969,GSE7793,mouse,GSM189065|GSM189066|GSM189068|GSM189069|GSM189070|GSM189071,GPL1261,,,1.0
drug:3398,Kidney (of BALB/c females) - Intraperitoneal - 50mg/kg,GSM189072|GSM189073|GSM189074|GSM189075|GSM189076|GSM189077,cadimo,Vancomycin,DB14969,GSE7793,mouse,GSM189078|GSM189079|GSM189080|GSM189081|GSM189082|GSM189083,GPL1261,,,1.0
drug:3399,Kidney (of BALB/c females) - Intraperitoneal - 200mg/kg,GSM189072|GSM189073|GSM189074|GSM189075|GSM189076|GSM189077,cadimo,Vancomycin,DB14969,GSE7793,mouse,GSM189084|GSM189085|GSM189086|GSM189087|GSM189088|GSM189089,GPL1261,,,1.0
drug:3428,ileum (wild type),GSM96861|GSM96862|GSM96863,MicrotaskManic,Quercetin,DB04216,GSE4262,mouse,GSM96864|GSM96865|GSM96866,GPL339,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3429,jejunum (wild type),GSM96873|GSM96874|GSM96875,MicrotaskManic,Quercetin,DB04216,GSE4262,mouse,GSM96876|GSM96877|GSM96878,GPL339,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3549,Nasal EPITHELIA exposed to 6 ppm - Inhalation - 8 Days,GSM159779|GSM159780|GSM159781|GSM159782|GSM159783,cadimo,Formaldehyde,,GSE7002,rat,GSM159730|GSM159731|GSM159732|GSM159733,GPL1355,712.0,C=O,1.0
drug:3646,Livers ( from inbred Kyotos - fed a diet with 1% orotic acid) - 14 Day,GSM10001|GSM10002,cadimo,Orotic acid,,GSE665,rat,GSM10000|GSM9999,GPL85,967.0,C1=C(NC(=O)NC1=O)C(=O)O,1.0
drug:3640,Bone marrow Sca+ SP hematopoeitic stem cells (HSC) - 30 Day,GSM26734|GSM26735,cadimo,Fluorouracil,DB00544,GSE1559,mouse,GSM26746|GSM26747,GPL81,3385.0,C1=C(C(=O)NC(=O)N1)F,1.0
drug:3641,Livers ( from outbred Wistars - fed a diet with 1% orotic acid) - 1 Day,GSM10009|GSM10010|GSM13064,cadimo,Orotic acid,,GSE665,rat,GSM10003|GSM10004,GPL85,967.0,C1=C(NC(=O)NC1=O)C(=O)O,1.0
drug:2469,"brain, 4 week treatment",GSM149811|GSM149812|GSM149813,candicek,Clozapine,DB00363,GSE6511,mouse,GSM149805|GSM149806|GSM149807,GPL81,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,1.0
drug:2468,Kidney,GSM1239947|GSM1239948|GSM1239949|GSM1239950,nbongio,Monuron,,GSE51163,rat,GSM1239943|GSM1239944|GSM1239945|GSM1239946,GPL1355,8800.0,CN(C)C(=O)NC1=CC=C(C=C1)Cl,1.0
drug:2464,"brain, 12 week treatment",GSM148677|GSM148678|GSM148679|GSM148680|GSM148681|GSM148682|GSM148683|GSM148684|GSM148685|GSM148686,candicek,Clozapine,DB00363,GSE6467,mouse,GSM148657|GSM148658|GSM148659|GSM148660|GSM148661|GSM148662|GSM148663|GSM148664|GSM148665|GSM148666,GPL339,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,1.0
drug:2467,"rat proximal renal tubule cell line (NRK-52E), 72h treatment",GSM1239940|GSM1239941|GSM1239942,nbongio,Monuron,,GSE51163,rat,GSM1239937|GSM1239938|GSM1239939,GPL1355,8800.0,CN(C)C(=O)NC1=CC=C(C=C1)Cl,1.0
drug:2466,"brain, 12 week treatment",GSM148677|GSM148678|GSM148679|GSM148680|GSM148681|GSM148682|GSM148683|GSM148684|GSM148685|GSM148686,candicek,Haloperidol,DB00502,GSE6467,mouse,GSM148667|GSM148668|GSM148669|GSM148670|GSM148671|GSM148672|GSM148673|GSM148674|GSM148675|GSM148676,GPL339,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,1.0
drug:2461,HL60 cells,GSM112915|GSM112916|GSM112918,saulc07,Tretinoin,DB00755,GSE5007,human,GSM112919|GSM112920|GSM112921,GPL96,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:2463,"rat proximal renal tubule cell line (NRK-52E), 6h treatment",GSM1239928|GSM1239929|GSM1239930,nbongio,Monuron,,GSE51163,rat,GSM1239925|GSM1239926|GSM1239927,GPL1355,8800.0,CN(C)C(=O)NC1=CC=C(C=C1)Cl,1.0
drug:2462,liver,GSM154968|GSM154969|GSM154970|GSM154971,candicek,Phenobarbital sodium,,GSE6721,mouse,GSM154964|GSM154965|GSM154966|GSM154967,GPL339,23674889.0,CCC1(C(=O)NC(=NC1=O)[O-])C2=CC=CC=C2.[Na+],1.0
drug:2606,skin lesion,GSM300750|GSM300756|GSM300762|GSM300768|GSM300774|GSM300780|GSM300786|GSM300792|GSM300798|GSM300804|GSM300810|GSM300815|GSM300821|GSM300827|GSM300833,MicrotaskManic,Etanercept,DB00005,GSE11903,human,GSM300751|GSM300757|GSM300763|GSM300769|GSM300775|GSM300781|GSM300787|GSM300793|GSM300799|GSM300805|GSM300811|GSM300816|GSM300822|GSM300828|GSM300834,GPL571,,,1.0
drug:3194,Colon,GSM948585|GSM948586,MicrotaskManic,Azathioprine,DB00993,GSE38713,human,GSM948573|GSM948575|GSM948579|GSM948583|GSM948589|GSM948590|GSM948591|GSM948592,GPL570,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],1.0
drug:3348,HepG2 cells (metabolically competent) - 0.5 Hours after exposure,GSM149381|GSM149382|GSM149383,cadimo,"2,2',4,4',5,5'-hexachlorobiphenyl   (pcb-153)",,GSE6878,human,GSM149384|GSM149385|GSM149386,GPL570,37034.0,C1=C(C(=CC(=C1Cl)Cl)Cl)C2=CC(=C(C=C2Cl)Cl)Cl,1.0
drug:3195,Colon,GSM948585|GSM948586,MicrotaskManic,Mesalazine,DB00244,GSE38713,human,GSM948571|GSM948577|GSM948581|GSM948588,GPL570,4075.0,C1=CC(=C(C=C1N)C(=O)O)O,1.0
drug:3654,Whole brain - 10 exposures,GSM11379|GSM11380|GSM11381|GSM5082|GSM5084|GSM5085|GSM5086|GSM5087|GSM5090|GSM5105|GSM5106|GSM5107,cadimo,Isoflurane,DB00753,GSE6433,rat,GSM5114|GSM5115|GSM5116,GPL85,3763.0,C(C(F)(F)F)(OC(F)F)Cl,1.0
drug:2716,copenhagen,GSM92207|GSM92208|GSM92209,Axel,Diethylstilbestrol,DB00255,GSE4028,rat,GSM92210|GSM92211|GSM92212|GSM92213,GPL1355,448537.0,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3375,A673,GSM159861|GSM159862|GSM159863|GSM159864|GSM159865|GSM159866,AliDot,Cytarabine,DB00987,GSE6930,human,GSM159873|GSM159874|GSM159875,GPL4685,6253.0,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,1.0
drug:2804,NA,GSM99239|GSM99244|GSM99247|GSM99261|GSM99274|GSM99285|GSM99291|GSM99295|GSM99301|GSM99303,Axel,Propofol,DB00818,GSE4386,human,GSM99241|GSM99246|GSM99249|GSM99265|GSM99277|GSM99287|GSM99292|GSM99296|GSM99302|GSM99304,GPL570,4943.0,CC(C)C1=C(C(=CC=C1)C(C)C)O,1.0
drug:3372,A673,GSM159856|GSM159857|GSM159858|GSM159859|GSM159860,AliDot,"Puromycin, 2xec50, 3 d",,GSE6930,human,GSM159914|GSM159915|GSM159916,GPL4685,439530.0,CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)NC(=O)C(CC4=CC=C(C=C4)OC)N)O,1.0
drug:3373,A673,GSM159850|GSM159851|GSM159852|GSM159853|GSM159854|GSM159855,AliDot,Cytarabine,DB00987,GSE6930,human,GSM159867|GSM159868|GSM159869,GPL4685,6253.0,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,1.0
drug:3276,Forebrain astrocytes - 12 Hours,GSM634513|GSM634521|GSM634529|GSM634537,cadimo,Fasudil,,GSE25829,mouse,GSM634514|GSM634522|GSM634530|GSM634538,GPL6885,3547.0,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,1.0
drug:3501,MCF7 cells,GSM624008|GSM624009|GSM624010,MicrotaskManic,Resveratrol,DB02709,GSE25412,human,GSM624014|GSM624015|GSM624016,GPL6244,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:2587,3T3-L1 adipocytes,GSM24459|GSM24460|GSM24461,nbongio,Pioglitazone,DB01132,GSE1458,mouse,GSM24462|GSM24463,GPL81,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,1.0
drug:2584,lapatinib-sensitive ErbB2-positive cells treated with 1 uM lapatinib,GSM940873|GSM940874|GSM940875,cadimo,Lapatinib,DB01259,GSE38376,human,GSM940879|GSM940880|GSM940881,GPL6947,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1.0
drug:2585,lapatinib-resistant ErbB2-positive cells treated with 0.1 uM lapatinib,GSM940882|GSM940883|GSM940884,cadimo,Lapatinib,DB01259,GSE38376,human,GSM940885|GSM940886|GSM940887,GPL6947,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1.0
drug:2815,diabetes,GSM286169|GSM286173|GSM286176|GSM286178|GSM286430,Axel,Rosiglitazone,DB00412,GSE11343,mouse,GSM286437|GSM286438|GSM286591|GSM286592|GSM286593,GPL1261,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:3112,Pituitary gland (postnatal day70 male rats exposed in utero to dioxin at gestational day15),GSM1168486|GSM1168487|GSM1168488,cadimo,"2,3,7,8-tetrachlorodibenzo-p-dioxin",,GSE48100,rat,GSM1168489|GSM1168490|GSM1168491,GPL6101,10852289.0,CC(C)C=CC(=O)ONC(=O)COC1=CC=C(C=C1)[N+](=O)[O-],1.0
drug:2816,NA,GSM99229|GSM99252|GSM99255|GSM99258|GSM99268|GSM99280|GSM99289|GSM99293|GSM99298|GSM99305,Axel,Sevoflurane,DB01236,GSE4386,human,GSM99235|GSM99253|GSM99257|GSM99259|GSM99271|GSM99282|GSM99290|GSM99294|GSM99299|GSM99306,GPL570,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,1.0
drug:2583,lapatinib-sensitive ErbB2-positive cells treated with 0.1 uM lapatinib,GSM940873|GSM940874|GSM940875,cadimo,Lapatinib,DB01259,GSE38376,human,GSM940876|GSM940877|GSM940878,GPL6947,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1.0
drug:2580,BT474 (lapatinib-sensitive) HER2+ breast cancer cells,GSM799168|GSM799169|GSM799170,cadimo,Lapatinib,DB01259,GSE16179,human,GSM799171|GSM799172|GSM799173,GPL570,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1.0
drug:2581,BT474-J4 (acquired lapatinib-resistance) HER2+ breast cancer cells,GSM799174|GSM799175|GSM799176,cadimo,Lapatinib,DB01259,GSE16179,human,GSM799180|GSM799181|GSM799182,GPL570,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1.0
drug:3619,Uterus - - single injection of 400 ug/kg - 1 Hour after treatment,GSM31735|GSM40014|GSM40028,cadimo,Estradiol,DB00783,GSE2195,mouse,GSM31736|GSM40015|GSM40029,GPL81,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3521,liver,GSM326944|GSM326946|GSM326948|GSM326950|GSM326952,MicrotaskManic,Perfluorooctanoic acid,,GSE13044,mouse,GSM326964|GSM326966|GSM326968|GSM326970|GSM326972,GPL1261,9554.0,C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,1.0
drug:3418,Frontal Cerebral Cortex - 10mg/kg,GSM190915|GSM195231|GSM195232|GSM195233|GSM195234|GSM195235|GSM195236|GSM195237|GSM195238|GSM195239|GSM195240|GSM195241,cadimo,Permethrin,DB04930,GSE7955,rat,GSM195254|GSM195255|GSM195256|GSM195257|GSM195258|GSM195259|GSM195260|GSM195261,GPL1355,40326.0,CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,1.0
drug:2796,NA,GSM201542|GSM201543|GSM201544|GSM201545|GSM201829|GSM201830|GSM201831|GSM201832|GSM201833|GSM201834,Axel,Pioglitazone,DB01132,GSE8157,human,GSM201835|GSM201836|GSM201837|GSM201838|GSM201839|GSM201840|GSM201841|GSM201842|GSM201843|GSM201844,GPL570,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,1.0
drug:3119,PC-3 prostate cancer cells,GSM86079|GSM86080|GSM86081|GSM86082,AliDot,Arachidonic acid,,GSE3737,human,GSM86083|GSM86084|GSM86085|GSM86086,GPL96,444899.0,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,1.0
drug:2795,3 months,GSM506974|GSM506975|GSM506976|GSM506977|GSM506978|GSM506979|GSM506980|GSM506981,Axel,Pioglitazone,DB01132,GSE20219,rat,GSM506982|GSM506983|GSM506984|GSM506985|GSM506986|GSM506987|GSM506988|GSM506989,GPL1355,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,1.0
drug:2794,17 months,GSM506990|GSM506991|GSM506992|GSM506993|GSM506994|GSM506995|GSM506996,Axel,Pioglitazone,DB01132,GSE20219,rat,GSM506997|GSM506998|GSM506999|GSM507000|GSM507001|GSM507002,GPL1355,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,1.0
drug:2733,NA,GSM659805|GSM659806,Axel,Estradiol,DB00783,GSE26834,human,GSM659807|GSM659808|GSM659809,GPL571,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3238,paclitaxel-resistant MDA-MB-231 cancer cells,GSM320838|GSM320842|GSM320846|GSM320850,cadimo,Paclitaxel,DB01229,GSE12791,human,GSM320839|GSM320843|GSM320847|GSM320851,GPL96,36314.0,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,1.0
drug:3417,Frontal Cerebral Cortex - 1mg/kg,GSM190915|GSM195231|GSM195232|GSM195233|GSM195234|GSM195235|GSM195236|GSM195237|GSM195238|GSM195239|GSM195240|GSM195241,cadimo,Permethrin,DB04930,GSE7955,rat,GSM195242|GSM195243|GSM195248|GSM195249|GSM195250|GSM195251|GSM195252|GSM195253,GPL1355,40326.0,CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,1.0
drug:3416,Caco-2 colon cancer cells - 10 days after treatment,GSM174949|GSM174950,cadimo,Quercetin,,GSE7259,human,GSM174947|GSM174948,GPL571,5280343.0,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,1.0
drug:3415,Caco-2 colon cancer cells - 5 days after treatment,GSM174945|GSM174946,cadimo,Quercetin,,GSE7259,human,GSM174819|GSM174944,GPL571,5280343.0,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,1.0
drug:3414,Testis - animals treated for 20 Hours,GSM240630|GSM240631|GSM240632,cadimo,Cadmium chloride,,GSE9480,rat,GSM240635|GSM240636,GPL1355,24947.0,Cl[Cd]Cl,1.0
drug:3413,Testis - animals treated for 8 Hours,GSM240630|GSM240631|GSM240632,cadimo,Cadmium chloride,,GSE9480,rat,GSM240633|GSM240634,GPL1355,24947.0,Cl[Cd]Cl,1.0
drug:3412,Embryonic FIBROLAST - Rb null mutant,GSM143373|GSM143374|GSM143375,cadimo,Cisplatin,DB00515,GSE6206,mouse,GSM143376|GSM143377|GSM143378,GPL339,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3411,LNCaP prostate cancer cells - 16 Hours,GSM190812|GSM190815|GSM190818,cadimo,Androstanolone,,GSE7868,human,GSM190814|GSM190817|GSM190820,GPL570,10635.0,CC12CCC(=O)CC1CCC3C2CCC4(C3CCC4O)C,1.0
drug:3410,LNCaP prostate cancer cells - 4 Hours,GSM190812|GSM190815|GSM190818,cadimo,Androstanolone,,GSE7868,human,GSM190813|GSM190816|GSM190819,GPL570,10635.0,CC12CCC(=O)CC1CCC3C2CCC4(C3CCC4O)C,1.0
drug:2676,proximal small intestine,GSM42559|GSM42560|GSM42561|GSM42562|GSM42563|GSM42564,Axel,Amoxicillin,DB01060,GSE2354,rat,GSM42541|GSM42542|GSM42543|GSM42544|GSM42546|GSM42547,GPL341,33613.0,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,1.0
drug:2518,Philadelphia chromosome positive CML CD34+ cells,GSM307000|GSM307012|GSM307013|GSM307018|GSM307020|GSM307023,mmluxy,Imatinib (glivec),,GSE12211,human,GSM307028|GSM307030|GSM307031|GSM307032|GSM307053|GSM307072,GPL571,123596.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,1.0
drug:3093,OE-E6/7 cells,GSM1319897|GSM1319901|GSM1319905,cadimo,Dexamethasone,DB01234,GSE54608,human,GSM1319900|GSM1319904|GSM1319908,GPL10558,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:3091,kidney,GSM172979|GSM172980|GSM172981,justinenoel,Rosiglitazone,,GSE7193,mouse,GSM172982|GSM172983|GSM172984,GPL1355,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,1.0
drug:3090,bronchial biopsies,GSM397588|GSM397589|GSM397590|GSM397591,justinenoel,Fluticasone,,GSE15823,human,GSM397596|GSM397597|GSM397598|GSM397599,GPL8300,5311101.0,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,1.0
drug:3097,breast cancer biopsies,GSM125123|GSM125125|GSM125127|GSM125129|GSM125131|GSM125133|GSM125135|GSM125137|GSM125139|GSM125141|GSM125143|GSM125145|GSM125147|GSM125149|GSM125151|GSM125153|GSM125155|GSM125157|GSM125159|GSM125161|GSM125163|GSM125165|GSM125167|GSM125169|GSM125171|GSM125173|GSM125175|GSM125177|GSM125179|GSM125181|GSM125183|GSM125185|GSM125187|GSM125189|GSM125191|GSM125193|GSM125195|GSM125197|GSM125199|GSM125201|GSM125203|GSM125205|GSM125207|GSM125209|GSM125211|GSM125213|GSM125215|GSM125217|GSM125219|GSM125221|GSM125223|GSM125225|GSM125227|GSM125229|GSM125231|GSM125233|GSM125235|GSM125237,AliDot,Letrozole,DB01006,GSE5462,human,GSM125124|GSM125126|GSM125128|GSM125130|GSM125132|GSM125134|GSM125136|GSM125138|GSM125140|GSM125142|GSM125144|GSM125146|GSM125148|GSM125150|GSM125152|GSM125154|GSM125156|GSM125158|GSM125160|GSM125162|GSM125164|GSM125166|GSM125168|GSM125170|GSM125172|GSM125174|GSM125176|GSM125178|GSM125180|GSM125182|GSM125184|GSM125186|GSM125188|GSM125190|GSM125192|GSM125194|GSM125196|GSM125198|GSM125200|GSM125202|GSM125204|GSM125206|GSM125208|GSM125210|GSM125212|GSM125214|GSM125216|GSM125218|GSM125220|GSM125222|GSM125224|GSM125226|GSM125228|GSM125230|GSM125232|GSM125234|GSM125236|GSM125238,GPL96,3902.0,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,1.0
drug:3096,NCI-H460 human lung large cell carcinoma cell line - 24 Hours,GSM1034084|GSM1034085|GSM1034086,cadimo,Cisplatin,DB00515,GSE42172,human,GSM1034102|GSM1034103|GSM1034104,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3095,NCI-H460 human lung large cell carcinoma cell line - 2 Hours,GSM1034057|GSM1034058|GSM1034059,cadimo,Cisplatin,DB00515,GSE42172,human,GSM1034075|GSM1034076|GSM1034077,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3094,hippocampal CA1 region,GSM923289|GSM923290|GSM923291|GSM923292|GSM923293|GSM923294|GSM923295|GSM923296|GSM923297|GSM923298,justinenoel,Corticosterone,,GSE37618,rat,GSM923299|GSM923300|GSM923301|GSM923302|GSM923303|GSM923304|GSM923305|GSM923306|GSM923307,GPL85,5753.0,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O,1.0
drug:3099,stromal-vascular cells,GSM860622|GSM860623,justinenoel,Rosiglitazone effect on prdm16-deficient inguinal white adipose tissue,,GSE35011,mouse,GSM860626|GSM860627,GPL8321,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,1.0
drug:3098,A549 lung cancer cells,GSM147365|GSM147366|GSM147367,AliDot,Actinomycin d,,GSE6400,human,GSM147099|GSM147363|GSM147364,GPL570,2019.0,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,1.0
drug:3251,SW480 cancer cells,GSM1340521|GSM1340522,Pascal,Mek inhibitor (meki : azd6244),,GSE55624,human,GSM1340535|GSM1340536,GPL570,10127622.0,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,1.0
drug:2514,synovial knee tissue,GSM607508|GSM609031|GSM609033|GSM609035|GSM609037|GSM609386|GSM609388|GSM609390|GSM609392|GSM609394|GSM609396|GSM609398,mmluxy,Rituximab,DB00073,GSE24742,human,GSM607509|GSM609032|GSM609034|GSM609036|GSM609038|GSM609387|GSM609389|GSM609391|GSM609393|GSM609395|GSM609397|GSM609399,GPL570,,,1.0
drug:3259,U937 cell line (monocyte),GSM276209|GSM276217|GSM276225,Pascal,Curcumin,,GSE10896,human,GSM276214|GSM276222|GSM276230,GPL570,969516.0,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,1.0
drug:3258,U937 cell line (monocyte),GSM276209|GSM276217|GSM276225,Pascal,Curcumin,,GSE10896,human,GSM276210|GSM276218|GSM276226,GPL570,969516.0,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,1.0
drug:3420,Frontal Cerebral Cortex - 0.3mg/kg,GSM190915|GSM195231|GSM195232|GSM195233|GSM195234|GSM195235|GSM195236|GSM195237|GSM195238|GSM195239|GSM195240|GSM195241,cadimo,Deltamethrin,,GSE7955,rat,GSM195276|GSM195278|GSM195280|GSM195281|GSM195283|GSM195285|GSM195286|GSM195288,GPL1355,40585.0,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C,1.0
drug:2478,Alveolar Macrophages,GSM219241|GSM219242|GSM219243|GSM219244|GSM219245|GSM219246|GSM219247|GSM219248|GSM219249|GSM219250|GSM219251,timkenny92,Cigarette smoke,,GSE8823,human,GSM219252|GSM219253|GSM219254|GSM219255|GSM219256|GSM219257|GSM219258|GSM219259|GSM219260|GSM219261|GSM219262|GSM219263|GSM219264,GPL570,57288536.0,C1=CC(=CC=C1N)S(=O)(=O)OC2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],1.0
drug:2479,TOV112D,GSM878200|GSM878201|GSM878202,timkenny92,Nsc319726,,GSE35972,human,GSM878203|GSM878204|GSM878205,GPL570,5351307.0,CC(=NNC(=S)N1CCC1)C2=CC=CC=N2,1.0
drug:2477,"lung epithelial A549 cells, 24h treatment",GSM128897|GSM128898|GSM128906|GSM128915,nbongio,Interferon gamma-1b,DB00033,GSE5542,human,GSM128889|GSM128895|GSM128904|GSM128913,GPL96,,,1.0
drug:3423,A673,GSM159856|GSM159857|GSM159858|GSM159859|GSM159860,AliDot,Cytarabine,DB00987,GSE6930,human,GSM159879|GSM159880|GSM159881,GPL4685,6253.0,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,1.0
drug:3496,3T3-L1 progenitor adipocytes,GSM170939|GSM179962|GSM179964,MicrotaskManic,Resveratrol,DB02709,GSE7111,mouse,GSM179965|GSM179966|GSM179968,GPL1261,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:2618,hippocampus,GSM148900|GSM148901,candicek,Fluoxetine,,GSE6476,mouse,GSM148902|GSM148903,GPL1261,62857.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl,1.0
drug:3679,Aorta - 14 Days,GSM447071|GSM447072|GSM447073|GSM447074|GSM447075|GSM447076,cadimo,Angiotensin ii,,GSE17901,mouse,GSM447089|GSM447090|GSM447091|GSM447092|GSM447093,GPL4134,172198.0,CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N,1.0
drug:3678,Aorta - 7 Days,GSM447065|GSM447066|GSM447067|GSM447068|GSM447069|GSM447070,cadimo,Angiotensin ii,,GSE17901,mouse,GSM447082|GSM447083|GSM447084|GSM447085,GPL4134,172198.0,CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N,1.0
drug:3473,PC-3 cells,GSM1286084|GSM1286089,MicrotaskManic,Luteolin,,GSE53180,human,GSM1286086|GSM1286091,GPL4133,5280445.0,C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O,1.0
drug:3673,Skeletal muscle - 72 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5209|GSM5210|GSM5211,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3376,hNHEPS hepatocytes exposed to 10&Icirc;&frac14;M,GSM830925|GSM830926|GSM830927|GSM830928,cadimo,Vx,,GSE33606,human,GSM830936|GSM830937|GSM830938|GSM830939,GPL570,39793.0,CCOP(=O)(C)SCCN(C(C)C)C(C)C,1.0
drug:3671,Skeletal muscle - 30 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5186|GSM5187,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3185,Peripheral mononuclear blood cells (NAB+) - 24 months,GSM641342|GSM641346|GSM641350|GSM641354,cadimo,Interferon beta-1b,DB00068,GSE26104,human,GSM641345|GSM641353|GSM641357,GPL570,,,1.0
drug:2735,NA,GSM21906|GSM21907,Axel,Estradiol,DB00783,GSE1153,human,GSM21908|GSM21909,GPL91,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2732,NA,GSM606107|GSM606108|GSM606109,Axel,Estradiol,DB00783,GSE24592,human,GSM606110|GSM606111|GSM606112,GPL571,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3531,HepG2 - liver carcinoma cells,GSM159303|GSM159305|GSM159306,cadimo,Nickel,,GSE6907,human,GSM159322|GSM159324|GSM159325,GPL201,935.0,[Ni],1.0
drug:3187,Peripheral mononuclear blood cells (NAB-) 12 months,GSM641358|GSM641362|GSM641366|GSM641370,cadimo,Interferon beta-1a,DB00060,GSE26104,human,GSM641364|GSM641368|GSM641372,GPL570,,,1.0
drug:3600,17.5 day fetal hearts - 1.5ug/kg,GSM60894|GSM60895|GSM60896|GSM60897|GSM60902|GSM60903|GSM60906|GSM60907,cadimo,"2,3,7,8-tetrachlorodibenzo-p-dioxin",,GSE2812,mouse,GSM60898|GSM60901|GSM60904|GSM60908,GPL81,10852289.0,CC(C)C=CC(=O)ONC(=O)COC1=CC=C(C=C1)[N+](=O)[O-],1.0
drug:2811,NA,GSM172979|GSM172980|GSM172981|GSM172987|GSM172989|GSM172990,Axel,Rosiglitazone,DB00412,GSE7193,rat,GSM172982|GSM172983|GSM172984|GSM172985|GSM172986|GSM172988,GPL1355,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:3601,17.5 day fetal hearts - 3ug/kg,GSM60894|GSM60895|GSM60896|GSM60897|GSM60902|GSM60903|GSM60906|GSM60907,cadimo,"2,3,7,8-tetrachlorodibenzo-p-dioxin",,GSE2812,mouse,GSM60899|GSM60900|GSM60905|GSM60909,GPL81,10852289.0,CC(C)C=CC(=O)ONC(=O)COC1=CC=C(C=C1)[N+](=O)[O-],1.0
drug:3606,Thymus (of ovariectomized C57BL/6) - 6 Days,GSM63205|GSM63206,cadimo,Genistein,,GSE2889,mouse,GSM63212|GSM63213,GPL339,5280961.0,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,1.0
drug:2851,NA,GSM50717|GSM50721,Axel,Bleomycin,DB00290,GSE2640,mouse,GSM50715|GSM50719,GPL339,5360373.0,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1.0
drug:3533,HepG2 - liver carcinoma cells,GSM159303|GSM159305|GSM159306,cadimo,Mercury,,GSE6907,human,GSM159330|GSM159331|GSM159332,GPL201,23931.0,[Hg],1.0
drug:3170,Primary smooth muscle cells,GSM116104|GSM116105|GSM116106,shvetank,Calcitriol,DB00136,GSE5145,human,GSM116101|GSM116102|GSM116103,GPL570,,O[C@H]1C[C@H](O)C(=C)/C(=C\C=C\2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](CCCC(O)(C)C)C)C)/C1,1.0
drug:3181,CD3+ T cell,GSM349729|GSM349730|GSM349734|GSM349739,cadimo,Nitric oxide,DB00435,GSE13887,human,GSM349725|GSM349731|GSM349736|GSM349740,GPL570,145068.0,[N]=O,1.0
drug:3180,KJD SV40 virus transformed epidermal keratinocyte,GSM1400400|GSM1400401,cadimo,Doxorubicin,DB00997,GSE58074,human,GSM1400412|GSM1400413,GPL10558,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3593,Liver,GSM71311|GSM71368|GSM71369|GSM71370,cadimo,"3h-1,2-dithiole-3-thione",,GSE3173,rat,GSM71371|GSM71372|GSM71373|GSM71374,GPL85,68296.0,C1=CSSC1=S,1.0
drug:3591,Ramos B-cell lymphoma line,GSM64867|GSM64868|GSM64869,cadimo,Motexafin gadolinium,DB05428,GSE2964,human,GSM64876|GSM64877|GSM64878,GPL570,,[O-]C(=O)C.[O-]C(=O)C.OCCCC1=C(C)/C/2=C/N=c/3\cc(OCCOCCOCCOC)c(c\c3=N/C=C/3\N=C(/C=c/4\[n-]/c(=C\C1=N2)/c(CC)c4CC)C(=C3C)CCCO)OCCOCCOCCOC.[Gd+3],1.0
drug:3426,HL-60 cells,GSM405501|GSM405502,MicrotaskManic,"2,3,7,8-tetrachlorodibenzo-p-dioxin (tcdd)",,GSE16160,human,GSM405499|GSM405500,GPL571,15625.0,C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl,1.0
drug:3594,Adult mononuclear cells - 5 ug/ml LPS,GSM70121|GSM70122|GSM70123,cadimo,Lipopolysaccharide,,GSE3140,human,GSM70124|GSM71079|GSM71080,GPL201,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:3595,Neonatal mononuclear cells (from cord blood incubated) - 5 ug/ml LPS,GSM71081|GSM71082|GSM71083,cadimo,Lipopolysaccharide,,GSE3140,human,GSM71084|GSM71085|GSM71086,GPL201,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:3653,Whole brain - 5 exposures,GSM11379|GSM11380|GSM11381|GSM5082|GSM5084|GSM5085|GSM5086|GSM5087|GSM5090|GSM5105|GSM5106|GSM5107,cadimo,Isoflurane,DB00753,GSE6433,rat,GSM5117|GSM5118|GSM5119,GPL85,3763.0,C(C(F)(F)F)(OC(F)F)Cl,1.0
drug:2718,NA,GSM32181|GSM32182|GSM32183,Axel,Diethylstilbestrol,DB00255,GSE1839,mouse,GSM32190|GSM32191|GSM32192,GPL81,448537.0,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3144,HeyC2 ovarian carcinoma cell line,GSM1160730|GSM1160731|GSM1160732,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160733|GSM1160734|GSM1160735,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3400,Kidney (of BALB/c females) - Intraperitoneal - 400mg/kg,GSM189072|GSM189073|GSM189074|GSM189075|GSM189076|GSM189077,cadimo,Vancomycin,DB14969,GSE7793,mouse,GSM189090|GSM189091|GSM189092|GSM189093|GSM189094|GSM189095,GPL1261,,,1.0
drug:2813,NA,GSM860620|GSM860621,Axel,Rosiglitazone,DB00412,GSE35011,mouse,GSM860622|GSM860623,GPL8321,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:3652,Whole brain - 10 exposures,GSM11379|GSM11380|GSM11381|GSM5082|GSM5084|GSM5085|GSM5086|GSM5087|GSM5090|GSM5105|GSM5106|GSM5107,cadimo,Halothane,DB01159,GSE6433,rat,GSM5108|GSM5109|GSM5110,GPL85,3562.0,C(C(F)(F)F)(Cl)Br,1.0
drug:3084,F9 embryonal carcinoma cell line,GSM24053|GSM24054|GSM24055,cadimo,Tretinoin,DB00755,GSE1437,mouse,GSM24143|GSM24144|GSM24145,GPL81,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:3085,F9 embryonal carcinoma cell line,GSM24053|GSM24054|GSM24055,cadimo,Trichostatin a,,GSE1437,mouse,GSM24146|GSM24147|GSM24148,GPL81,444732.0,CC(C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C,1.0
drug:3087,Breast Cancer tumor core biopsies,GSM832390|GSM832392|GSM832394|GSM832396|GSM832398|GSM832400|GSM832402|GSM832404|GSM832406|GSM832408|GSM832410,vcogliani,Anastrozole,DB01217,GSE33658,human,GSM832391|GSM832393|GSM832395|GSM832397|GSM832399|GSM832401|GSM832403|GSM832405|GSM832407|GSM832409|GSM832411,GPL570,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,1.0
drug:3080,RKO colorectal carcinoma cell line (6 Hours after exposure to 20uM),GSM43955|GSM45094|GSM45108,cadimo,4-hydroxynonenal,,GSE2397,human,GSM43957|GSM45098|GSM45110,GPL570,5283344.0,CCCCCC(C=CC=O)O,1.0
drug:3081,RKO colorectal carcinoma cell line (24 Hours after exposure to 20uM),GSM45086|GSM45100|GSM45112,cadimo,4-hydroxynonenal,,GSE2397,human,GSM45088|GSM45104|GSM45114,GPL570,5283344.0,CCCCCC(C=CC=O)O,1.0
drug:3082,RKO colorectal carcinoma cell line (6 Hours after exposure to 60uM),GSM43955|GSM45094|GSM45108,cadimo,4-hydroxynonenal,,GSE2397,human,GSM43958|GSM45099|GSM45111,GPL570,5283344.0,CCCCCC(C=CC=O)O,1.0
drug:3083,RKO colorectal carcinoma cell line (24 Hours after exposure to 60uM),GSM45086|GSM45100|GSM45112,cadimo,4-hydroxynonenal,,GSE2397,human,GSM45090|GSM45106|GSM45115,GPL570,5283344.0,CCCCCC(C=CC=O)O,1.0
drug:3088,DHT-stimulated LNCaP prostate cells,GSM187369|GSM187370|GSM187377|GSM187378|GSM187379,vcogliani,Bicalutamide,DB01128,GSE7708,human,GSM187374|GSM187375|GSM187376,GPL570,2375.0,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,1.0
drug:3089,epithelial ovarian cancer cell line,GSM341224|GSM341225|GSM341226|GSM341230|GSM341231|GSM341232,vcogliani,Carboplatin,DB00958,GSE13525,human,GSM341221|GSM341222|GSM341223|GSM341227|GSM341228|GSM341229,GPL570,38904.0,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],1.0
drug:3242,MCF-7 breast cancer cells,GSM545861|GSM545862|GSM545863|GSM545864,cadimo,Gamma-tocotrienol,,GSE21946,human,GSM545865|GSM545866|GSM545867|GSM545868,GPL571,5282349.0,CC1=C(C=C2CCC(OC2=C1C)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)O,1.0
drug:3240,MCF7 breast cancer cells - 500nM,GSM645710|GSM645711|GSM645718|GSM645719,cadimo,4-hydroxytamoxifen,,GSE26298,human,GSM645714|GSM645715,GPL570,449459.0,CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,1.0
drug:3241,MCF-7 breast cancer cells - 24 Hours,GSM659813|GSM659814|GSM659815,cadimo,Estradiol,DB00783,GSE26834,human,GSM659816|GSM659817|GSM659818,GPL571,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3246,Cell lines U937-ZXD family zinc finger C,GSM1103973|GSM1103977|GSM1103981,justinenoel,Phorbol 12-myristate 13-acetate (pma),,GSE45417,human,GSM1103975|GSM1103979|GSM1103983,GPL570,27924.0,CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C,1.0
drug:3247,SW480 cancer cells,GSM1340521|GSM1340522,Pascal,Nvp-tnks656 (tankyrase inhibitor),,GSE55624,human,GSM1340525|GSM1340526,GPL570,71227201.0,COC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)N(CC3CC3)CC4=NC(=O)C5=C(N4)CCOC5,1.0
drug:3244,human multiple myeloma cell line,GSM1267153|GSM1267154|GSM1267155,justinenoel,Fgfr-specific pd173074 inhibitor,,GSE52452,human,GSM1267156|GSM1267157|GSM1267158,GPL6244,1401.0,CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C,1.0
drug:3248,Islets of Balb/c mice,GSM936823|GSM936824|GSM936825,justinenoel,Streptozocin,DB00428,GSE38215,mouse,GSM936826|GSM936827,GPL1261,29327.0,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,1.0
drug:3249,SW480 cancer cells,GSM1340521|GSM1340522,Pascal,Nvp-tnks656,,GSE55624,human,GSM1340533|GSM1340534,GPL570,27924.0,CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C,1.0
drug:3060,NSCLC adenocarcinoma cell line,GSM162889|GSM162890,cadimo,Carboplatin,DB00958,GSE7035,human,GSM162893|GSM162894,GPL96,38904.0,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],1.0
drug:3061,MCF7/BUS human breast cancer cells - 10 pM,GSM105292|GSM105293|GSM105294|GSM105295|GSM105296,cadimo,Estradiol,DB00783,GSE4668,human,GSM105297|GSM105298|GSM105299|GSM105300|GSM105301,GPL96,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2599,diffuse large B cell lymphoma SKI-DLCL cells,GSM132917|GSM132918|GSM132920,nbongio,Cytarabine,DB00987,GSE5681,human,GSM132949|GSM132950|GSM132953,GPL571,6253.0,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,1.0
drug:2598,diffuse large B cell lymphoma SKI-DLCL cells,GSM132917|GSM132918|GSM132920,nbongio,Aplidin,,GSE5681,human,GSM132941|GSM132944|GSM132947,GPL571,56928089.0,CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O,1.0
drug:3064,lymphoblast,GSM144122|GSM144123|GSM144124|GSM144125|GSM144126|GSM144127|GSM144128|GSM144129|GSM144130,justinenoel,Nicotine,DB00184,GSE6264,human,GSM144131|GSM144132|GSM144133|GSM144134|GSM144135|GSM144136,GPL1426,942.0,CN1CCCC1C2=CN=CC=C2,1.0
drug:3539,Nasal EPITHELIA exposed to 0.7ppm - Inhalation - 8 Days,GSM159779|GSM159780|GSM159781|GSM159782|GSM159783,cadimo,Formaldehyde,,GSE7002,rat,GSM159808|GSM159809|GSM159810|GSM159811,GPL1355,712.0,C=O,1.0
drug:3408,U937 monoctyes exposed to oxidative stress - 18 Hours,GSM276215|GSM276223|GSM276231,cadimo,Curcumin,,GSE10896,human,GSM276216|GSM276224|GSM276232,GPL570,969516.0,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,1.0
drug:3409,Colonic mucosa (animals fed a diet supplemented with quercetin),GSM180920|GSM181037|GSM181038|GSM181039,cadimo,Quercetin,,GSE7479,rat,GSM181040|GSM181041|GSM181042|GSM181043,GPL1355,5280343.0,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,1.0
drug:3666,Skeletal muscle - 6 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5206|GSM5207|GSM5208,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3661,Skeletal muscle - 1 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5180|GSM5181|GSM5182,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:2839,NA,GSM3900|GSM3904|GSM3905,Axel,Vitamin a,DB00162,GSE284,rat,GSM3902|GSM3907,GPL85,,OC/C=C(/C=C/C=C(/C=C/C1=C(C)CCCC1(C)C)\C)\C,1.0
drug:3419,Frontal Cerebral Cortex - 1mg/kg,GSM190915|GSM195231|GSM195232|GSM195233|GSM195234|GSM195235|GSM195236|GSM195237|GSM195238|GSM195239|GSM195240|GSM195241,cadimo,Deltamethrin,,GSE7955,rat,GSM195289|GSM195290|GSM195291|GSM195292|GSM195293|GSM195295|GSM195296|GSM195297,GPL1355,40585.0,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C,1.0
drug:2629,primary human hepatocytes (PHH),GSM231324|GSM231326,AliDot,Trovafloxacin,DB00685,GSE9166,human,GSM231513|GSM231514,GPL96,62959.0,C1C2C(C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,1.0
drug:2628,primary human hepatocytes (PHH),GSM231324|GSM231326,AliDot,Levofloxacin,DB01137,GSE9166,human,GSM231511|GSM231512,GPL96,149096.0,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,1.0
drug:2623,HepG2,GSM231526|GSM231527|GSM231530|GSM231531,AliDot,Trovafloxacin,DB00685,GSE9166,human,GSM231519|GSM231522|GSM231529,GPL96,62959.0,C1C2C(C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,1.0
drug:2622,"striatum, day 15 withdrawal",GSM751170|GSM751205|GSM751229,candicek,Heroin,DB01452,GSE30305,mouse,GSM751164|GSM751199|GSM751217,GPL6887,5462328.0,CC(=O)OC1C=CC2C3CC4=C5C2(C1OC5=C(C=C4)OC(=O)C)CCN3C,1.0
drug:2621,"striatum, day 15 withdrawal",GSM751170|GSM751205|GSM751229,candicek,Methamphetamine,DB01577,GSE30305,mouse,GSM751211|GSM751223|GSM751235,GPL6887,10836.0,CC(CC1=CC=CC=C1)NC,1.0
drug:2627,primary human hepatocytes (PHH),GSM231324|GSM231326,AliDot,Grepafloxacin,,GSE9166,human,GSM231509|GSM231510,GPL96,72474.0,CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F,1.0
drug:2626,primary human hepatocytes (PHH),GSM231324|GSM231326,AliDot,Gatifloxacin,DB01044,GSE9166,human,GSM231505|GSM231507,GPL96,5379.0,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,1.0
drug:2625,primary human hepatocytes (PHH),GSM231324|GSM231326,AliDot,Clinafloxacin,,GSE9166,human,GSM231482|GSM231503,GPL96,60063.0,C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)Cl)N4CCC(C4)N)F)C(=O)O,1.0
drug:2480,C57BL/6J kidneys,GSM1129870|GSM1129872|GSM1129874|GSM1129876|GSM1129878|GSM1129880,timkenny92,Colistin,DB00803,GSE46410,mouse,GSM1129871|GSM1129873|GSM1129875|GSM1129877|GSM1129879|GSM1129881,GPL6887,5311054.0,CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O,1.0
drug:2820,NA,GSM92147|GSM92148,Axel,Tamoxifen,DB00675,GSE4025,human,GSM92152|GSM92153|GSM92154,GPL96,2733526.0,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,1.0
drug:3670,Skeletal muscle - 18 Hour,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5177|GSM5178|GSM5179,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:2829,NA,GSM775293|GSM775297|GSM775301,Axel,Tretinoin,DB00755,GSE31280,mouse,GSM775294|GSM775298|GSM775302,GPL1261,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:2828,NA,GSM594067|GSM594068|GSM594069,Axel,Tretinoin,DB00755,GSE23702,human,GSM594073|GSM594074|GSM594075,GPL6244,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:2476,"lung epithelial A549 cells, 6h treatment",GSM128888|GSM128893|GSM128902|GSM128911,nbongio,Interferon gamma-1b,DB00033,GSE5542,human,GSM128885|GSM128891|GSM128900|GSM128909,GPL96,,,1.0
drug:2685,c57bl6j,GSM4167|GSM4168,Axel,Bleomycin,DB00290,GSE485,mouse,GSM4161|GSM4162,GPL81,5360373.0,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1.0
drug:3312,Liver ( B6C3F1/J strain) - 24 hours after treatment,GSM597080|GSM597098|GSM597117,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597132|GSM597147|GSM597160,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:2657,Ishikawa endometrial cells - 24 Hours 10nM,GSM439991|GSM439992|GSM439993|GSM439994,cadimo,Bisphenol a,,GSE17624,human,GSM440003|GSM440004|GSM440005|GSM440006,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3250,SW480 cancer cells,GSM1340521|GSM1340522,Pascal,Mek inhibitor (meki : azd6244),,GSE55624,human,GSM1340527|GSM1340528,GPL570,10127622.0,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,1.0
drug:2475,lung subsegment,GSM1004101|GSM1004103|GSM1004105|GSM1004107|GSM1004109|GSM1004111|GSM1004113,candicek,Lipopolysaccharide,,GSE40885,human,GSM1004102|GSM1004104|GSM1004106|GSM1004108|GSM1004110|GSM1004112|GSM1004114,GPL570,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:2686,NA,GSM766676|GSM766677|GSM766678,Axel,Bortezomib,DB00188,GSE30931,human,GSM766682|GSM766683|GSM766684,GPL10558,,CC(C[C@@H](B(O)O)NC(=O)[C@@H](NC(=O)c1cnccn1)Cc1ccccc1)C,1.0
drug:3109,Sciatic nerve,GSM718697|GSM718698,cadimo,Acrylamide,,GSE29004,rat,GSM718699|GSM718700,GPL1355,6579.0,C=CC(=O)N,1.0
drug:3255,perpheral sciatic nerve,GSM286431|GSM286432|GSM286433|GSM286434|GSM286436,Pascal,Rosiglitazone,DB00412,GSE11343,mouse,GSM286159|GSM286160|GSM286163|GSM286165,GPL1261,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:3256,dorsal skin,GSM1003251|GSM1003252|GSM1003253,Pascal,Phorbol ester 12-o-tetradecanoylphorbol-13-acetate (tpa),,GSE40849,mouse,GSM1003248|GSM1003249|GSM1003250,GPL6246,27924.0,CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C,1.0
drug:2472,midbrain,GSM1324893|GSM1324894|GSM1324895|GSM1324899|GSM1324900|GSM1324901|GSM1324905|GSM1324906|GSM1324907|GSM1324911|GSM1324912|GSM1324913|GSM1324917|GSM1324918|GSM1324919|GSM1324923|GSM1324924|GSM1324925|GSM1324929|GSM1324930|GSM1324931|GSM1324935|GSM1324936|GSM1324937|GSM1324941|GSM1324942|GSM1324943|GSM1324947|GSM1324948|GSM1324949,candicek,Cocaine,,GSE54839,human,GSM1324896|GSM1324897|GSM1324898|GSM1324902|GSM1324903|GSM1324904|GSM1324908|GSM1324909|GSM1324910|GSM1324914|GSM1324915|GSM1324916|GSM1324920|GSM1324921|GSM1324922|GSM1324926|GSM1324927|GSM1324928|GSM1324932|GSM1324933|GSM1324934|GSM1324938|GSM1324939|GSM1324940|GSM1324944|GSM1324945|GSM1324946|GSM1324950|GSM1324951|GSM1324952,GPL6947,446220.0,CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC,1.0
drug:2473,"lung epithelial A549 cells, 6h treatment",GSM128888|GSM128893|GSM128902|GSM128911,nbongio,Natural alpha interferon,DB05258,GSE5542,human,GSM128884|GSM128890|GSM128899|GSM128908,GPL96,,,1.0
drug:3079,RKO colorectal carcinoma cell line (24 Hours after exposure to 5uM),GSM45086|GSM45100|GSM45112,cadimo,4-hydroxynonenal,,GSE2397,human,GSM45087|GSM45101|GSM45113,GPL570,5283344.0,CCCCCC(C=CC=O)O,1.0
drug:3078,RKO colorectal carcinoma cell line ( 6 Hours after exposure to 5uM),GSM43955|GSM45094|GSM45108,cadimo,4-hydroxynonenal,,GSE2397,human,GSM43956|GSM45097|GSM45109,GPL570,5283344.0,CCCCCC(C=CC=O)O,1.0
drug:3590,Ramos B-cell lymphoma line - 50 uM,GSM64867|GSM64868|GSM64869,cadimo,Zinc acetate,,GSE2964,human,GSM64873|GSM64874|GSM64875,GPL570,11192.0,CC(=O)[O-].CC(=O)[O-].[Zn+2],1.0
drug:3174,OV1002 ovarian cancer cell line - Day 2,GSM1202099|GSM1202102|GSM1202105|GSM1202159|GSM1202160|GSM1202161,cadimo,Carboplatin,DB00958,GSE49577,human,GSM1202143|GSM1202145|GSM1202148|GSM1202149|GSM1202153|GSM1202157|GSM1202162|GSM1202163,GPL10558,38904.0,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],1.0
drug:3176,OV1002 ovarian cancer cell line - Day 1,GSM1202121|GSM1202124|GSM1202128|GSM1202180|GSM1202182|GSM1202185,cadimo,Carboplatin,DB00958,GSE49577,human,GSM1202110|GSM1202114|GSM1202116|GSM1202117|GSM1202164|GSM1202170|GSM1202173,GPL10558,38904.0,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],1.0
drug:2654,Ishikawa endometrial cells - 8 Hours 100 pM,GSM439987|GSM439988|GSM439989|GSM439990,cadimo,Bisphenol a,,GSE17624,human,GSM440011|GSM440012|GSM440013|GSM440014,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3073,psoriatic skin from back,GSM684685|GSM684686|GSM684687,vcogliani,Imiquimod,DB00724,GSE27628,mouse,GSM684682|GSM684683|GSM684684,GPL1261,57469.0,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,1.0
drug:3465,liver,GSM378096|GSM378097|GSM378098,MicrotaskManic,Ubiquinol,,GSE15129,mouse,GSM378102|GSM378103|GSM378104,GPL1261,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:2834,skeletal muscle,GSM533026|GSM533027|GSM533028,Axel,Troglitazone,DB00197,GSE21329,rat,GSM533038|GSM533039|GSM533040,GPL341,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC1(C)CCc2c(O1)c(C)c(c(c2C)O)C,1.0
drug:3644,Livers ( from inbred Kyotos - fed a diet with 1% orotic acid) - 1 Day,GSM10001|GSM10002,cadimo,Orotic acid,,GSE665,rat,GSM9995|GSM9996,GPL85,967.0,C1=C(NC(=O)NC1=O)C(=O)O,1.0
drug:2822,NA,GSM709770|GSM709773|GSM709774|GSM709776,Axel,Tamoxifen,DB00675,GSE28645,human,GSM709764|GSM709766|GSM709768|GSM709777,GPL570,2733526.0,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,1.0
drug:3077,HeLa cells - 6 Hours,GSM50309|GSM50318|GSM50326,cadimo,Doxycycline,DB00254,GSE2624,human,GSM50305|GSM50314|GSM50322|GSM50330,GPL8300,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:2832,adipose tissue,GSM532990|GSM532991|GSM532992,Axel,Troglitazone,DB00197,GSE21329,rat,GSM533002|GSM533003|GSM533004,GPL341,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC1(C)CCc2c(O1)c(C)c(c(c2C)O)C,1.0
drug:3481,Skins biopsies from nickel-allergic patients whose skins were exposed to nickel - 96 hours,GSM144434|GSM144437|GSM144441|GSM144444,cadimo,Nickel,,GSE6281,human,GSM144433|GSM144436|GSM144440|GSM144443|GSM144446|GSM144449,GPL570,935.0,[Ni],1.0
drug:3645,Livers ( from inbred Kyotos - fed a diet with 1% orotic acid) - 3 Day,GSM10001|GSM10002,cadimo,Orotic acid,,GSE665,rat,GSM9997|GSM9998,GPL85,967.0,C1=C(NC(=O)NC1=O)C(=O)O,1.0
drug:3277,Forebrain astrocytes - 24 Hours,GSM634515|GSM634523|GSM634531|GSM634539,cadimo,Fasudil,,GSE25829,mouse,GSM634516|GSM634524|GSM634532|GSM634540,GPL6885,3547.0,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,1.0
drug:3275,Forebrain astrocytes - 6 Hours,GSM634511|GSM634519|GSM634527|GSM634535,cadimo,Fasudil,,GSE25829,mouse,GSM634512|GSM634520|GSM634528|GSM634536,GPL6885,3547.0,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,1.0
drug:3273,HepG2 liver cell line - 24 Hours,GSM158373|GSM158374|GSM158375,cadimo,"3,3',4,4'-tetrachlorobiphenyl",,GSE6878,human,GSM158382|GSM158383|GSM158384,GPL570,36187.0,C1=CC(=C(C=C1C2=CC(=C(C=C2)Cl)Cl)Cl)Cl,1.0
drug:3272,HepG2 liver cell line - 6 Hours,GSM158373|GSM158374|GSM158375,cadimo,"3,3',4,4'-tetrachlorobiphenyl",,GSE6878,human,GSM158379|GSM158380|GSM158381,GPL570,36187.0,C1=CC(=C(C=C1C2=CC(=C(C=C2)Cl)Cl)Cl)Cl,1.0
drug:3271,HepG2 liver cell line - 0.5 Hours,GSM158373|GSM158374|GSM158375,cadimo,"3,3',4,4'-tetrachlorobiphenyl",,GSE6878,human,GSM158376|GSM158377|GSM158378,GPL570,36187.0,C1=CC(=C(C=C1C2=CC(=C(C=C2)Cl)Cl)Cl)Cl,1.0
drug:3270,A673,GSM159861|GSM159862|GSM159863|GSM159864|GSM159865|GSM159866,AliDot,"Puromycin, ec50, 5 d",,GSE6930,human,GSM159908|GSM159909|GSM159910,GPL4685,439530.0,CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)NC(=O)C(CC4=CC=C(C=C4)OC)N)O,1.0
drug:3279,H4-II-E-C3 LIVER-derived cell line - 140 uM,GSM782280|GSM782281|GSM782291|GSM782292|GSM782302|GSM782303|GSM782313|GSM782314,cadimo,Nickel chloride,,GSE31503,rat,GSM782283|GSM782294|GSM782305|GSM782316,GPL1355,24385.0,Cl[Ni]Cl,1.0
drug:3278,H4-II-E-C3 LIVER-derived cell line - 400 uM,GSM782280|GSM782281|GSM782291|GSM782292|GSM782302|GSM782303|GSM782313|GSM782314,cadimo,Nickel chloride,,GSE31503,rat,GSM782284|GSM782295|GSM782306|GSM782317,GPL1355,24385.0,Cl[Ni]Cl,1.0
drug:2586,lapatinib-resistant ErbB2-positive cells treated with 1 uM lapatinib,GSM940882|GSM940883|GSM940884,cadimo,Lapatinib,DB01259,GSE38376,human,GSM940888|GSM940889|GSM940890,GPL6947,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1.0
drug:2582,BT474-J4 (acquired lapatinib-resistance) HER2+ breast cancer cells,GSM799174|GSM799175|GSM799176,cadimo,Foretinib,,GSE16179,human,GSM799177|GSM799178|GSM799179,GPL570,42642645.0,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,1.0
drug:3057,THP-1 acute monocytic leukemia cells,GSM697694|GSM697695,maroulisv,Diclofenac,DB00586,GSE28185,human,GSM697698|GSM697699,GPL571,3033.0,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,1.0
drug:3642,Livers ( from outbred Wistars - fed a diet with 1% orotic acid) - 3 Day,GSM10009|GSM10010|GSM13064,cadimo,Orotic acid,,GSE665,rat,GSM10005|GSM10006,GPL85,967.0,C1=C(NC(=O)NC1=O)C(=O)O,1.0
drug:3052,MCF7 breast adenocarcinoma cells - 12 Hours,GSM212654|GSM212661|GSM297803,cadimo,Argyrin a,,GSE8565,human,GSM297801|GSM297804,GPL570,24978550.0,CCC1C2=NC(=CS2)C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(=C)C(=O)N(CC(=O)N1)C)C)CC3=CNC4=C3C(=CC=C4)OC)CC5=CNC6=CC=CC=C65,1.0
drug:2588,3T3-L1 adipocytes,GSM24459|GSM24460|GSM24461,nbongio,Rosiglitazone,,GSE1458,mouse,GSM24464|GSM24465|GSM24466,GPL81,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,1.0
drug:2589,3T3-L1 adipocytes,GSM24459|GSM24460|GSM24461,nbongio,Troglitazone,,GSE1458,mouse,GSM24467|GSM24468|GSM24469,GPL81,5591.0,CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O,1.0
drug:3486,Peripheral blood-derived MONOCYTES - 24 hours,GSM126988|GSM126993,cadimo,Lipopolysaccharide,,GSE5504,human,GSM127010|GSM127011,GPL570,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:2457,K562 leukemia cell line,GSM34927|GSM34928|GSM34929,saulc07,Imatinib,DB00619,GSE1922,human,GSM34930|GSM34931|GSM34932,GPL96,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:3189,Hematopoietic CD34+ cells,GSM595118|GSM595120|GSM595122|GSM595124,cadimo,"2,3,7,8-tetrachlorodibenzo-p-dioxin",,GSE24193,human,GSM595119|GSM595121|GSM595123|GSM595125,GPL96,10852289.0,CC(C)C=CC(=O)ONC(=O)COC1=CC=C(C=C1)[N+](=O)[O-],1.0
drug:3188,Peripheral mononuclear blood cells (NAB-) 24 months,GSM641358|GSM641362|GSM641366|GSM641370,cadimo,Interferon beta-1a,DB00060,GSE26104,human,GSM641365|GSM641369|GSM641373,GPL570,,,1.0
drug:3186,Peripheral mononuclear blood cells (NAB-) 3 months,GSM641358|GSM641362|GSM641366|GSM641370,cadimo,Interferon beta-1a,DB00060,GSE26104,human,GSM641363|GSM641367|GSM641371,GPL570,,,1.0
drug:2458,Primary Colorectal Adenocarcinoma,GSM283128|GSM283130|GSM283131|GSM283133|GSM283137|GSM283139|GSM283140|GSM283141|GSM283143|GSM283144|GSM283146|GSM283149,saulc07,Celecoxib,DB00482,GSE11237,human,GSM283127|GSM283129|GSM283132|GSM283134|GSM283135|GSM283136|GSM283138|GSM283142|GSM283145|GSM283147|GSM283148,GPL8300,2662.0,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,1.0
drug:2459,T cell lymphoblastic leukemia cell line CEM-c1,GSM136055|GSM136056|GSM136057,saulc07,Sirolimus,DB00877,GSE5824,human,GSM136064|GSM136065|GSM136066,GPL96,,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C,1.0
drug:3182,CD14+ monocytes (from individuals on a diet supplemented with quercetin for 2 weeks),GSM350084|GSM350085|GSM350086,cadimo,Quercetin,,GSE13899,human,GSM350087|GSM350088|GSM350089,GPL570,5280343.0,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,1.0
drug:3502,CD133+ and CD133- cells,GSM609023|GSM609025|GSM609027|GSM609029,MicrotaskManic,Laminin,,GSE24716,human,GSM609024|GSM609026|GSM609028|GSM609030,GPL571,44342165.0,CCC(C)C(C(=O)NCC(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N,1.0
drug:3477,Brains of aged (30-month-old) B6C3F1 animals fed a diet containing alpha-tocopherol,GSM201796|GSM201797|GSM201799|GSM201801|GSM201802,cadimo,Vitamin e,DB00163,GSE8150,mouse,GSM201804|GSM201805|GSM201806|GSM201808|GSM201809,GPL1261,14985.0,CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O,1.0
drug:3471,cerebellum,GSM1521850|GSM1521851|GSM1521852|GSM1521853,MicrotaskManic,Nicotinamide riboside,,GSE62194,mouse,GSM1521854|GSM1521855|GSM1521856|GSM1521857,GPL6885,439924.0,C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)N,1.0
drug:2470,Liver,GSM1239955|GSM1239956|GSM1239957|GSM1239958,nbongio,Monuron,,GSE51163,rat,GSM1239951|GSM1239952|GSM1239953|GSM1239954,GPL1355,8800.0,CN(C)C(=O)NC1=CC=C(C=C1)Cl,1.0
drug:2471,"brain, 4 week treatment",GSM149811|GSM149812|GSM149813,candicek,Haloperidol,DB00502,GSE6511,mouse,GSM149808|GSM149809|GSM149810,GPL81,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,1.0
drug:2638,Hippocampus (of Sprauge-Dawley males) - 6 Hours after exposure,GSM338857|GSM338858|GSM338859,cadimo,Soman,,GSE13428,rat,GSM338871|GSM338872|GSM338873,GPL1355,7305.0,CC(C(C)(C)C)OP(=O)(C)F,1.0
drug:2639,Hippocampus (of Sprauge-Dawley males) - 72 Hours after exposure,GSM338857|GSM338858|GSM338859,cadimo,Soman,,GSE13428,rat,GSM338885|GSM338886|GSM338887|GSM338888,GPL1355,7305.0,CC(C(C)(C)C)OP(=O)(C)F,1.0
drug:2634,Hippocampus (of Sprauge-Dawley males) - 1 Hour after exposure,GSM338857|GSM338858|GSM338859,cadimo,Soman,,GSE13428,rat,GSM338860|GSM338861|GSM338863,GPL1355,7305.0,CC(C(C)(C)C)OP(=O)(C)F,1.0
drug:2635,Hippocampus (of Sprauge-Dawley males) - 24 Hours after exposure,GSM338857|GSM338858|GSM338859,cadimo,Soman,,GSE13428,rat,GSM338878|GSM338879|GSM338881,GPL1355,7305.0,CC(C(C)(C)C)OP(=O)(C)F,1.0
drug:2637,Hippocampus (of Sprauge-Dawley males) - 48 Hours after exposure,GSM338857|GSM338858|GSM338859,cadimo,Soman,,GSE13428,rat,GSM338882|GSM338883|GSM338884,GPL1355,7305.0,CC(C(C)(C)C)OP(=O)(C)F,1.0
drug:2631,primary lung fibroblasts,GSM748875|GSM748880|GSM748887|GSM748892,wangzc,Formoterol,DB00983,GSE30242,human,GSM748876|GSM748877|GSM748888|GSM748889,GPL96,3410.0,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,1.0
drug:2633,Hippocampus (of Sprauge-Dawley males) - 168 Hours after exposure,GSM338857|GSM338858|GSM338859,cadimo,Soman,,GSE13428,rat,GSM338892|GSM338893|GSM338894,GPL1355,7305.0,CC(C(C)(C)C)OP(=O)(C)F,1.0
drug:3558,Lung fibroblasts - 24 Hours,GSM120306|GSM120307|GSM120308,cadimo,Vanadium pentoxide,,GSE5339,human,GSM120336|GSM120337|GSM120338,GPL571,14814.0,O=[V](=O)O[V](=O)=O,1.0
drug:3559,LIVER from Sprague Dawleys,GSM89873|GSM89875|GSM89878|GSM89881,cadimo,Fenretinide,,GSE3952,rat,GSM89841|GSM89843|GSM89846|GSM89870,GPL85,5288209.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,1.0
drug:3555,Lung fibroblasts - 4 Hours,GSM120309|GSM120310|GSM120311,cadimo,Vanadium pentoxide,,GSE5339,human,GSM120339|GSM120340|GSM120341,GPL571,14814.0,O=[V](=O)O[V](=O)=O,1.0
drug:2833,liver,GSM533008|GSM533009|GSM533010,Axel,Troglitazone,DB00197,GSE21329,rat,GSM533020|GSM533021|GSM533022,GPL341,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCC1(C)CCc2c(O1)c(C)c(c(c2C)O)C,1.0
drug:2579,pancreas,GSM845195|GSM845196|GSM845197|GSM845198,vcogliani,Tamoxifen,DB00675,GSE34232,mouse,GSM845203|GSM845204|GSM845205|GSM845206,GPL6246,2733526.0,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,1.0
drug:3551,Nasal EPITHELIA exposed to 15 ppm - Inhalation - 6 Hours,GSM159785|GSM159786|GSM159787|GSM159788|GSM159789|GSM159796|GSM159797|GSM159798,cadimo,Formaldehyde,,GSE7002,rat,GSM159770|GSM159771|GSM159772|GSM159784,GPL1355,712.0,C=O,1.0
drug:3114,MH1C1 liver cell line - 160 uM,GSM1240490|GSM1240493|GSM1240496|GSM1240499,cadimo,Cobalt dichloride hexahydrate,,GSE51207,rat,GSM1240491|GSM1240494|GSM1240497|GSM1240500,GPL1355,24643.0,O.O.O.O.O.O.[Cl-].[Cl-].[Co+2],1.0
drug:3202,AEC (primary airway epithelial cells) -  6 Hours with 4mM,GSM245430|GSM245432|GSM245440|GSM245452,cadimo,Hypochlorous acid,,GSE11630,human,GSM245429|GSM245431|GSM245439|GSM245451,GPL571,24341.0,OCl,1.0
drug:2667,"striatum, day 24 withdrawal",GSM751165|GSM751183|GSM751213,candicek,Methamphetamine,DB01577,GSE30305,mouse,GSM751171|GSM751189|GSM751206,GPL6887,10836.0,CC(CC1=CC=CC=C1)NC,1.0
drug:2465,"rat proximal renal tubule cell line (NRK-52E), 24h treatment",GSM1239934|GSM1239935|GSM1239936,nbongio,Monuron,,GSE51163,rat,GSM1239931|GSM1239932|GSM1239933,GPL1355,8800.0,CN(C)C(=O)NC1=CC=C(C=C1)Cl,1.0
drug:3245,lapatinib sensitive and lapatinib resistant ErbB2-positive breast cancer cells,GSM940876|GSM940877|GSM940878,justinenoel,Lapatinib,DB01259,GSE38376,human,GSM940885|GSM940886|GSM940887,GPL6947,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1.0
drug:3625,Uterus - single injection of 400 ug/kg - 72 Hours after treatment,GSM31753|GSM40026|GSM40040,cadimo,Estradiol,DB00783,GSE2195,mouse,GSM31754|GSM40027|GSM40041,GPL81,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3113,HEK293,GSM28627|GSM28628|GSM28629,AliDot,Neocarzinostatin,,GSE1676,human,GSM28630|GSM28631|GSM28632,GPL201,5282473.0,CC1C(C(C(C(O1)OC2C3CC#CC4C(O4)(C#CC3=CC2OC(=O)C5=C(C=CC6=C(C=C(C=C65)OC)C)O)C7COC(=O)O7)NC)O)O,1.0
drug:3179,SCC25 tongue epidermal keratinocyte,GSM1400402|GSM1400403,cadimo,Doxorubicin,DB00997,GSE58074,human,GSM1400404|GSM1400405,GPL10558,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:2460,F9 teratocarcinoma cells,GSM775291|GSM775295|GSM775299,saulc07,Tretinoin,DB00755,GSE31280,mouse,GSM775292|GSM775296|GSM775300,GPL1261,444795.0,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,1.0
drug:2680,NA,GSM159355|GSM159356|GSM159357|GSM159358,Axel,Bexarotene,DB00307,GSE6914,human,GSM159359|GSM159360|GSM159361|GSM159362,GPL96,82146.0,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,1.0
drug:3268,A673,GSM159850|GSM159851|GSM159852|GSM159853|GSM159854|GSM159855,AliDot,"Puromycin, ec50, 1 d",,GSE6930,human,GSM159902|GSM159903|GSM159904,GPL4685,439530.0,CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)NC(=O)C(CC4=CC=C(C=C4)OC)N)O,1.0
drug:3269,A673,GSM159856|GSM159857|GSM159858|GSM159859|GSM159860,AliDot,"Puromycin, ec50, 3 d",,GSE6930,human,GSM159905|GSM159906|GSM159907,GPL4685,439530.0,CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)NC(=O)C(CC4=CC=C(C=C4)OC)N)O,1.0
drug:3260,A673,GSM159850|GSM159851|GSM159852|GSM159853|GSM159854|GSM159855,AliDot,Doxorubicin,DB00997,GSE6930,human,GSM159885|GSM159886|GSM159887,GPL4685,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3261,A673,GSM159856|GSM159857|GSM159858|GSM159859|GSM159860,AliDot,Doxorubicin,DB00997,GSE6930,human,GSM159888|GSM159889|GSM159890,GPL4685,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3262,A673,GSM159861|GSM159862|GSM159863|GSM159864|GSM159865|GSM159866,AliDot,Doxorubicin,DB00997,GSE6930,human,GSM159891|GSM159892|GSM159893,GPL4685,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3263,A673,GSM159850|GSM159851|GSM159852|GSM159853|GSM159854|GSM159855,AliDot,Doxorubicin,DB00997,GSE6930,human,GSM159894|GSM159895|GSM159896,GPL4685,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3264,A673,GSM159856|GSM159857|GSM159858|GSM159859|GSM159860,AliDot,Doxorubicin,DB00997,GSE6930,human,GSM159897|GSM159898|GSM159899,GPL4685,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3265,A673,GSM159861|GSM159862|GSM159863|GSM159864|GSM159865|GSM159866,AliDot,Doxorubicin,DB00997,GSE6930,human,GSM159900|GSM159901,GPL4685,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3266,RS4.11 leukemia cell line,GSM492838|GSM492846,cadimo,Sb 216763,,GSE19736,human,GSM492847|GSM492848|GSM492849,GPL6244,176158.0,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl,1.0
drug:3267,Stromal-vascular cells (PRDM16-deficient inguinal white adipose tissue),GSM860624|GSM860625,cadimo,Rosiglitazone,DB00412,GSE35011,mouse,GSM860626|GSM860627,GPL8321,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:3040,RT112 cancer cell line (FGFR3 knocked down with shRNA 4-1),GSM1007032|GSM1007033|GSM1007046,cadimo,Doxycycline,DB00254,GSE41035,human,GSM1007038|GSM1007039|GSM1007052,GPL570,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:3041,RT112 cancer cell line (FGFR3 knocked down with shRNA 6-16),GSM1007032|GSM1007033|GSM1007046,cadimo,Doxycycline,DB00254,GSE41035,human,GSM1007041|GSM1007042|GSM1007055,GPL570,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:3042,HepG3 cell line (THRA wild type),GSM721654|GSM721655|GSM721656,cadimo,Triiodothyronine-[13c6] hydrochloride (t3 thyronine),,GSE29159,human,GSM721657|GSM721658|GSM721659,GPL6244,53442265.0,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O.Cl,1.0
drug:3043,HepG3 cell line (THRB wild type),GSM721660|GSM721661|GSM721662,cadimo,Triiodothyronine-[13c6] hydrochloride (t3 thyronine),,GSE29159,human,GSM721663|GSM721664|GSM721665,GPL6244,53442265.0,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O.Cl,1.0
drug:3044,HepG3 cell line (THRA-HCC Mutant al),GSM721666|GSM721667|GSM721668,cadimo,Triiodothyronine-[13c6] hydrochloride (t3 thyronine),,GSE29159,human,GSM721669|GSM721670|GSM721671,GPL6244,53442265.0,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O.Cl,1.0
drug:3045,HepG3 cell line (THRA-RCCC Mutant 6a),GSM721672|GSM721673|GSM721674,cadimo,Triiodothyronine-[13c6] hydrochloride (t3 thyronine),,GSE29159,human,GSM721675|GSM721676|GSM721677,GPL6244,53442265.0,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O.Cl,1.0
drug:3046,HepG3 cell line (THRB- HCC mutant bN),GSM721678|GSM721679|GSM721680,cadimo,Triiodothyronine-[13c6] hydrochloride (t3 thyronine),,GSE29159,human,GSM721681|GSM721682|GSM721683,GPL6244,53442265.0,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O.Cl,1.0
drug:3047,HepG3 cell line (THRB-RCCC Mutant 15b),GSM721684|GSM721685|GSM721686,cadimo,Triiodothyronine-[13c6] hydrochloride (t3 thyronine),,GSE29159,human,GSM721687|GSM721688|GSM721689,GPL6244,53442265.0,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O.Cl,1.0
drug:3048,LNCaP prostate cancer cells,GSM560828|GSM560829|GSM560830,cadimo,R1881,,GSE22606,human,GSM560831|GSM560832|GSM560833,GPL570,13766.0,CC1(CCC2C1(C=CC3=C4CCC(=O)C=C4CCC23)C)O,1.0
drug:3049,SRF Silenced cells,GSM560834|GSM560835|GSM560836,cadimo,R1881,,GSE22606,human,GSM560837|GSM560838|GSM560839,GPL570,13766.0,CC1(CCC2C1(C=CC3=C4CCC(=O)C=C4CCC23)C)O,1.0
drug:3518,lung,GSM326973|GSM326975|GSM326977|GSM326979|GSM326981,MicrotaskManic,Perfluorooctanoic acid,,GSE13044,mouse,GSM326984|GSM326986|GSM326988|GSM326990,GPL1261,9554.0,C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,1.0
drug:3519,lung,GSM326973|GSM326975|GSM326977|GSM326979|GSM326981,MicrotaskManic,Perfluorooctanoic acid,,GSE13044,mouse,GSM326992|GSM326994|GSM326996|GSM326998|GSM327000,GPL1261,9554.0,C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,1.0
drug:3196,Peripheral blood monocytes,GSM287667|GSM287668|GSM287669,cadimo,Atorvastatin,DB01076,GSE11393,human,GSM287670|GSM287671|GSM287672,GPL571,,OC(CC(CC(=O)[O-])O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1,1.0
drug:3197,AEC (primary airway epithelial cells) - 2 Hours with 0.4mM,GSM245436|GSM245444|GSM245448|GSM245456,cadimo,Hypochlorous acid,,GSE11630,human,GSM245433|GSM245441|GSM245445|GSM245453,GPL571,24341.0,OCl,1.0
drug:3192,H720 cell line(lung cancer),GSM71936|GSM71937|GSM71938,Juliana,Mk-886,,GSE3202,human,GSM71939|GSM71940|GSM71941,GPL570,3651377.0,CC(C)C1=CC2=C(C=C1)N(C(=C2SC(C)(C)C)CC(C)(C)C(=O)O)CC3=CC=C(C=C3)Cl,1.0
drug:3193,A549 cell line (lung cancer),GSM75009|GSM75010|GSM75013|GSM75015,Juliana,Mk-886,,GSE3202,human,GSM75011|GSM75012|GSM75014|GSM75016,GPL570,3651377.0,CC(C)C1=CC2=C(C=C1)N(C(=C2SC(C)(C)C)CC(C)(C)C(=O)O)CC3=CC=C(C=C3)Cl,1.0
drug:3118,Haematopoietic stem cells (male),GSM1274470|GSM1274471|GSM1274472,cadimo,Estradiol,DB00783,GSE52711,mouse,GSM1274473|GSM1274474|GSM1274475,GPL6246,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3468,cerebellum,GSM1521833|GSM1521834|GSM1521835,MicrotaskManic,Nicotinamide riboside,,GSE62194,mouse,GSM1521829|GSM1521830|GSM1521831|GSM1521832,GPL6885,439924.0,C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)N,1.0
drug:3466,cerebellum,GSM1521806|GSM1521807|GSM1521808|GSM1521809|GSM1521810|GSM1521811,MicrotaskManic,Resveratrol,DB02709,GSE62194,mouse,GSM1521800|GSM1521801|GSM1521802|GSM1521803|GSM1521804|GSM1521805,GPL6885,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3467,cerebellum,GSM1521825|GSM1521826|GSM1521827|GSM1521828,MicrotaskManic,Resveratrol,DB02709,GSE62194,mouse,GSM1521820|GSM1521821|GSM1521822|GSM1521823|GSM1521824,GPL6885,,Oc1ccc(cc1)/C=C/c1cc(O)cc(c1)O,1.0
drug:3464,liver,GSM378096|GSM378097|GSM378098,MicrotaskManic,Coenzyme q10,,GSE15129,mouse,GSM378099|GSM378100|GSM378101,GPL1261,5281915.0,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:2515,K562 leukemia cell line (V) - 24 Hours,GSM34921|GSM34922|GSM34923,cadimo,Imatinib,DB00619,GSE1922,human,GSM34924|GSM34925|GSM34926,GPL96,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:3462,liver,GSM378087|GSM378088|GSM378089,MicrotaskManic,Coenzyme q10,,GSE15129,mouse,GSM378090|GSM378091|GSM378092,GPL1261,5281915.0,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3463,liver,GSM378087|GSM378088|GSM378089,MicrotaskManic,Ubiquinol,,GSE15129,mouse,GSM378093|GSM378094|GSM378095,GPL1261,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3460,kidney,GSM378078|GSM378079|GSM378080,MicrotaskManic,Coenzyme q10,,GSE15129,mouse,GSM378081|GSM378082|GSM378083,GPL1261,5281915.0,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3461,kidney,GSM378078|GSM378079|GSM378080,MicrotaskManic,Ubiquinol,,GSE15129,mouse,GSM378084|GSM378085|GSM378086,GPL1261,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:2488,glucocorticoid (GC)-resistant lymphoblastic leukemia CEM-C7H2 T-ALL cell line,GSM550942|GSM550943|GSM550944|GSM550945|GSM550946|GSM550947,timkenny92,Dexamethasone,DB01234,GSE22152,human,GSM550954|GSM550955|GSM550956|GSM550957|GSM550958|GSM550959,GPL570,5743.0,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,1.0
drug:2482,Liver,GSM929282|GSM929283|GSM929284,timkenny92,Acetaminophen,DB00316,GSE37874,mouse,GSM929285|GSM929286|GSM929287,GPL8321,1983.0,CC(=O)NC1=CC=C(C=C1)O,1.0
drug:3688,Hepatocytes,GSM1681326|GSM1681328|GSM1681330|GSM1681332|GSM1681334|GSM1681336|GSM1681338|GSM1681340|GSM1681342|GSM1681344|GSM1681346|GSM1681348,cadimo,1-[3-(trifluoromethyl)phenyl]piperazine,,GSE68785,rat,GSM1681331|GSM1681333|GSM1681335,GPL1355,4296.0,C1CN(CCN1)C2=CC=CC(=C2)C(F)(F)F,1.0
drug:3689,Hepatocytes,GSM1681326|GSM1681328|GSM1681330|GSM1681332|GSM1681334|GSM1681336|GSM1681338|GSM1681340|GSM1681342|GSM1681344|GSM1681346|GSM1681348,cadimo,1-(4-methoxyphenyl)piperazine,,GSE68785,rat,GSM1681337|GSM1681339|GSM1681341,GPL1355,269722.0,COC1=CC=C(C=C1)N2CCNCC2,1.0
drug:2608,skin lesion,GSM300750|GSM300756|GSM300762|GSM300768|GSM300774|GSM300780|GSM300786|GSM300792|GSM300798|GSM300804|GSM300815|GSM300821|GSM300827|GSM300833,MicrotaskManic,Etanercept,DB00005,GSE11903,human,GSM300753|GSM300759|GSM300765|GSM300771|GSM300777|GSM300783|GSM300789|GSM300795|GSM300801|GSM300807|GSM300818|GSM300824|GSM300830|GSM300836,GPL571,,,1.0
drug:3622,Uterus - single injection of 400 ug/kg - 8 Hours after treatment,GSM31744|GSM40020|GSM40034,cadimo,Estradiol,DB00783,GSE2195,mouse,GSM31745|GSM40021|GSM40035,GPL81,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2751,normal scar,GSM194118|GSM194119|GSM194120|GSM194121|GSM194122,Axel,Hydrocortisone,DB00741,GSE7890,human,GSM194114|GSM194115|GSM194116|GSM194117,GPL570,5754.0,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,1.0
drug:3436,liver,GSM935660|GSM935661|GSM935662|GSM935663|GSM935664|GSM935665,MicrotaskManic,Quercetin,DB04216,GSE38136,mouse,GSM935666|GSM935667|GSM935668|GSM935669|GSM935670|GSM935671,GPL1261,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3438,liver,GSM935660|GSM935661|GSM935662|GSM935663|GSM935664|GSM935665,MicrotaskManic,Quercetin,DB04216,GSE38136,mouse,GSM935678|GSM935679|GSM935680|GSM935681|GSM935682|GSM935683,GPL1261,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3384,RAW 264.7 macrophage cell line - 2.1 mM,GSM387601|GSM387602|GSM387605|GSM387606,cadimo,Hypochlorous acid,,GSE15457,mouse,GSM387701|GSM387702|GSM387703,GPL1261,24341.0,OCl,1.0
drug:3104,LUNG (wild type),GSM1068446|GSM1068447|GSM1068448,cadimo,Bleomycin,DB00290,GSE43695,mouse,GSM1068449|GSM1068450|GSM1068451,GPL6246,5360373.0,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1.0
drug:3659,Skeletal muscle - 30 minutes,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5188|GSM5189|GSM5190,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3107,lung alveolar type 2 cells (Sprague-Dawley males following 6 weeks of chronic ingestion of alcohol),GSM1332324|GSM1332325|GSM1332326|GSM1332327,cadimo,Ethanol,DB00898,GSE55243,rat,GSM1332328|GSM1332329|GSM1332330,GPL85,702.0,CCO,1.0
drug:3658,Skeletal muscle - 15 minutes,GSM5047|GSM5048|GSM5049|GSM5071,cadimo,Methylprednisolone,DB00959,GSE490,rat,GSM5075|GSM5076|GSM5077,GPL85,6741.0,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,1.0
drug:3106,Lung (Fra-1 deficient mutants),GSM1068452|GSM1068453|GSM1068454,cadimo,Bleomycin,DB00290,GSE43695,mouse,GSM1068455|GSM1068456|GSM1068457,GPL6246,5360373.0,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1.0
drug:3687,Hepatocytes,GSM1681326|GSM1681328|GSM1681330|GSM1681332|GSM1681334|GSM1681336|GSM1681338|GSM1681340|GSM1681342|GSM1681344|GSM1681346|GSM1681348,cadimo,1-benzylpiperazine,,GSE68785,rat,GSM1681325|GSM1681327|GSM1681329,GPL1355,75994.0,C1CN(CCN1)CC2=CC=CC=C2,1.0
drug:2616,"striatum, day 12 treatment",GSM751180|GSM751210|GSM751234,candicek,Methamphetamine,DB01577,GSE30305,mouse,GSM751168|GSM751186|GSM751216,GPL6887,10836.0,CC(CC1=CC=CC=C1)NC,1.0
drug:3101,A549 lung cancer cells,GSM147365|GSM147366|GSM147367,AliDot,Sapphyrin pci-2050 (1.25 &icirc;&frac14;m),,GSE6400,human,GSM147368|GSM147369|GSM147370,GPL570,9855235.0,CCC1=C(C2=C3C(=C(C(=N3)C=C4C(=C(C(=CC5=C(C(=C(N5)C=C6C(=C(C(=CC1=N2)N6)C)CCCOC(=O)N(CCOCCOCCOC)CCOCCOCCOC)CC)CC)N4)CCCOC(=O)N(CCOCCOCCOC)CCOCCOCCOC)C)CC)C)C,1.0
drug:3100,hearts from obese diabetic C57BL/KsJ-db/db mice,GSM904679|GSM904680|GSM904681|GSM904682|GSM904683,justinenoel,Rosiglitazone,,GSE36875,mouse,GSM904684|GSM904685|GSM904686|GSM904687|GSM904688,GPL4134,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,1.0
drug:3611,Lungs - 1 Hour after exposure,GSM49336|GSM49337|GSM49338|GSM49339|GSM49340|GSM49341,cadimo,Phosgene,,GSE2565,mouse,GSM49334|GSM49335|GSM49348|GSM49349|GSM49358|GSM49359,GPL339,6371.0,C(=O)(Cl)Cl,1.0
drug:2614,"striatum, day 6 treatment",GSM751162|GSM751197|GSM751215,candicek,Methamphetamine,DB01577,GSE30305,mouse,GSM751191|GSM751203|GSM751227,GPL6887,10836.0,CC(CC1=CC=CC=C1)NC,1.0
drug:2592,plaque on epidermis,GSM1155752|GSM1155757|GSM1155763|GSM1155769|GSM1155775|GSM1155780,MicrotaskManic,Etanercept,DB00005,GSE47751,human,GSM1155754|GSM1155759|GSM1155765|GSM1155771|GSM1155782,GPL570,,,1.0
drug:2523,Bach2 wildtype pre-B ALL cells,GSM766000|GSM766017|GSM766018,cadimo,Imatinib,DB00619,GSE30883,mouse,GSM766019|GSM766020|GSM766021,GPL6246,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1.0
drug:3103,chondrocytes,GSM107800|GSM107801|GSM107802,AliDot,Decitabine,DB01262,GSE4768,mouse,GSM107803|GSM107804|GSM107805,GPL1261,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:2568,M229_R5 melanoma resistant sub-line,GSM611403|GSM611405,cadimo,Plx4032,DB05238,GSE24862,human,GSM611415|GSM611417,GPL6244,,,1.0
drug:3456,heart,GSM378060|GSM378061|GSM378062,MicrotaskManic,Coenzyme q10,,GSE15129,mouse,GSM378063|GSM378064|GSM378065,GPL1261,5281915.0,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3102,A549 lung cancer cells,GSM147365|GSM147366|GSM147367,AliDot,Sapphyrin pci-2050 (2.5 &icirc;&frac14;m),,GSE6400,human,GSM147520|GSM147521|GSM147522,GPL570,9855235.0,CCC1=C(C2=C3C(=C(C(=N3)C=C4C(=C(C(=CC5=C(C(=C(N5)C=C6C(=C(C(=CC1=N2)N6)C)CCCOC(=O)N(CCOCCOCCOC)CCOCCOCCOC)CC)CC)N4)CCCOC(=O)N(CCOCCOCCOC)CCOCCOCCOC)C)CC)C)C,1.0
drug:2529,CD34+ CML cells,GSM435978|GSM435979|GSM435980,cadimo,Fenretinide,DB05076,GSE17480,human,GSM435981|GSM435982|GSM435983|GSM435984|GSM435985,GPL570,,O=C(Nc1ccc(cc1)O)/C=C(/C=C/C=C(/C=C/C1=C(C)CCCC1(C)C)\C)\C,1.0
drug:2569,M238 melanoma cell line,GSM611406|GSM611408,cadimo,Plx4032,DB05238,GSE24862,human,GSM611418|GSM611420,GPL6244,,,1.0
drug:3051,Adrenocortical carcinoma cell line,GSM213193|GSM213194|GSM213197,cadimo,Pbde 85,,GSE8588,human,GSM213204|GSM213205|GSM213210,GPL570,177368.0,C1=CC(=C(C=C1Br)Br)OC2=C(C(=C(C=C2)Br)Br)Br,1.0
drug:3307,Lymphoblastoid Cell Lines,GSM1277537|GSM1277538,gswaminath,Methylphenidate,DB00422,GSE52889,human,GSM1277539|GSM1277540,GPL570,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,1.0
drug:2722,NA,GSM11708|GSM11735,Axel,Doxorubicin,DB00997,GSE763,human,GSM11732|GSM11844,GPL550,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:2610,skin lesion,GSM300750|GSM300756|GSM300762|GSM300768|GSM300774|GSM300780|GSM300786|GSM300792|GSM300798|GSM300804|GSM300810|GSM300815|GSM300821|GSM300827|GSM300833,MicrotaskManic,Etanercept,DB00005,GSE11903,human,GSM300754|GSM300760|GSM300766|GSM300772|GSM300778|GSM300784|GSM300790|GSM300796|GSM300802|GSM300808|GSM300813|GSM300819|GSM300825|GSM300831|GSM300837,GPL571,,,1.0
drug:3219,AML FAB class M2 - acute myeloid leukemia lymphoblasts,GSM766231|GSM766233|GSM766245,cadimo,Adenosine triphosphate,,GSE30903,human,GSM766232|GSM766234|GSM766246,GPL570,5957.0,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,1.0
drug:3215,Mammary epithelial cells (MCF10A/HER2/FKBP/HA cells),GSM554579|GSM554580|GSM554581,cadimo,Heregulin,,GSE22288,human,GSM554588|GSM554589|GSM554590,GPL6244,56310950.0,CC(CCNS(=O)(=O)C1=CC2=C(C=C1)NC(=O)C(=O)N2)C3=CC=CC=C3,1.0
drug:3214,Colon (DSS - induced colitis),GSM856810|GSM856811|GSM856812,cadimo,L-arginine,,GSE34874,mouse,GSM856816|GSM856817|GSM856818,GPL6246,6322.0,C(CC(C(=O)O)N)CN=C(N)N,1.0
drug:3217,Heart (PKC&Icirc;&para; - Knockout),GSM721519|GSM721520|GSM721521,cadimo,Angiotensin ii,,GSE29145,mouse,GSM721517|GSM721518,GPL1261,172198.0,CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N,1.0
drug:3216,Heart (Wild Type),GSM721525|GSM721526,cadimo,Angiotensin ii,,GSE29145,mouse,GSM721522|GSM721523|GSM721524,GPL1261,172198.0,CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N,1.0
drug:3620,Uterus - single injection of 400 ug/kg - 2 Hours after treatment,GSM31738|GSM40016|GSM40030,cadimo,Estradiol,DB00783,GSE2195,mouse,GSM31739|GSM40017|GSM40031,GPL81,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:2611,"striatum, day 1 treatment",GSM751172|GSM751190|GSM751226,candicek,Heroin,DB01452,GSE30305,mouse,GSM751166|GSM751184|GSM751214,GPL6887,5462328.0,CC(=O)OC1C=CC2C3CC4=C5C2(C1OC5=C(C=C4)OC(=O)C)CCN3C,1.0
drug:3037,"hippocampus, female",GSM1085673|GSM1085679|GSM1085694|GSM1085696|GSM1085699|GSM1085701,candicek,Ethanol,DB00898,GSE44456,human,GSM1085677|GSM1085681|GSM1085685|GSM1085689|GSM1085695|GSM1085698,GPL6244,702.0,CCO,1.0
drug:3036,primary hepatocytes (PHs) and HepG2 liver cells,GSM231329|GSM231331,MicrotaskManic,Trovafloxacin,DB00685,GSE9166,human,GSM231515|GSM231516,GPL96,62959.0,C1C2C(C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,1.0
drug:3031,36M2 epithelial ovarian cancer cells,GSM341225|GSM341231,AliDot,Carboplatin (30 h),,GSE13525,human,GSM341222|GSM341228,GPL570,10339178.0,C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2],1.0
drug:3030,36M2 epithelial ovarian cancer cells,GSM341224|GSM341230,AliDot,Carboplatin (24 h),,GSE13525,human,GSM341221|GSM341227,GPL570,10339178.0,C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2],1.0
drug:3033,hippocampus,GSM53447|GSM53448|GSM53449|GSM53450|GSM53451|GSM53452|GSM53453,candicek,Phenytoin,DB00252,GSE2880,rat,GSM53419|GSM53420|GSM53421|GSM53422|GSM53423|GSM53424|GSM53425,GPL1355,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,1.0
drug:3032,36M2 epithelial ovarian cancer cells,GSM341226|GSM341232,AliDot,Carboplatin (36 h),,GSE13525,human,GSM341223|GSM341229,GPL570,10339178.0,C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2],1.0
drug:3651,Whole brain - 5 exposures,GSM11379|GSM11380|GSM11381|GSM5082|GSM5084|GSM5085|GSM5086|GSM5087|GSM5090|GSM5105|GSM5106|GSM5107,cadimo,Halothane,DB01159,GSE6433,rat,GSM5111|GSM5112|GSM5113,GPL85,3562.0,C(C(F)(F)F)(Cl)Br,1.0
drug:3321,Liver ( NOD/LtJ strain) - 24 hours after treatment,GSM597092|GSM597110|GSM597127,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597108|GSM597141|GSM597170,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3323,Liver ( PDW/PhJ strain) - 24 hours after treatment,GSM597094|GSM597112|GSM597129,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597089|GSM597143|GSM597157,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3322,Liver ( NZW/LacJ strain) - 24 hours after treatment,GSM597109|GSM597142|GSM597156,cadimo,Trichloroethylene,,GSE24278,mouse,GSM597093|GSM597111|GSM597128,GPL7202,6575.0,C(=C(Cl)Cl)Cl,1.0
drug:3325,Lung (from B6D2F1 females infected with Mycobacterium tuberculosis) - 42 days post infection,GSM1165960|GSM1165961|GSM1165962|GSM1165963|GSM1165964|GSM1165965,cadimo,Pyrazinamide,DB00339,GSE48027,mouse,GSM1165968|GSM1165969,GPL6246,1046.0,C1=CN=C(C=N1)C(=O)N,1.0
drug:3455,heart,GSM378051|GSM378052|GSM378053,MicrotaskManic,Ubiquinol,,GSE15129,mouse,GSM378057|GSM378058|GSM378059,GPL1261,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3459,kidney,GSM378069|GSM378070|GSM378071,MicrotaskManic,Ubiquinol,,GSE15129,mouse,GSM378075|GSM378076|GSM378077,GPL1261,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3108,osteoblasts,GSM107797|GSM107798|GSM107799,AliDot,Decitabine,DB01262,GSE4768,mouse,GSM107794|GSM107795|GSM107796,GPL1261,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:2490,MCF-7 breast cancer cells,GSM1115765|GSM1115767|GSM1115769,mmluxy,Laccaic acid,,GSE45804,human,GSM1115766|GSM1115768|GSM1115770,GPL6244,5355255.0,CCC1=C(C2=C(C(=C1C(=O)C)O)C(=O)C3=C(C(=C(C=C3C2=O)O)C(=O)O)C(=O)O)O,1.0
drug:2491,liver tissue,GSM159830|GSM159833|GSM159834|GSM159835,mmluxy,Sunitinib,DB01268,GSE6929,rat,GSM159831|GSM159832|GSM159837|GSM159838,GPL1355,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,1.0
drug:2492,colon epithelium,GSM531768|GSM531769|GSM531770,,Ursodeoxycholic acid,DB01586,GSE21266,mouse,GSM531771|GSM531772|GSM531773,GPL8321,31401.0,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,1.0
drug:2493,RWPE1 cells,GSM400051|GSM400052|GSM400053|GSM400054|GSM400059|GSM400060|GSM400061|GSM400062|GSM400067|GSM400068|GSM400069|GSM400070,mmluxy,"1,25 dihydroxyvitamin d",,GSE15947,human,GSM400055|GSM400056|GSM400057|GSM400058|GSM400063|GSM400064|GSM400065|GSM400066|GSM400071|GSM400072|GSM400073|GSM400074,GPL570,5280453.0,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,1.0
drug:2494,L-540,GSM769260|GSM769261|GSM769262,saulc07,Hodgkin lymphoma,,GSE31059,human,GSM769263|GSM769264|GSM769265,GPL6947,148177.0,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,1.0
drug:2495,BRAFV600E A375 human melanoma cells,GSM1052615|GSM1052616|GSM1052617,mmluxy,Vemurafenib,,GSE42872,human,GSM1052618|GSM1052619|GSM1052620,GPL6244,42611257.0,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,1.0
drug:2497,HepG2,GSM118418|GSM118419|GSM118420|GSM118421,saulc07,Decitabine,DB01262,GSE5230,human,GSM118422|GSM118423|GSM118424|GSM118425,GPL570,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
drug:3143,HeyA8 ovarian carcinoma cell line,GSM1160723|GSM1160724|GSM1160725|GSM1160726|GSM1160727,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160728|GSM1160729,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3145,A2780 ovarian carcinoma cell line,GSM1160736|GSM1160737|GSM1160738,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160739|GSM1160740|GSM1160741,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3147,OVCA429 ovarian carcinoma cell line,GSM1160748|GSM1160749|GSM1160750,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160751|GSM1160752|GSM1160753,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:2727,NA,GSM105292|GSM105293|GSM105294|GSM105295|GSM105296,Axel,Estradiol,DB00783,GSE4668,human,GSM105312|GSM105313|GSM105314|GSM105315|GSM105316,GPL96,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3484,Peripheral blood-derived MONOCYTES - 4 hours,GSM126988|GSM126993,cadimo,Lipopolysaccharide,,GSE5504,human,GSM126996|GSM126997,GPL570,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:3485,Peripheral blood-derived MONOCYTES - 8 hours,GSM126988|GSM126993,cadimo,Lipopolysaccharide,,GSE5504,human,GSM126998|GSM126999,GPL570,11970143.0,CCCCCCCCCCCCCCCC1C(OC(C(C1OC(=O)CC(CCCCCCCCCCC)O)O)COC2C(C(C(C(O2)COC3(CC(C(C(O3)C(CO)O)OC4C(C(C(C(O4)C(CO)O)OP(=O)(O)OP(=O)(O)OCCN)OC5C(C(C(C(O5)C(COC6C(C(C(CO6)(C(CO)O)O)O)O)O)OP(=O)(O)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)C)OC1C(C(C(C(O1)CO)O)OC1C(CC(C(O1)C)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)O)O)O)OC1(CC(C(C(O1)C(CO)O)O)OC1(CC(C(C(O1)C(CO)O)O)O)C(=O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)CP(=O)(O)O,1.0
drug:3223,AGS gastric adenocarcinoma cells,GSM646075|GSM646076,cadimo,Lysophosphatidic acid,,GSE26309,human,GSM646069|GSM646070,GPL571,3988.0,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O,1.0
drug:3626,Pancreatic islets (from BDC2.5/NOD transgenics) - 200 mg/kg -1 Day after treatment,GSM41439|GSM41440|GSM41441|GSM41442|GSM41443|GSM41444|GSM41445|GSM41446,cadimo,Cyclophosphamide,DB00531,GSE2254,mouse,GSM41447|GSM41448|GSM41449|GSM41450,GPL81,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,1.0
drug:2843,skeletal muscle,GSM533026|GSM533027|GSM533028,Axel,Pioglitazone,DB01132,GSE21329,rat,GSM533032|GSM533033|GSM533034,GPL341,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,1.0
drug:3628,Pancreatic islets (from BDC2.5/NOD transgenics) - 200 mg/kg - 3 Day after treatment,GSM41439|GSM41440|GSM41441|GSM41442|GSM41443|GSM41444|GSM41445|GSM41446,cadimo,Cyclophosphamide,DB00531,GSE2254,mouse,GSM41454|GSM41455|GSM41456,GPL81,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,1.0
drug:2842,liver,GSM533008|GSM533009|GSM533010,Axel,Pioglitazone,DB01132,GSE21329,rat,GSM533014|GSM533015|GSM533016,GPL341,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,1.0
drug:2558,COLO829 human melanoma cell line-MITF Knockdown (BRAFV600E mutated),GSM1225717|GSM1225718,cadimo,Plx4032,DB05238,GSE50649,human,GSM1225719|GSM1225720,GPL6244,,,1.0
drug:2666,"striatum, day 18 withdrawal",GSM751188|GSM751200|GSM751218,candicek,Heroin,DB01452,GSE30305,mouse,GSM751182|GSM751212|GSM751236,GPL6887,5462328.0,CC(=O)OC1C=CC2C3CC4=C5C2(C1OC5=C(C=C4)OC(=O)C)CCN3C,1.0
drug:2565,M229 melanoma cell line,GSM611399|GSM611404,cadimo,Plx4032,DB05238,GSE24862,human,GSM611411|GSM611416,GPL6244,,,1.0
drug:3690,Hepatocytes,GSM1681326|GSM1681328|GSM1681330|GSM1681332|GSM1681334|GSM1681336|GSM1681338|GSM1681340|GSM1681342|GSM1681344|GSM1681346|GSM1681348,cadimo,1-piperonylpiperazine,,GSE68785,rat,GSM1681343|GSM1681345|GSM1681347,GPL1355,94426.0,C1CN(CCN1)CC2=CC3=C(C=C2)OCO3,1.0
drug:3693,DRG neurons - 10 &Acirc;&micro;M for 30 min,GSM1442972|GSM1442973|GSM1442974|GSM1442975,cadimo,Capsaicin,,GSE59727,rat,GSM1442976|GSM1442977|GSM1442978|GSM1442979,GPL6101,1548943.0,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,1.0
drug:3274,Forebrain astrocytes - 2 Hours,GSM634509|GSM634517|GSM634525|GSM634533,cadimo,Fasudil,,GSE25829,mouse,GSM634510|GSM634518|GSM634526|GSM634534,GPL6885,3547.0,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,1.0
drug:3171,PC3 prostate cancer cell line,GSM86079|GSM86081,shvetank,Arachidonic acid,DB04557,GSE3737,human,GSM86085|GSM86086,GPL96,,CCCCC/C=C/C/C=C/C/C=C/C/C=C/CCCC(=O)O,1.0
drug:2724,NA,GSM11706|GSM11853,Axel,Doxorubicin,DB00997,GSE763,human,GSM11731|GSM11839,GPL550,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:2559,SW1736  thyroid cancer cell line (vemurafenib-refractory cell line) - 1 Hour,GSM919379|GSM919380|GSM919381,cadimo,Vemurafenib,DB08881,GSE37441,human,GSM919382|GSM919383|GSM919384,GPL10558,,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F,1.0
drug:3532,HepG2 - liver carcinoma cells,GSM159303|GSM159305|GSM159306,cadimo,Antimony,,GSE6907,human,GSM159327|GSM159328|GSM159329,GPL201,5354495.0,[Sb],1.0
drug:3695,T47D breast cancer cells,GSM1649569|GSM1649573|GSM1649577,cadimo,Telapristone acetate,,GSE67561,human,GSM1649571|GSM1649575|GSM1649579,GPL10558,9806190.0,CC(=O)OC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)C(=O)COC,1.0
drug:3534,HepG2 - liver carcinoma cells,GSM159303|GSM159305|GSM159306,cadimo,Chromium,,GSE6907,human,GSM159333|GSM159334|GSM159335,GPL201,23976.0,[Cr],1.0
drug:3535,Peripheral blood mononuclear cells,GSM185545|GSM185546|GSM185547|GSM185548|GSM185549|GSM185550|GSM185551|GSM185552,cadimo,"1,2,4-benzenetriol",,GSE7664,human,GSM185537|GSM185538|GSM185539|GSM185540|GSM185541|GSM185542|GSM185543|GSM185544,GPL571,10787.0,C1=CC(=C(C=C1O)O)O,1.0
drug:3478,Hearts of 30-month-old B6C3F1 animals fed a diet supplemented with alpha-tocopherol,GSM201741|GSM201753|GSM201767|GSM201768|GSM201770,cadimo,Vitamin e,DB00163,GSE8146,mouse,GSM201772|GSM201773|GSM201775|GSM201777|GSM201778,GPL81,14985.0,CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O,1.0
drug:3536,Nasal EPITHELIA exposed to 0.7ppm - Inhalation - 6 Hours,GSM159785|GSM159786|GSM159787|GSM159788|GSM159789|GSM159796|GSM159797|GSM159798,cadimo,Formaldehyde,,GSE7002,rat,GSM159727|GSM159728|GSM159806|GSM159807,GPL1355,712.0,C=O,1.0
drug:3537,Nasal EPITHELIA exposed to 0.7ppm - Inhalation - 24 Hours,GSM159802|GSM159803|GSM159804|GSM159805,cadimo,Formaldehyde,,GSE7002,rat,GSM159817|GSM159818|GSM159819|GSM159820,GPL1355,712.0,C=O,1.0
drug:3694,T47D breast cancer cells,GSM1649569|GSM1649573|GSM1649577,cadimo,Promegestone,,GSE67561,human,GSM1649570|GSM1649574|GSM1649578,GPL10558,36709.0,CCC(=O)C1(CCC2C1(CCC3=C4CCC(=O)C=C4CCC23)C)C,1.0
drug:2665,"striatum, day 18 withdrawal",GSM751188|GSM751200|GSM751218,candicek,Methamphetamine,DB01577,GSE30305,mouse,GSM751176|GSM751194|GSM751230,GPL6887,10836.0,CC(CC1=CC=CC=C1)NC,1.0
drug:2605,lesioned skin,GSM1021327|GSM1021333|GSM1021339|GSM1021345|GSM1021355|GSM1021360|GSM1021366|GSM1021372,MicrotaskManic,Etanercept,DB00005,GSE41663,human,GSM1021331|GSM1021337|GSM1021343|GSM1021349|GSM1021358|GSM1021364|GSM1021370|GSM1021376,GPL570,,,1.0
drug:3421,Frontal Cerebral Cortex - 3mg/kg,GSM190915|GSM195231|GSM195232|GSM195233|GSM195234|GSM195235|GSM195236|GSM195237|GSM195238|GSM195239|GSM195240|GSM195241,cadimo,Deltamethrin,,GSE7955,rat,GSM195298|GSM195299|GSM195300|GSM195301|GSM195302|GSM195303|GSM195304|GSM195305,GPL1355,40585.0,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C,1.0
drug:2678,colon,GSM42548|GSM42549|GSM42550|GSM42551|GSM42552,Axel,Amoxicillin,DB01060,GSE2354,rat,GSM42527|GSM42528|GSM42529|GSM42530|GSM42532|GSM42533,GPL341,33613.0,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,1.0
drug:3175,OV1002 ovarian cancer cell line - Day 4,GSM1202099|GSM1202102|GSM1202105|GSM1202159|GSM1202160|GSM1202161,cadimo,Carboplatin,DB00958,GSE49577,human,GSM1202119|GSM1202122|GSM1202125|GSM1202127|GSM1202188|GSM1202189|GSM1202197,GPL10558,38904.0,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],1.0
drug:2607,skin lesion,GSM300750|GSM300756|GSM300762|GSM300768|GSM300774|GSM300780|GSM300786|GSM300792|GSM300798|GSM300804|GSM300810|GSM300815|GSM300821|GSM300827|GSM300833,MicrotaskManic,Etanercept,DB00005,GSE11903,human,GSM300752|GSM300758|GSM300764|GSM300770|GSM300776|GSM300782|GSM300788|GSM300794|GSM300800|GSM300806|GSM300812|GSM300817|GSM300823|GSM300829|GSM300835,GPL571,,,1.0
drug:2845,liver,GSM533008|GSM533009|GSM533010,Axel,Rosiglitazone,DB00412,GSE21329,rat,GSM533017|GSM533018|GSM533019,GPL341,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:2486,E&Acirc;&micro;-myc transgenic lymphoma cells deficient in Suv39h1,GSM1083870|GSM1083872|GSM1083874|GSM1083876|GSM1083878,timkenny92,Doxorubicin,DB00997,GSE44355,mouse,GSM1083871|GSM1083873|GSM1083875|GSM1083877|GSM1083879,GPL1261,31703.0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,1.0
drug:3177,OV1002 ovarian cancer cell line - Day 7,GSM1202108|GSM1202111|GSM1202115|GSM1202165|GSM1202166|GSM1202172,cadimo,Carboplatin,DB00958,GSE49577,human,GSM1202131|GSM1202135|GSM1202138|GSM1202140|GSM1202177|GSM1202179|GSM1202183|GSM1202186,GPL10558,38904.0,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],1.0
drug:2792,NA,GSM190915|GSM195231|GSM195232|GSM195233|GSM195234|GSM195235|GSM195236|GSM195237|GSM195238|GSM195239|GSM195240|GSM195241,Axel,Permethrin,DB04930,GSE7955,rat,GSM195263|GSM195264|GSM195265|GSM195266|GSM195267|GSM195269|GSM195270|GSM195272,GPL1355,40326.0,CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,1.0
drug:3178,OV1002 ovarian cancer cell line - Day 14,GSM1202130|GSM1202133|GSM1202136|GSM1202178|GSM1202181|GSM1202184,cadimo,Carboplatin,DB00958,GSE49577,human,GSM1202098|GSM1202101|GSM1202104|GSM1202107|GSM1202167|GSM1202169|GSM1202171|GSM1202174,GPL10558,38904.0,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],1.0
drug:2664,Ishikawa endometrial cells - 48 Hours 1pM,GSM439995|GSM439996|GSM439997|GSM439998,cadimo,Bisphenol a,,GSE17624,human,GSM440043|GSM440044|GSM440045|GSM440046,GPL570,6623.0,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,1.0
drug:3208,Embryoid bodies -  24 Hours,GSM739478|GSM739479|GSM739480,cadimo,Doxycycline,DB00254,GSE29848,mouse,GSM739481|GSM739482|GSM739483,GPL1261,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:3209,Embryoid bodies -  48 Hours,GSM739484|GSM739485|GSM739486,cadimo,Doxycycline,DB00254,GSE29848,mouse,GSM739487|GSM739488|GSM739489,GPL1261,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:3206,Skeletal muscles (of HIV-infected males),GSM113921|GSM115323|GSM115325|GSM115326|GSM115327|GSM115328|GSM115329|GSM115330|GSM115331,cadimo,Testosterone,DB00624,GSE5106,human,GSM115332|GSM115333|GSM115334|GSM115335|GSM115336|GSM115337|GSM115338|GSM115339|GSM115340|GSM115341,GPL571,6013.0,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,1.0
drug:3207,Embryoid bodies -  12 Hours,GSM739472|GSM739473|GSM739474,cadimo,Doxycycline,DB00254,GSE29848,mouse,GSM739475|GSM739476|GSM739477,GPL1261,5281011.0,CC1C2C(C3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,1.0
drug:3204,Endometrium (postmenopausal),GSM312508|GSM312549|GSM312551|GSM312552|GSM312553|GSM312554|GSM312555|GSM312557|GSM312559,cadimo,Tibolone,,GSE12446,human,GSM312675|GSM312676|GSM312677|GSM312678|GSM312679|GSM312680|GSM312681|GSM312682|GSM312683,GPL570,444008.0,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,1.0
drug:3205,Brains of C57Bl/6J animals (fed a creatine supplemented diet for 6 months),GSM115532|GSM115533|GSM115534|GSM115535|GSM115536|GSM115537|GSM115538,cadimo,Creatine,DB00148,GSE5140,mouse,GSM115526|GSM115527|GSM115528|GSM115529|GSM115530|GSM115531,GPL1261,586.0,CN(CC(=O)O)C(=N)N,1.0
drug:2600,granulocyte,GSM1025129|GSM1025130|GSM1025131|GSM1025132|GSM1025133|GSM1025134|GSM1025135|GSM1025136|GSM1025137|GSM1025138|GSM1025139|GSM1025140|GSM1025141,MicrotaskManic,Methotrexate,DB00563,GSE41831,human,GSM1025142|GSM1025143|GSM1025144|GSM1025145|GSM1025146|GSM1025147|GSM1025148|GSM1025149|GSM1025150|GSM1025151,GPL570,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,1.0
drug:3203,Endometrium (postmenopausal),GSM312508|GSM312549|GSM312551|GSM312552|GSM312553|GSM312554|GSM312555|GSM312557|GSM312559,cadimo,Estradiol,DB00783,GSE12446,human,GSM312560|GSM312561|GSM312563|GSM312564|GSM312565|GSM312566|GSM312567,GPL570,5757.0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,1.0
drug:3200,AEC (primary airway epithelial cells) -  6 Hours with 1mM,GSM245430|GSM245432|GSM245440|GSM245452,cadimo,Hypochlorous acid,,GSE11630,human,GSM245428|GSM245438|GSM245450|GSM245458,GPL571,24341.0,OCl,1.0
drug:3201,AEC (primary airway epithelial cells) -  2 Hours with 4mM,GSM245436|GSM245444|GSM245448|GSM245456,cadimo,Hypochlorous acid,,GSE11630,human,GSM245435|GSM245443|GSM245447|GSM245455,GPL571,24341.0,OCl,1.0
drug:2809,NA,GSM132919|GSM132923|GSM132927,Axel,Rosiglitazone,DB00412,GSE5679,human,GSM132921|GSM132924|GSM132928,GPL570,,O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C,1.0
drug:2602,lesioned skin,GSM1021297|GSM1021302|GSM1021307|GSM1021312|GSM1021317|GSM1021322|GSM1021327|GSM1021333|GSM1021339|GSM1021345|GSM1021351|GSM1021355|GSM1021360|GSM1021366|GSM1021372,MicrotaskManic,Etanercept,DB00005,GSE41663,human,GSM1021298|GSM1021303|GSM1021308|GSM1021313|GSM1021318|GSM1021323|GSM1021328|GSM1021334|GSM1021340|GSM1021346|GSM1021352|GSM1021356|GSM1021361|GSM1021367|GSM1021373,GPL570,,,1.0
drug:3444,HepG2 cells,GSM378688|GSM378690|GSM378692|GSM378694,MicrotaskManic,Quercetin,DB04216,GSE15162,human,GSM378689|GSM378691|GSM378693|GSM378695,GPL570,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3445,MCF10A cells,GSM713517|GSM713518|GSM713519|GSM713520,MicrotaskManic,Sulforaphane,,GSE28813,human,GSM713521|GSM713522|GSM713523|GSM713524,GPL4133,5350.0,CS(=O)CCCCN=C=S,1.0
drug:3446,osteoclasts (wild type),GSM1487524|GSM1487525|GSM1487526,MicrotaskManic,Calcitonin,,GSE60761,mouse,GSM1487527|GSM1487528|GSM1487529,GPL1261,16132288.0,CCC(C)C(C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)N)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC4=CN=CN4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CS)N,1.0
drug:3447,osteoclasts (CT-receptor-knockout),GSM1487530|GSM1487531|GSM1487532,MicrotaskManic,Calcitonin,,GSE60761,mouse,GSM1487533|GSM1487534|GSM1487535,GPL1261,16132288.0,CCC(C)C(C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)N)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC4=CN=CN4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CS)N,1.0
drug:3440,liver (treated with streptozotocin),GSM933357|GSM933358|GSM933359|GSM933360|GSM933361|GSM933362,MicrotaskManic,Quercetin,DB04216,GSE38067,mouse,GSM933363|GSM933364|GSM933365|GSM933366|GSM933367|GSM933368,GPL1261,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3441,liver (treated with streptozotocin),GSM933357|GSM933358|GSM933359|GSM933360|GSM933361|GSM933362,MicrotaskManic,Quercetin,DB04216,GSE38067,mouse,GSM933369|GSM933370|GSM933371|GSM933372|GSM933373|GSM933374,GPL1261,,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,1.0
drug:3442,BV-2 microglial cells,GSM579953|GSM579957|GSM579961,MicrotaskManic,Curcumin,,GSE23639,mouse,GSM579954|GSM579958|GSM579962,GPL4134,969516.0,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,1.0
drug:3448,monocyte,GSM533554|GSM533555|GSM533556,MicrotaskManic,Ubiquinol,,GSE21351,human,GSM533557|GSM533558|GSM533559,GPL570,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3449,monocyte,GSM489343|GSM489344|GSM489345,MicrotaskManic,Ubiquinol,,GSE19627,human,GSM489352|GSM489353|GSM489354,GPL570,9962735.0,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,1.0
drug:3152,FU-OV-1 ovarian carcinoma cell line,GSM1160778|GSM1160779|GSM1160780,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160781|GSM1160782|GSM1160783,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3153,A2008 ovarian carcinoma cell line,GSM1160784|GSM1160785|GSM1160786,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160787|GSM1160788|GSM1160789,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3150,CH1 ovarian carcinoma cell line,GSM1160766|GSM1160767|GSM1160768,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160769|GSM1160770|GSM1160771,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3151,OV90 ovarian carcinoma cell line,GSM1160772|GSM1160773|GSM1160774,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160775|GSM1160776|GSM1160777,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3156,OVCAR-10 ovarian carcinoma cell line,GSM1160804|GSM1160805|GSM1160806,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160807|GSM1160808|GSM1160809,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:3154,DOV13 ovarian carcinoma cell line,GSM1160790|GSM1160791|GSM1160792|GSM1160793|GSM1160794,cadimo,Cisplatin,DB00515,GSE47856,human,GSM1160795|GSM1160796|GSM1160797,GPL6244,441203.0,N.N.Cl[Pt+2]Cl,1.0
drug:2551,TK6,GSM509193|GSM509194,alanstern,Arsenic,,GSE20320,human,GSM509191|GSM509192,GPL6244,5359596.0,[As],1.0
drug:2550,TK6,GSM509197|GSM509198,alanstern,Cadmium,,GSE20320,human,GSM509195|GSM509196,GPL6244,23973.0,[Cd],1.0
drug:2553,DBTRG,GSM1062686|GSM1062687,AliDot,Y15,,GSE43452,human,GSM1062688|GSM1062689,GPL10558,23627197.0,CC(COCC1=CC=CC=C1)(C(N)S)NC(=O)C(CC2CCCCC2)NC(=O)N3CCOCC3,1.0
drug:2555,U87,GSM1062690|GSM1062691,AliDot,Temozolomide,DB00853,GSE43452,human,GSM1062692|GSM1062693,GPL10558,5394.0,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,1.0
drug:2554,U87,GSM1062690|GSM1062691,AliDot,Y15,,GSE43452,human,GSM1062694|GSM1062695,GPL10558,23627197.0,CC(COCC1=CC=CC=C1)(C(N)S)NC(=O)C(CC2CCCCC2)NC(=O)N3CCOCC3,1.0
drug:2557,COLO829 human melanoma cell line (BRAFV600E mutated),GSM1225721|GSM1225722,cadimo,Plx4032,DB05238,GSE50649,human,GSM1225723|GSM1225724,GPL6244,,,1.0
drug:2556,WM164 BRAF mutant Melanoma cells,GSM1322672|GSM1322673|GSM1322674,cadimo,Plx4032,DB05238,GSE54711,human,GSM1322675|GSM1322676|GSM1322677,GPL6244,,,1.0
drug:2771,fear,GSM30804|GSM30805|GSM30806|GSM30807|GSM30808,Axel,Isoflurane,DB00753,GSE1779,rat,GSM30809|GSM30810|GSM30811|GSM30812|GSM30813,GPL341,3763.0,C(C(F)(F)F)(OC(F)F)Cl,1.0
drug:2770,control,GSM30790|GSM30791|GSM30792|GSM30793|GSM30794|GSM30795|GSM30796|GSM30797|GSM30798,Axel,Isoflurane,DB00753,GSE1779,rat,GSM99800|GSM99801|GSM99802|GSM99803|GSM99804,GPL341,3763.0,C(C(F)(F)F)(OC(F)F)Cl,1.0
drug:2772,NA,GSM263915|GSM263916|GSM263917,Axel,Isotretinoin,DB00982,GSE10432,human,GSM263918|GSM263919|GSM263920,GPL8300,,C/C(=C\C=C\C(=C/C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C,1.0
drug:2777,frontal cortex,GSM53468|GSM53469|GSM53470|GSM53471|GSM53472|GSM53473,Axel,Levetiracetam,DB01202,GSE2880,rat,GSM53454|GSM53455|GSM53456|GSM53457|GSM53458|GSM53459|GSM53460,GPL1355,441341.0,CCC(C(=O)N)N1CCCC1=O,1.0
drug:3439,liver,GSM933351|GSM933352|GSM933353|GSM933354|GSM933355|GSM933356,MicrotaskManic,Streptozocin,DB00428,GSE38067,mouse,GSM933357|GSM933358|GSM933359|GSM933360|GSM933361|GSM933362,GPL1261,29327.0,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,1.0
drug:2701,tristerapolin-deficient,GSM120229|GSM120239|GSM120249|GSM120259,Axel,Dactinomycin,DB00970,GSE5324,mouse,GSM120231|GSM120241|GSM120251|GSM120269,GPL1261,,O=C1N[C@H](C(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)N([C@H](C(=O)O[C@@H]([C@@H]1NC(=O)c1c2nc3c(ccc(c3oc2c(c(=O)c1N)C)C)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C(=O)[C@H]2N(C(=O)[C@H](NC1=O)C(C)C)CCC2)C)C)C(C)C)C,1.0
drug:2703,melanoma,GSM230901|GSM230903|GSM230905|GSM230907|GSM230909|GSM230911,Axel,Decitabine,DB01262,GSE9118,human,GSM230902|GSM230904|GSM230906|GSM230908|GSM230910|GSM230912,GPL96,451668.0,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,1.0
